STATE OF
MINNESOTA
Journal of the House
NINETY-THIRD
SESSION - 2024
_____________________
ONE
HUNDRED SIXTH DAY
Saint Paul, Minnesota, Friday, April 26, 2024
The House of Representatives convened at
11:00 a.m. and was called to order by Kaohly Vang Her, Speaker pro tempore.
Prayer was offered by Rabbi Tobias Moss,
Temple Israel, Minneapolis, Minnesota.
The members of the House gave the pledge
of allegiance to the flag of the United States of America.
The roll was called and the following
members were present:
Acomb
Agbaje
Altendorf
Anderson, P. E.
Anderson, P. H.
Backer
Bahner
Baker
Becker-Finn
Berg
Bierman
Brand
Burkel
Carroll
Cha
Clardy
Coulter
Curran
Daniels
Davids
Davis
Dotseth
Edelson
Elkins
Engen
Feist
Finke
Fischer
Fogelman
Franson
Frederick
Freiberg
Garofalo
Gomez
Greenman
Hansen, R.
Hanson, J.
Harder
Hassan
Heintzeman
Hemmingsen-Jaeger
Her
Hicks
Hill
Hollins
Hornstein
Howard
Hudella
Huot
Hussein
Jacob
Jordan
Keeler
Kiel
Klevorn
Koegel
Koznick
Kraft
Kresha
Lee, F.
Lee, K.
Liebling
Lillie
Lislegard
Long
McDonald
Moller
Mueller
Murphy
Myers
Nadeau
Nelson, M.
Nelson, N.
Neu Brindley
Newton
Niska
Noor
Norris
Novotny
Olson, B.
Olson, L.
Pelowski
Pérez-Vega
Perryman
Petersburg
Pfarr
Pinto
Pryor
Pursell
Quam
Rarick
Reyer
Robbins
Schomacker
Schultz
Scott
Sencer-Mura
Skraba
Smith
Swedzinski
Tabke
Torkelson
Vang
Virnig
Wiener
Witte
Wolgamott
Xiong
Youakim
Spk. Hortman
A quorum was present.
Bakeberg, Bennett, Bliss, Demuth, Frazier,
Gillman, Grossell, Hudson, Igo, Johnson, Joy, Knudsen, Kotyza‑Witthuhn,
Kozlowski, Lawrence, Mekeland, Nash, O'Driscoll, Rehm, Stephenson, Urdahl,
West, Wiens and Zeleznikar were excused.
The Chief Clerk proceeded to read the
Journal of the preceding day. There
being no objection, further reading of the Journal was dispensed with and the
Journal was approved as corrected by the Chief Clerk.
REPORTS OF STANDING COMMITTEES
AND DIVISIONS
Olson, L., from the Committee on Ways and Means to which was referred:
H. F. No. 2476, A bill for an act relating to children; modifying provisions related to child protection, economic supports, housing and homelessness, child care licensing, the Department of Children, Youth, and Families, and early childhood education; requiring reports; appropriating money; amending Minnesota Statutes 2022, sections 245.975, subdivisions 2, 4, 9; 256.045, subdivisions 3b, as amended, 5, as amended, 7, as amended; 256.0451, subdivisions 1, as amended, 22, 24; 256.046, subdivision 2, as amended; 256E.35, subdivision 5; 256N.26, subdivisions 12, 13; 260C.331, by adding a subdivision; Minnesota Statutes 2023 Supplement, sections 124D.151, subdivision 6; 124D.165, subdivisions 3, 6; 256.01, subdivision 12b; 256.043, subdivisions 3, 3a; 256.045, subdivision 3, as amended; 256E.35, subdivision 2; 256E.38, subdivision 4; 518A.42, subdivision 3; Laws 2023, chapter 54, section 20, subdivisions 6, 24; Laws 2023, chapter 70, article 12, section 30, subdivisions 2, 3; article 14, section 42, by adding a subdivision; article 20, sections 2, subdivisions 22, 24; 23; Laws 2024, chapter 80, article 1, sections 38, subdivisions 1, 2, 5, 6, 7, 9; 96; article 4, section 26; article 6, section 4; proposing coding for new law in Minnesota Statutes, chapters 142A; 256D; 260E; proposing coding for new law as Minnesota Statutes, chapter 142B; repealing Minnesota Statutes 2022, sections 245.975, subdivision 8; 245A.065; 256.01, subdivisions 12, 12a; Laws 2024, chapter 80, article 1, sections 38, subdivisions 3, 4, 11; 39; 43, subdivision 2; article 7, sections 3; 9; Minnesota Rules, part 9560.0232, subpart 5.
Reported the same back with the following amendments:
Page 8, after line 27, insert:
"(5) the superintendent of the Bureau of Criminal Apprehension, or a designee;"
Renumber the clauses in sequence
Page 9, line 11, delete "(5)" and insert "(6)" and delete the second "(6)" and insert "(7)"
Page 40, delete lines 20 and 21
Renumber the clauses in sequence
Page 51, delete article 6
Page 70, after line 20, insert:
"Sec. 11. APPROPRIATIONS
GIVEN EFFECT ONCE.
If an appropriation or transfer under
this article is enacted more than once during the 2024 regular session, the
appropriation or transfer must be given effect once.
Sec. 12. EXPIRATION
OF UNCODIFIED LANGUAGE.
All uncodified language contained in this article expires on June 30, 2025, unless a different expiration date is explicit."
Renumber the articles in sequence
Renumber the sections in sequence
Amend the title as follows:
Page 1, line 3, after the third comma, insert "and"
Page 1, line 4, delete ", and early childhood education"
Correct the title numbers accordingly
With the recommendation that when so amended the bill be placed on the General Register.
The
report was adopted.
Olson, L., from the Committee on Ways and Means to which was referred:
H. F. No. 4124, A bill for an act relating to state government; appropriating money from the outdoor heritage fund, clean water fund, parks and trails fund, and arts and cultural heritage fund; modifying and extending prior appropriations; amending Laws 2023, chapter 40, article 3, sections 2, subdivision 1; 3; 4.
Reported the same back with the following amendments:
Page 28, line 31, delete "$4,434,000" and insert "$3,434,000"
Page 30, after line 10, insert:
"(e) $1,000,000 the second year is for conservation easements acquired under Minnesota Statutes, sections 103F.501 to 103F.535, or for grants or contracts to local units of government or Tribal governments, including for fee title acquisition or for long-term protection of groundwater supply sources. Consideration must be given to drinking water supply management areas and alternative management tools in the Department of Agriculture Minnesota Nitrogen Fertilizer Management Plan, including using low‑nitrogen cropping systems or implementing nitrogen fertilizer best management practices. Priority must be placed on land that is located where the vulnerability of the drinking water supply is designated as high or very high by the commissioner of health, where drinking water protection plans have identified specific activities that will achieve long-term protection, and on lands with expiring conservation contracts. Up to $50,000 is for deposit in a conservation easement stewardship account established according to Minnesota Statutes, section 103B.103. This appropriation, including the conditions and considerations, is added to the appropriation in Laws 2023, chapter 40, article 2, section 6, paragraph (g)."
Reletter the paragraphs in sequence
Page 41, line 4, delete "Pullman Company" and insert "Minnesota Transportation Museum"
With the recommendation that when so amended the bill be placed on the General Register.
The
report was adopted.
Liebling from the Committee on Health Finance and Policy to which was referred:
H. F. No. 4571, A bill for an act relating to health; correcting an appropriation to the commissioner of health; amending Laws 2023, chapter 70, article 20, section 3, subdivision 2.
Reported the same back with the following amendments:
Delete everything after the enacting clause and insert:
"ARTICLE 1
DEPARTMENT OF HUMAN SERVICES HEALTH CARE FINANCE
Section 1. [62V.12]
STATE-FUNDED COST-SHARING REDUCTIONS.
Subdivision 1. Establishment. (a) The board must develop and
administer a state-funded cost-sharing reduction program for eligible persons
who enroll in a silver level qualified health plan through MNsure. The board must implement the cost-sharing
reduction program for plan years beginning on or after January 1, 2027.
(b) For purposes of this
section, an "eligible person" is an individual who meets the
eligibility criteria to receive a cost-sharing reduction under Code of Federal
Regulations, title 45, section 155.305(g).
Subd. 2. Reduction in cost-sharing. The cost-sharing reduction program must use state money to reduce enrollee cost-sharing by increasing the actuarial value of silver level health plans for eligible persons beyond the 73 percent value established in Code of Federal Regulations, title 45, section 156.420(a)(3)(ii), to an actuarial value of 87 percent.
Subd. 3. Administration. The board, when administering the
program, must:
(1) allow eligible
persons to enroll in a silver level health plan with a state-funded
cost-sharing reduction;
(2) modify the MNsure
shopping tool to display the total cost-sharing reduction benefit available to
individuals eligible under this section; and
(3) reimburse health
carriers on a quarterly basis for the cost to the health plan providing the
state-funded cost‑sharing reductions.
Sec. 2. Minnesota Statutes 2023 Supplement, section 256.9631, is amended to read:
256.9631 DIRECT PAYMENT SYSTEM ALTERNATIVE CARE DELIVERY
MODELS FOR MEDICAL ASSISTANCE AND MINNESOTACARE.
Subdivision 1. Direction
to the commissioner. (a) The
commissioner, in order to deliver services to eligible individuals, achieve
better health outcomes, and reduce the cost of health care for the state, shall
develop an implementation plan plans for a direct
payment system to deliver services to eligible individuals in order to achieve
better health outcomes and reduce the cost of health care for the state. Under this system, at least three care
delivery models that:
(1) are alternatives to
the use of commercial managed care plans to deliver health care to Minnesota
health care program enrollees; and
(2) do not shift
financial risk to nongovernmental entities.
(b) One of the
alternative models must be a direct payment system under which eligible
individuals must receive services through the medical assistance
fee-for-service system, county-based purchasing plans, or and
county-owned health maintenance organizations.
At least one additional model must include county-based purchasing
plans and county-owned health maintenance organizations in their design, and
must allow these entities to deliver care in geographic areas on a single plan
basis, if:
(1) these entities
contract with all providers that agree to contract terms for network
participation; and
(2) the commissioner of
human services determines that an entity's provider network is adequate to
ensure enrollee access and choice.
(c) Before determining the
alternative models for which implementation plans will be developed, the
commissioner shall consult with the chairs and ranking minority members of the
legislative committees with jurisdiction over health care finance and policy.
(d) The commissioner
shall present an implementation plan plans for the direct
payment system selected models to the chairs and ranking minority
members of the legislative committees with jurisdiction over health care
finance and policy by January 15, 2026. The
commissioner may contract for technical assistance in developing the
implementation plan plans and conducting related studies and
analyses.
(b) For the purposes of
the direct payment system, the commissioner shall make the following assumptions:
(1) health care
providers are reimbursed directly for all medical assistance covered services
provided to eligible individuals, using the fee-for-service payment methods
specified in chapters 256, 256B, 256R, and 256S;
(2) payments to a
qualified hospital provider are equivalent to the payments that would have been
received based on managed care direct payment arrangements. If necessary, a qualified hospital provider
may use a county-owned health maintenance organization to receive direct
payments as described in section 256B.1973; and
(3) county-based
purchasing plans and county-owned health maintenance organizations must be
reimbursed at the capitation rate determined under sections 256B.69 and
256B.692.
Subd. 2. Definitions. (a) For purposes of this section, the following terms have the meanings given.
(b) "Eligible
individuals" means qualified all medical assistance enrollees,
defined as persons eligible for medical assistance as families and children and
adults without children and MinnesotaCare enrollees.
(c) "Minnesota
health care programs" means the medical assistance and MinnesotaCare
programs.
(c) (d) "Qualified
hospital provider" means a nonstate government teaching hospital with high
medical assistance utilization and a level 1 trauma center, and all of the
hospital's owned or affiliated health care professionals, ambulance services,
sites, and clinics.
Subd. 3. Implementation
plan plans. (a) The
Each implementation plan must include:
(1) a timeline for the
development and recommended implementation date of the direct payment system
alternative model. In
recommending a timeline, the commissioner must consider:
(i) timelines required by the existing contracts with managed care plans and county-based purchasing plans to sunset existing delivery models;
(ii) in counties that choose to operate a county-based purchasing plan under section 256B.692, timelines for any new procurements required for those counties to establish a new county-based purchasing plan or participate in an existing county-based purchasing plan;
(iii) in counties that choose to operate a county-owned health maintenance organization under section 256B.69, timelines for any new procurements required for those counties to establish a new county-owned health maintenance organization or to continue serving enrollees through an existing county-owned health maintenance organization; and
(iv) a recommendation on
whether the commissioner should contract with a third-party administrator to
administer the direct payment system alternative model, and the
timeline needed for procuring an administrator;
(2) the procedures to be used to ensure continuity of care for enrollees who transition from managed care to fee‑for-service and any administrative resources needed to carry out these procedures;
(3) recommended quality measures for health care service delivery;
(4) any changes to fee-for-service payment rates that the commissioner determines are necessary to ensure provider access and high-quality care and to reduce health disparities;
(5) recommendations on
ensuring effective care coordination under the direct payment system alternative
model, especially for enrollees who:
(i) are age 65 or older,
blind, or have disabilities;
(ii) have complex
medical conditions, who;
(iii) face
socioeconomic barriers to receiving care, or who; or
(iv) are from underserved populations that experience health disparities;
(6) recommendations on whether
the direct payment system should provide supplemental payments payment
arrangements for care coordination, including:
(i) the provider types
eligible for supplemental care coordination payments;
(ii) procedures to
coordinate supplemental care coordination payments with existing
supplemental or cost-based payment methods or to replace these existing
methods; and
(iii) procedures to align
care coordination initiatives funded through supplemental payments under
this section the alternative model with existing care
coordination initiatives;
(7) recommendations on
whether the direct payment system alternative model should
include funding to providers for outreach initiatives to patients who, because
of mental illness, homelessness, or other circumstances, are unlikely to obtain
needed care and treatment;
(8) recommendations for a
supplemental payment to qualified hospital providers to offset any potential
revenue losses resulting from the shift from managed care payments; and
(9) recommendations on
whether and how the direct payment system should be expanded to deliver
services and care coordination to medical assistance enrollees who are age 65
or older, are blind, or have a disability and to persons enrolled in
MinnesotaCare; and
(10) (9) recommendations
for statutory changes necessary to implement the direct payment system alternative
model.
(b) In developing the
each implementation plan, the commissioner shall:
(1) calculate the projected
cost of a direct payment system the alternative model relative to
the cost of the current system;
(2) assess gaps in care coordination under the current medical assistance and MinnesotaCare programs;
(3) evaluate the effectiveness of approaches other states have taken to coordinate care under a fee-for-service system, including the coordination of care provided to persons who are age 65 or older, are blind, or have disabilities;
(4) estimate the loss of revenue and cost savings from other payment enhancements based on managed care plan directed payments and pass-throughs;
(5) estimate cost trends
under a direct payment system the alternative model for managed
care payments to county-based purchasing plans and county-owned health
maintenance organizations;
(6) estimate the impact of a
direct payment system the alternative model on other revenue,
including taxes, surcharges, or other federally approved in lieu of services
and on other arrangements allowed under managed care;
(7) consider allowing eligible individuals to opt out of managed care as an alternative approach;
(8) assess the
feasibility of a medical assistance outpatient prescription drug benefit
carve-out under section 256B.69, subdivision 6d, and in consultation with the
commissioners of commerce and health, assess the feasibility of including
MinnesotaCare enrollees and private sector enrollees of health plan companies
in the drug benefit carve-out. The
assessment of feasibility must address and include recommendations related to
the process and terms
by which the commissioner
would contract with health plan companies to administer prescription drug
benefits and develop and manage a drug formulary, and the impact of the
drug-benefit carve-out on health care providers, including small pharmacies;
(9) (8) consult
with the commissioners of health and commerce and the contractor or contractors
analyzing the Minnesota Health Plan under section 19 and other health
reform models on plan design and assumptions; and
(10) (9) conduct
other analyses necessary to develop the implementation plan.
EFFECTIVE DATE. This
section is effective the day following final enactment.
Sec. 3. Minnesota Statutes 2022, section 256.9657, is amended by adding a subdivision to read:
Subd. 2a. Teaching
hospital surcharge. (a) Each
teaching hospital shall pay to the medical assistance account a surcharge equal
to 0.01 percent of net non-Medicare patient care revenue. The initial surcharge must be paid 60 days
after both this subdivision and section 256.969, subdivision 2g, have received
federal approval, and subsequent surcharge payments must be made annually in
the form and manner specified by the commissioner.
(b) The commissioner
shall use revenue from the surcharge only to pay the nonfederal share of the
medical assistance supplemental payments described in section 256.969,
subdivision 2g, and to supplement, and not supplant, medical assistance
reimbursement to teaching hospitals. The
surcharge must comply with Code of Federal Regulations, title 42, section
433.63.
(c) For purposes of this
subdivision, "teaching hospital" means any Minnesota hospital, except
facilities of the federal Indian Health Service and regional treatment centers,
with a Centers for Medicare and Medicaid Services designation of "teaching
hospital" as reported on form CMS-2552-10, worksheet S-2, line 56, that is
eligible for reimbursement under section 256.969, subdivision 2g.
EFFECTIVE DATE. This
section is effective the later of January 1, 2025, or federal approval of this
section and sections 4 and 5. The
commissioner of human services shall notify the revisor of statutes when
federal approval is obtained.
Sec. 4. Minnesota Statutes 2023 Supplement, section 256.969, subdivision 2b, is amended to read:
Subd. 2b. Hospital payment rates. (a) For discharges occurring on or after November 1, 2014, hospital inpatient services for hospitals located in Minnesota shall be paid according to the following:
(1) critical access hospitals as defined by Medicare shall be paid using a cost-based methodology;
(2) long-term hospitals as defined by Medicare shall be paid on a per diem methodology under subdivision 25;
(3) rehabilitation hospitals or units of hospitals that are recognized as rehabilitation distinct parts as defined by Medicare shall be paid according to the methodology under subdivision 12; and
(4) all other hospitals shall be paid on a diagnosis-related group (DRG) methodology.
(b) For the period beginning January 1, 2011, through October 31, 2014, rates shall not be rebased, except that a Minnesota long-term hospital shall be rebased effective January 1, 2011, based on its most recent Medicare cost report ending on or before September 1, 2008, with the provisions under subdivisions 9 and 23, based on the rates in effect on December 31, 2010. For rate setting periods after November 1, 2014, in which the base years are updated, a Minnesota long-term hospital's base year shall remain within the same period as other hospitals.
(c) Effective for discharges occurring on and after November 1, 2014, payment rates for hospital inpatient services provided by hospitals located in Minnesota or the local trade area, except for the hospitals paid under the methodologies described in paragraph (a), clauses (2) and (3), shall be rebased, incorporating cost and payment methodologies in a manner similar to Medicare. The base year or years for the rates effective November 1, 2014, shall be calendar year 2012. The rebasing under this paragraph shall be budget neutral, ensuring that the total aggregate payments under the rebased system are equal to the total aggregate payments that were made for the same number and types of services in the base year. Separate budget neutrality calculations shall be determined for payments made to critical access hospitals and payments made to hospitals paid under the DRG system. Only the rate increases or decreases under subdivision 3a or 3c that applied to the hospitals being rebased during the entire base period shall be incorporated into the budget neutrality calculation.
(d) For discharges occurring on or after November 1, 2014, through the next rebasing that occurs, the rebased rates under paragraph (c) that apply to hospitals under paragraph (a), clause (4), shall include adjustments to the projected rates that result in no greater than a five percent increase or decrease from the base year payments for any hospital. Any adjustments to the rates made by the commissioner under this paragraph and paragraph (e) shall maintain budget neutrality as described in paragraph (c).
(e) For discharges occurring on or after November 1, 2014, the commissioner may make additional adjustments to the rebased rates, and when evaluating whether additional adjustments should be made, the commissioner shall consider the impact of the rates on the following:
(1) pediatric services;
(2) behavioral health services;
(3) trauma services as defined by the National Uniform Billing Committee;
(4) transplant services;
(5) obstetric services, newborn services, and behavioral health services provided by hospitals outside the seven‑county metropolitan area;
(6) outlier admissions;
(7) low-volume providers; and
(8) services provided by small rural hospitals that are not critical access hospitals.
(f) Hospital payment rates established under paragraph (c) must incorporate the following:
(1) for hospitals paid under the DRG methodology, the base year payment rate per admission is standardized by the applicable Medicare wage index and adjusted by the hospital's disproportionate population adjustment;
(2) for critical access hospitals, payment rates for discharges between November 1, 2014, and June 30, 2015, shall be set to the same rate of payment that applied for discharges on October 31, 2014;
(3) the cost and charge data used to establish hospital payment rates must only reflect inpatient services covered by medical assistance; and
(4) in determining hospital payment rates for discharges occurring on or after the rate year beginning January 1, 2011, through December 31, 2012, the hospital payment rate per discharge shall be based on the cost-finding methods and allowable costs of the Medicare program in effect during the base year or years. In determining hospital payment rates for discharges in subsequent base years, the per discharge rates shall be based on the cost‑finding methods and allowable costs of the Medicare program in effect during the base year or years.
(g) The commissioner shall validate the rates effective November 1, 2014, by applying the rates established under paragraph (c), and any adjustments made to the rates under paragraph (d) or (e), to hospital claims paid in calendar year 2013 to determine whether the total aggregate payments for the same number and types of services under the rebased rates are equal to the total aggregate payments made during calendar year 2013.
(h) Effective for discharges occurring on or after July 1, 2017, and every two years thereafter, payment rates under this section shall be rebased to reflect only those changes in hospital costs between the existing base year or years and the next base year or years. In any year that inpatient claims volume falls below the threshold required to ensure a statistically valid sample of claims, the commissioner may combine claims data from two consecutive years to serve as the base year. Years in which inpatient claims volume is reduced or altered due to a pandemic or other public health emergency shall not be used as a base year or part of a base year if the base year includes more than one year. Changes in costs between base years shall be measured using the lower of the hospital cost index defined in subdivision 1, paragraph (a), or the percentage change in the case mix adjusted cost per claim. The commissioner shall establish the base year for each rebasing period considering the most recent year or years for which filed Medicare cost reports are available, except that the base years for the rebasing effective July 1, 2023, are calendar years 2018 and 2019. The estimated change in the average payment per hospital discharge resulting from a scheduled rebasing must be calculated and made available to the legislature by January 15 of each year in which rebasing is scheduled to occur, and must include by hospital the differential in payment rates compared to the individual hospital's costs.
(i) Effective for discharges occurring on or after July 1, 2015, inpatient payment rates for critical access hospitals located in Minnesota or the local trade area shall be determined using a new cost-based methodology. The commissioner shall establish within the methodology tiers of payment designed to promote efficiency and cost‑effectiveness. Payment rates for hospitals under this paragraph shall be set at a level that does not exceed the total cost for critical access hospitals as reflected in base year cost reports. Until the next rebasing that occurs, the new methodology shall result in no greater than a five percent decrease from the base year payments for any hospital, except a hospital that had payments that were greater than 100 percent of the hospital's costs in the base year shall have their rate set equal to 100 percent of costs in the base year. The rates paid for discharges on and after July 1, 2016, covered under this paragraph shall be increased by the inflation factor in subdivision 1, paragraph (a). The new cost-based rate shall be the final rate and shall not be settled to actual incurred costs. Hospitals shall be assigned a payment tier based on the following criteria:
(1) hospitals that had payments at or below 80 percent of their costs in the base year shall have a rate set that equals 85 percent of their base year costs;
(2) hospitals that had payments that were above 80 percent, up to and including 90 percent of their costs in the base year shall have a rate set that equals 95 percent of their base year costs; and
(3) hospitals that had payments that were above 90 percent of their costs in the base year shall have a rate set that equals 100 percent of their base year costs.
(j) The commissioner may refine the payment tiers and criteria for critical access hospitals to coincide with the next rebasing under paragraph (h). The factors used to develop the new methodology may include, but are not limited to:
(1) the ratio between the hospital's costs for treating medical assistance patients and the hospital's charges to the medical assistance program;
(2) the ratio between the hospital's costs for treating medical assistance patients and the hospital's payments received from the medical assistance program for the care of medical assistance patients;
(3) the ratio between the hospital's charges to the medical assistance program and the hospital's payments received from the medical assistance program for the care of medical assistance patients;
(4) the statewide average increases in the ratios identified in clauses (1), (2), and (3);
(5) the proportion of that hospital's costs that are administrative and trends in administrative costs; and
(6) geographic location.
(k) Subject to section 256.969, subdivision 2g, paragraph (i), effective for discharges occurring on or after January 1, 2024, the rates paid to hospitals described in paragraph (a), clauses (2) to (4), must include a rate factor specific to each hospital that qualifies for a medical education and research cost distribution under section 62J.692, subdivision 4, paragraph (a).
EFFECTIVE DATE. This
section is effective the later of January 1, 2025, or federal approval of this
section and sections 3 and 5. The
commissioner of human services shall notify the revisor of statutes when federal
approval is obtained.
Sec. 5. Minnesota Statutes 2022, section 256.969, is amended by adding a subdivision to read:
Subd. 2g. Annual
supplemental payments; direct and indirect physician graduate medical education. (a) For discharges occurring on or
after January 1, 2025, the commissioner shall determine and pay annual
supplemental payments to all eligible hospitals as provided in this subdivision
for direct and indirect physician graduate medical education cost reimbursement. A hospital must be an eligible hospital to
receive an annual supplemental payment under this subdivision.
(b) The commissioner must use the following information to calculate the total cost of direct graduate medical education incurred by each eligible hospital:
(1) the total allowable direct graduate medical education cost, as calculated by adding form CMS-2552-10, worksheet B, part 1, columns 21 and 22, line 202; and
(2) the Medicaid share
of total allowable direct graduate medical education cost percentage,
representing the allocation of total graduate medical education costs to
Medicaid based on the share of all Medicaid inpatient days, as reported on form
CMS-2552-10, worksheets S-2 and S-3, divided by the hospital's total inpatient
days, as reported on worksheet S-3.
(c) The commissioner may
obtain the information in paragraph (b) from an eligible hospital upon request
by the commissioner or from the eligible hospital's most recently filed form
CMS-2552-10.
(d) The commissioner must use
the following information to calculate the total allowable indirect cost of
graduate medical education incurred by each eligible hospital:
(1) for eligible hospitals that are not children's hospitals, the indirect graduate medical education amount attributable to Medicaid, calculated based on form CMS-2552-10, worksheet E, part A, including:
(i) the Medicare indirect medical education formula, using Medicaid variables;
(ii) Medicaid payments for inpatient services under fee-for-service and managed care, as determined by the commissioner in consultation with each eligible hospital;
(iii) total inpatient beds available, as reported on form CMS-2552-10, worksheet E, part A, line 4; and
(iv) full-time
employees, as determined by adding form CMS-2552-10, worksheet E, part A, lines
10 and 11; and
(2) for eligible hospitals that are children's hospitals:
(i) the Medicare indirect medical education formula, using Medicaid variables;
(ii) Medicaid payments
for inpatient services under fee-for-service and managed care, as determined by
the commissioner in consultation with each eligible hospital;
(iii) total inpatient beds available, as reported on form CMS-2552-10, worksheet S-3, part 1; and
(iv) full-time
equivalent interns and residents, as determined by adding form CMS-2552-10,
worksheet E-4, lines 6, 10.01, and 15.01.
(e) The commissioner shall determine each eligible hospital's maximum allowable Medicaid direct graduate medical education supplemental payment amount by calculating the sum of:
(1) the total allowable direct graduate medical education costs determined under paragraph (b), clause (1), multiplied by the Medicaid share of total allowable direct graduate medical education cost percentage in paragraph (b), clause (2); and
(2) the total allowable direct graduate medical education costs determined under paragraph (b), clause (1), multiplied by the most recently updated Medicaid utilization percentage from form CMS-2552-10, as submitted to Medicare by each eligible hospital.
(f) The commissioner
shall determine each eligible hospital's indirect graduate medical education
supplemental payment amount by multiplying the total allowable indirect cost of
graduate medical education amount calculated in paragraph (d) by:
(1) 0.95 for prospective payment system, for hospitals that are not children's hospitals and have fewer than 50 full-time equivalent trainees;
(2) 1.0 for prospective payment system, for hospitals that are not children's hospitals and have equal to or greater than 50 full-time equivalent trainees; and
(3) 1.05 for children's
hospitals.
(g) An eligible hospital's
annual supplemental payment under this subdivision equals the sum of the amount
calculated for the eligible hospital under paragraph (e) and the amount
calculated for the eligible hospital under paragraph (f).
(h) The annual supplemental payments under this subdivision are contingent upon federal approval and must conform with the requirements for permissible supplemental payments for direct and indirect graduate medical education under all applicable federal laws.
(i) An eligible hospital
is only eligible for reimbursement under section 62J.692 for nonphysician
graduate medical education training costs that are not accounted for in the
calculation of an annual supplemental payment under this section. An eligible hospital must not accept
reimbursement under section 62J.692 for physician graduate medical education
training costs that are accounted for in the calculation of an annual
supplemental payment under this section.
(j) For purposes of this
subdivision, "children's hospital" means a Minnesota hospital
designated as a children's hospital under Medicare.
(k) For purposes of this
subdivision, "eligible hospital" means a hospital located in
Minnesota:
(1) participating in
Minnesota's medical assistance program;
(2) that has received
fee-for-service medical assistance payments in the payment year; and
(3) that is either:
(i) eligible to receive graduate medical education payments from the Medicare program under Code of Federal Regulations, title 42, section 413.75; or
(ii) a children's
hospital.
EFFECTIVE DATE. This
section is effective the later of January 1, 2025, or federal approval of this
section and sections 3 and 4. The
commissioner of human services shall notify the revisor of statutes when
federal approval is obtained.
Sec. 6. Minnesota Statutes 2022, section 256.969, is amended by adding a subdivision to read:
Subd. 2h. Alternate
inpatient payment rate for a discharge.
(a) Effective retroactively from January 1, 2024, in any rate
year in which a children's hospital discharge is included in the federally
required disproportionate share hospital payment audit where the patient
discharged had resided in a children's hospital for over 20 years, the
commissioner shall compute an alternate inpatient rate for the children's
hospital. The alternate payment rate
must be the rate computed under this section excluding the disproportionate
share hospital payment under subdivision 9, paragraph (d), clause (1),
increased by an amount equal to 99 percent of what the disproportionate share
hospital payment would have been under subdivision 9, paragraph (d), clause
(1), had the discharge been excluded.
(b) In any rate year in
which payment to a children's hospital is made using this alternate payment
rate, payments must not be made to the hospital under subdivisions 2e, 2f, and
9.
EFFECTIVE DATE. This
section is effective upon federal approval.
The commissioner of human services shall notify the revisor of statutes
when federal approval is obtained.
Sec. 7. Minnesota Statutes 2023 Supplement, section 256B.0625, subdivision 13e, as amended by Laws 2024, chapter 85, section 66, is amended to read:
Subd. 13e. Payment
rates. (a) The basis for determining
the amount of payment shall be the lower of the ingredient costs of the drugs
plus the professional dispensing fee; or the usual and customary price charged
to the public. The usual and customary
price means the lowest price charged by the provider to a patient who pays for
the prescription by cash, check, or charge account and includes prices the
pharmacy charges to a patient enrolled in a prescription savings club or prescription
discount club administered by the pharmacy or pharmacy chain. The amount of payment basis must be reduced
to reflect all discount amounts applied to the charge by any third-party
provider/insurer agreement or contract for submitted charges to medical
assistance programs. The net submitted
charge may not be greater than the patient liability for the service. The professional dispensing fee shall be $10.77
$11.55 for prescriptions filled with legend drugs meeting the definition
of "covered outpatient drugs" according to United States Code, title
42, section 1396r-8(k)(2). The
dispensing fee for intravenous solutions that must be compounded by the
pharmacist shall be $10.77 $11.55 per claim. The professional dispensing fee for
prescriptions filled with over-the-counter drugs meeting the definition of
covered outpatient drugs shall be $10.77 $11.55 for dispensed
quantities equal to or greater than the number of units contained in the
manufacturer's original package. The
professional dispensing fee shall be prorated based on the percentage of the
package dispensed when the pharmacy dispenses a quantity less than the number
of units contained in the manufacturer's original package. The pharmacy dispensing fee for prescribed
over-the-counter drugs not meeting the definition of covered outpatient drugs
shall be $3.65 for quantities equal to or greater than the number of units
contained in the manufacturer's original package and shall be prorated based on
the percentage of the package dispensed when the pharmacy dispenses a quantity
less than the number of units contained in the manufacturer's original package. The National Average Drug Acquisition Cost
(NADAC) shall be used to determine the ingredient cost of a drug. For drugs for which a NADAC is not reported,
the commissioner shall estimate the ingredient cost at the wholesale
acquisition cost minus two percent. The
ingredient cost of a drug for a provider participating in the federal 340B Drug
Pricing Program shall be either the 340B Drug Pricing Program ceiling price
established by the Health Resources and Services Administration or NADAC,
whichever is lower. Wholesale
acquisition cost is defined as the manufacturer's list price for a drug or
biological to wholesalers or direct purchasers in the United States, not
including prompt pay or other discounts, rebates, or reductions in price, for
the most recent month for which information is available, as reported in
wholesale price guides or other publications of drug or biological pricing data. The maximum allowable cost of a multisource
drug may be set by the commissioner and it shall be comparable to the actual
acquisition cost of the drug product and no higher than the NADAC of the
generic product. Establishment of the
amount of payment for drugs shall not be subject to the requirements of the
Administrative Procedure Act.
(b) Pharmacies dispensing prescriptions to residents of long-term care facilities using an automated drug distribution system meeting the requirements of section 151.58, or a packaging system meeting the packaging standards set forth in Minnesota Rules, part 6800.2700, that govern the return of unused drugs to the pharmacy for reuse, may employ retrospective billing for prescription drugs dispensed to long-term care facility residents. A retrospectively billing pharmacy must submit a claim only for the quantity of medication used by the enrolled recipient during the defined billing period. A retrospectively billing pharmacy must use a billing period not less than one calendar month or 30 days.
(c) A pharmacy provider using packaging that meets the standards set forth in Minnesota Rules, part 6800.2700, is required to credit the department for the actual acquisition cost of all unused drugs that are eligible for reuse, unless the pharmacy is using retrospective billing. The commissioner may permit the drug clozapine to be dispensed in a quantity that is less than a 30-day supply.
(d) If a pharmacy dispenses a multisource drug, the ingredient cost shall be the NADAC of the generic product or the maximum allowable cost established by the commissioner unless prior authorization for the brand name product has been granted according to the criteria established by the Drug Formulary Committee as required by subdivision 13f, paragraph (a), and the prescriber has indicated "dispense as written" on the prescription in a manner consistent with section 151.21, subdivision 2.
(e) The basis for determining the amount of payment for drugs administered in an outpatient setting shall be the lower of the usual and customary cost submitted by the provider, 106 percent of the average sales price as determined by the United States Department of Health and Human Services pursuant to title XVIII, section 1847a of the federal Social Security Act, the specialty pharmacy rate, or the maximum allowable cost set by the commissioner. If average sales price is unavailable, the amount of payment must be lower of the usual and customary cost submitted by the provider, the wholesale acquisition cost, the specialty pharmacy rate, or the maximum allowable cost set by the commissioner. The commissioner shall discount the payment rate for drugs obtained through the federal 340B Drug Pricing Program by 28.6 percent. The payment for drugs administered in an outpatient setting shall be made to the administering facility or practitioner. A retail or specialty pharmacy dispensing a drug for administration in an outpatient setting is not eligible for direct reimbursement.
(f) The commissioner may establish maximum allowable cost rates for specialty pharmacy products that are lower than the ingredient cost formulas specified in paragraph (a). The commissioner may require individuals enrolled in the health care programs administered by the department to obtain specialty pharmacy products from providers with whom the commissioner has negotiated lower reimbursement rates. Specialty pharmacy products are defined as those used by a small number of recipients or recipients with complex and chronic diseases that require expensive and challenging drug regimens. Examples of these conditions include, but are not limited to: multiple sclerosis, HIV/AIDS, transplantation, hepatitis C, growth hormone deficiency, Crohn's Disease, rheumatoid arthritis, and certain forms of cancer. Specialty pharmaceutical products include injectable and infusion therapies, biotechnology drugs, antihemophilic factor products, high-cost therapies, and therapies that require complex care. The commissioner shall consult with the Formulary Committee to develop a list of specialty pharmacy products subject to maximum allowable cost reimbursement. In consulting with the Formulary Committee in developing this list, the commissioner shall take into consideration the population served by specialty pharmacy products, the current delivery system and standard of care in the state, and access to care issues. The commissioner shall have the discretion to adjust the maximum allowable cost to prevent access to care issues.
(g) Home infusion therapy services provided by home infusion therapy pharmacies must be paid at rates according to subdivision 8d.
(h) The commissioner shall contract with a vendor to conduct a cost of dispensing survey for all pharmacies that are physically located in the state of Minnesota that dispense outpatient drugs under medical assistance. The commissioner shall ensure that the vendor has prior experience in conducting cost of dispensing surveys. Each pharmacy enrolled with the department to dispense outpatient prescription drugs to fee-for-service members must respond to the cost of dispensing survey. The commissioner may sanction a pharmacy under section 256B.064 for failure to respond. The commissioner shall require the vendor to measure a single statewide cost of dispensing for specialty prescription drugs and a single statewide cost of dispensing for nonspecialty prescription drugs for all responding pharmacies to measure the mean, mean weighted by total prescription volume, mean weighted by medical assistance prescription volume, median, median weighted by total prescription volume, and median weighted by total medical assistance prescription volume. The commissioner shall post a copy of the final cost of dispensing survey report on the department's website. The initial survey must be completed no later than January 1, 2021, and repeated every three years. The commissioner shall provide a summary of the results of each cost of dispensing survey and provide recommendations for any changes to the dispensing fee to the chairs and ranking minority members of the legislative committees with jurisdiction over medical assistance pharmacy reimbursement. Notwithstanding section 256.01, subdivision 42, this paragraph does not expire.
(i) The commissioner shall increase the ingredient cost reimbursement calculated in paragraphs (a) and (f) by 1.8 percent for prescription and nonprescription drugs subject to the wholesale drug distributor tax under section 295.52.
EFFECTIVE DATE. This
section is effective July 1, 2024.
Sec. 8. Minnesota Statutes 2022, section 256B.69, is amended by adding a subdivision to read:
Subd. 38. Reimbursement
of network providers. (a) A
managed care plan that is a staff model health plan company, when reimbursing
network providers for services provided to medical assistance and MinnesotaCare
enrollees, must not reimburse network providers who are employees at a higher
rate than network providers who provide services under contract for each
separate service or grouping of services.
This requirement does not apply to reimbursement:
(1) of network providers
when participating in value-based purchasing models that are intended to
recognize value or outcomes over volume of services, including:
(i) total cost of care
and risk/gain sharing arrangements under section 256B.0755; and
(ii) other
pay-for-performance arrangements or service payments, as long as the terms and
conditions of the value-based purchasing model are applied uniformly to all
participating network providers; and
(2) for services
furnished by providers who are out-of-network.
(b) Any contract or
agreement between a managed care plan and a network administrator, for purposes
of delivering services to medical assistance and MinnesotaCare enrollees, must
require the network administrator to comply with the requirements that apply to
a managed care plan that is a staff model health plan company under paragraph
(a) when reimbursing providers who are employees of the network administrator
and providers who provide services under contract with the network
administrator. This provision applies
whether or not the managed care plan, network administrator, and providers are
under the same corporate ownership.
(c) For purposes of this
subdivision, "network provider" has the meaning specified in
subdivision 37. For purposes of this
subdivision, "network administrator" means any entity that furnishes
a provider network for a managed care plan company, or furnishes individual
health care providers or provider groups to a managed care plan for inclusion in
the managed care plan's provider network.
Sec. 9. COUNTY-ADMINISTERED
MEDICAL ASSISTANCE MODEL.
Subdivision 1. Model
development. (a) The
commissioner of human services, in collaboration with the Association of
Minnesota Counties and county-based purchasing plans, shall develop a
county-administered medical assistance (CAMA) model and a detailed plan for
implementing the CAMA model.
(b) The CAMA model must
be designed to achieve the following objectives:
(1) provide a distinct
county owned and administered alternative to the prepaid medical assistance
program;
(2) facilitate greater
integration of health care and social services to address social determinants
of health in rural and nonrural communities, with the degree of integration of
social services varying with each county's needs and resources;
(3) account for
differences between counties in the number of medical assistance enrollees and
locally available providers of behavioral health, oral health, specialty and
tertiary care, nonemergency medical transportation, and other health care
services in rural communities; and
(4) promote greater
accountability for health outcomes, health equity, customer service, community
outreach, and cost of care.
Subd. 2. County
participation. (a) The CAMA
model must give each rural and nonrural county the option of applying to
participate in the CAMA model as an alternative to participation in the prepaid
medical assistance program. The CAMA
model must include a process for the commissioner to determine whether and how
a county can participate.
(b) The CAMA model may
allow a county-administered managed care organization to deliver care on a
single‑plan basis to all medical assistance enrollees residing in a
county if:
(1) the managed care
organization contracts with all health care providers that agree to accept the
contract terms for network participation; and
(2) the commissioner
determines that the health care provider network of the managed care
organization is adequate to ensure enrollee access to care and enrollee choice
of providers.
Subd. 3. Report
to the legislature. (a) The
commissioner shall report recommendations and an implementation plan for the
CAMA model to the chairs and ranking minority members of the legislative
committees with jurisdiction over health care policy and finance by January 15,
2025. The CAMA model and implementation
plan must address the issues and consider the recommendations identified in the
document titled "Recommendations Not Contingent on Outcome(s) of Current
Litigation," attached to the September 13, 2022, e-filing to the Second
Judicial District Court (Correspondence for Judicial Approval Index #102), that
relates to the final contract decisions of the commissioner of human services
regarding South Country Health Alliance
v. Minnesota Department of Human Services, No. 62-CV-22-907 (Ramsey
Cnty. Dist. Ct. 2022).
(b) The report must also
identify the clarifications, approvals, and waivers that are needed from the
Centers for Medicare and Medicaid Services and include any draft legislation
necessary to implement the CAMA model.
Sec. 10. REVISOR
INSTRUCTION.
When the proposed rule
published at Federal Register, volume 88, page 25313, becomes effective, the
revisor of statutes must change: (1) the
reference in Minnesota Statutes, section 256B.06, subdivision 4, paragraph (d),
from Code of Federal Regulations, title 8, section 103.12, to Code of Federal
Regulations, title 42, section 435.4; and (2) the reference in Minnesota
Statutes, section 256L.04, subdivision 10, paragraph (a), from Code of Federal
Regulations, title 8, section 103.12, to Code of Federal Regulations, title 45,
section 155.20. The commissioner of
human services shall notify the revisor of statutes when the proposed rule
published at Federal Register, volume 88, page 25313, becomes effective.
ARTICLE 2
DEPARTMENT OF HUMAN SERVICES HEALTH CARE POLICY
Section 1. Minnesota Statutes 2023 Supplement, section 256.0471, subdivision 1, as amended by Laws 2024, chapter 80, article 1, section 76, is amended to read:
Subdivision 1. Qualifying
overpayment. Any overpayment for state-funded
medical assistance under chapter 256B and state-funded MinnesotaCare
under chapter 256L granted pursuant to section 256.045, subdivision 10; chapter
256B for state-funded medical assistance; and chapters 256D, 256I, 256K,
and 256L for state-funded MinnesotaCare except agency error claims, become a
judgment by operation of law 90 days after the notice of overpayment is
personally served upon the recipient in a manner that is sufficient under rule
4.03(a) of the Rules of Civil Procedure for district courts, or by certified
mail, return receipt requested. This
judgment shall be entitled to full faith and credit in this and any other
state.
EFFECTIVE DATE. This
section is effective July 1, 2024.
Sec. 2. Minnesota Statutes 2022, section 256.9657, subdivision 8, is amended to read:
Subd. 8. Commissioner's
duties. (a) Beginning October 1,
2023, the commissioner of human services shall annually report to the chairs
and ranking minority members of the legislative committees with jurisdiction
over health care policy and finance regarding the provider surcharge program. The report shall include information on total
billings, total collections, and administrative expenditures for the previous
fiscal year. This paragraph expires
January 1, 2032.
(b) (a) The
surcharge shall be adjusted by inflationary and caseload changes in future
bienniums to maintain reimbursement of health care providers in accordance with
the requirements of the state and federal laws governing the medical assistance
program, including the requirements of the Medicaid moratorium amendments of
1991 found in Public Law No. 102-234.
(c) (b) The
commissioner shall request the Minnesota congressional delegation to support a
change in federal law that would prohibit federal disallowances for any state
that makes a good faith effort to comply with Public Law 102-234 by enacting
conforming legislation prior to the issuance of federal implementing
regulations.
Sec. 3. Minnesota Statutes 2022, section 256B.056, subdivision 1a, is amended to read:
Subd. 1a. Income
and assets generally. (a)(1) Unless
specifically required by state law or rule or federal law or regulation, the
methodologies used in counting income and assets to determine eligibility for
medical assistance for persons whose eligibility category is based on
blindness, disability, or age of 65 or more years, the methodologies for the
Supplemental Security Income program shall be used, except as provided under
in clause (2) and subdivision 3, paragraph (a), clause (6).
(2) State tax credits,
rebates, and refunds must not be counted as income. State tax credits, rebates, and refunds must
not be counted as assets for a period of 12 months after the month of receipt.
(2) (3) Increases
in benefits under title II of the Social Security Act shall not be counted as
income for purposes of this subdivision until July 1 of each year. Effective upon federal approval, for children
eligible under section 256B.055, subdivision 12, or for home and
community-based waiver services whose eligibility for medical assistance is
determined without regard to parental income, child support payments, including
any payments made by an obligor in satisfaction of or in addition to a
temporary or permanent order for child support, and Social Security payments
are not counted as income.
(b)(1) The modified adjusted gross income methodology as defined in United States Code, title 42, section 1396a(e)(14), shall be used for eligibility categories based on:
(i) children under age 19 and their parents and relative caretakers as defined in section 256B.055, subdivision 3a;
(ii) children ages 19 to 20 as defined in section 256B.055, subdivision 16;
(iii) pregnant women as defined in section 256B.055, subdivision 6;
(iv) infants as defined in sections 256B.055, subdivision 10, and 256B.057, subdivision 1; and
(v) adults without children as defined in section 256B.055, subdivision 15.
For these purposes, a "methodology" does not include an asset or income standard, or accounting method, or method of determining effective dates.
(2) For individuals whose income eligibility is determined using the modified adjusted gross income methodology in clause (1):
(i) the commissioner shall subtract from the individual's modified adjusted gross income an amount equivalent to five percent of the federal poverty guidelines; and
(ii) the individual's current monthly income and household size is used to determine eligibility for the 12-month eligibility period. If an individual's income is expected to vary month to month, eligibility is determined based on the income predicted for the 12-month eligibility period.
EFFECTIVE DATE. This
section is effective the day following final enactment.
Sec. 4. Minnesota Statutes 2022, section 256B.056, subdivision 10, is amended to read:
Subd. 10. Eligibility verification. (a) The commissioner shall require women who are applying for the continuation of medical assistance coverage following the end of the 12-month postpartum period to update their income and asset information and to submit any required income or asset verification.
(b) The commissioner shall determine the eligibility of private-sector health care coverage for infants less than one year of age eligible under section 256B.055, subdivision 10, or 256B.057, subdivision 1, paragraph (c), and shall pay for private-sector coverage if this is determined to be cost-effective.
(c) The commissioner shall verify assets and income for all applicants, and for all recipients upon renewal.
(d) The commissioner shall utilize information obtained through the electronic service established by the secretary of the United States Department of Health and Human Services and other available electronic data sources in Code of Federal Regulations, title 42, sections 435.940 to 435.956, to verify eligibility requirements. The commissioner shall establish standards to define when information obtained electronically is reasonably compatible with information provided by applicants and enrollees, including use of self-attestation, to accomplish real-time eligibility determinations and maintain program integrity.
(e) Each person applying for
or receiving medical assistance under section 256B.055, subdivision 7, and any
other person whose resources are required by law to be disclosed to determine
the applicant's or recipient's eligibility must authorize the commissioner to
obtain information from financial institutions to identify unreported
accounts verify assets as required in section 256.01, subdivision
18f. If a person refuses or revokes the
authorization, the commissioner may determine that the applicant or recipient
is ineligible for medical assistance. For
purposes of this paragraph, an authorization to identify unreported accounts
verify assets meets the requirements of the Right to Financial Privacy
Act, United States Code, title 12, chapter 35, and need not be furnished to the
financial institution.
(f) County and tribal agencies shall comply with the standards established by the commissioner for appropriate use of the asset verification system specified in section 256.01, subdivision 18f.
Sec. 5. Minnesota Statutes 2023 Supplement, section 256B.0701, subdivision 6, is amended to read:
Subd. 6. Recuperative
care facility rate. (a) The
recuperative care facility rate is for facility costs and must be paid from
state money in an amount equal to the medical assistance room and board MSA
equivalent rate as defined in section 256I.03, subdivision 11a, at
the time the recuperative care services were provided. The eligibility standards in chapter 256I do
not apply to the recuperative care facility rate. The recuperative care facility rate is only
paid when the recuperative care services rate is paid to a provider. Providers may opt to only receive the
recuperative care services rate.
(b) Before a recipient is discharged from a recuperative care setting, the provider must ensure that the recipient's medical condition is stabilized or that the recipient is being discharged to a setting that is able to meet that recipient's needs.
Sec. 6. Minnesota Statutes 2022, section 256B.0757, subdivision 4a, is amended to read:
Subd. 4a. Behavioral health home services provider requirements. A behavioral health home services provider must:
(1) be an enrolled Minnesota Health Care Programs provider;
(2) provide a medical assistance covered primary care or behavioral health service;
(3) utilize an electronic health record;
(4) utilize an electronic patient registry that contains data elements required by the commissioner;
(5) demonstrate the organization's capacity to administer screenings approved by the commissioner for substance use disorder or alcohol and tobacco use;
(6) demonstrate the organization's capacity to refer an individual to resources appropriate to the individual's screening results;
(7) have policies and procedures to track referrals to ensure that the referral met the individual's needs;
(8) conduct a brief needs assessment when an individual begins receiving behavioral health home services. The brief needs assessment must be completed with input from the individual and the individual's identified supports. The brief needs assessment must address the individual's immediate safety and transportation needs and potential barriers to participating in behavioral health home services;
(9) conduct a health wellness assessment within 60 days after intake that contains all required elements identified by the commissioner;
(10) conduct a health action plan that contains all required elements identified by the commissioner. The plan must be completed within 90 days after intake and must be updated at least once every six months, or more frequently if significant changes to an individual's needs or goals occur;
(11) agree to cooperate with and participate in the state's monitoring and evaluation of behavioral health home services; and
(12) obtain the
individual's written consent to begin receiving behavioral health home
services using a form approved by the commissioner.
EFFECTIVE DATE. This
section is effective the day following final enactment.
Sec. 7. Minnesota Statutes 2022, section 256B.0757, subdivision 4d, is amended to read:
Subd. 4d. Behavioral health home services delivery standards. (a) A behavioral health home services provider must meet the following service delivery standards:
(1) establish and maintain processes to support the coordination of an individual's primary care, behavioral health, and dental care;
(2) maintain a team-based model of care, including regular coordination and communication between behavioral health home services team members;
(3) use evidence-based practices that recognize and are tailored to the medical, social, economic, behavioral health, functional impairment, cultural, and environmental factors affecting the individual's health and health care choices;
(4) use person-centered planning practices to ensure the individual's health action plan accurately reflects the individual's preferences, goals, resources, and optimal outcomes for the individual and the individual's identified supports;
(5) use the patient registry to identify individuals and population subgroups requiring specific levels or types of care and provide or refer the individual to needed treatment, intervention, or services;
(6) utilize the
Department of Human Services Partner Portal to identify past and current
treatment or services and identify potential gaps in care using a tool
approved by the commissioner;
(7) deliver services consistent with the standards for frequency and face-to-face contact required by the commissioner;
(8) ensure that a diagnostic assessment is completed for each individual receiving behavioral health home services within six months of the start of behavioral health home services;
(9) deliver services in locations and settings that meet the needs of the individual;
(10) provide a central point of contact to ensure that individuals and the individual's identified supports can successfully navigate the array of services that impact the individual's health and well-being;
(11) have capacity to assess an individual's readiness for change and the individual's capacity to integrate new health care or community supports into the individual's life;
(12) offer or facilitate the provision of wellness and prevention education on evidenced-based curriculums specific to the prevention and management of common chronic conditions;
(13) help an individual set up and prepare for medical, behavioral health, social service, or community support appointments, including accompanying the individual to appointments as appropriate, and providing follow-up with the individual after these appointments;
(14) offer or facilitate the provision of health coaching related to chronic disease management and how to navigate complex systems of care to the individual, the individual's family, and identified supports;
(15) connect an individual, the individual's family, and identified supports to appropriate support services that help the individual overcome access or service barriers, increase self-sufficiency skills, and improve overall health;
(16) provide effective referrals and timely access to services; and
(17) establish a continuous quality improvement process for providing behavioral health home services.
(b) The behavioral health home services provider must also create a plan, in partnership with the individual and the individual's identified supports, to support the individual after discharge from a hospital, residential treatment program, or other setting. The plan must include protocols for:
(1) maintaining contact between the behavioral health home services team member, the individual, and the individual's identified supports during and after discharge;
(2) linking the individual to new resources as needed;
(3) reestablishing the individual's existing services and community and social supports; and
(4) following up with appropriate entities to transfer or obtain the individual's service records as necessary for continued care.
(c) If the individual is enrolled in a managed care plan, a behavioral health home services provider must:
(1) notify the behavioral health home services contact designated by the managed care plan within 30 days of when the individual begins behavioral health home services; and
(2) adhere to the managed care plan communication and coordination requirements described in the behavioral health home services manual.
(d) Before terminating behavioral health home services, the behavioral health home services provider must:
(1) provide a 60-day notice of termination of behavioral health home services to all individuals receiving behavioral health home services, the commissioner, and managed care plans, if applicable; and
(2) refer individuals receiving behavioral health home services to a new behavioral health home services provider.
EFFECTIVE DATE. This
section is effective the day following final enactment.
Sec. 8. Minnesota Statutes 2023 Supplement, section 256B.764, is amended to read:
256B.764 REIMBURSEMENT FOR FAMILY PLANNING SERVICES.
(a) Effective for services rendered on or after July 1, 2007, payment rates for family planning services shall be increased by 25 percent over the rates in effect June 30, 2007, when these services are provided by a community clinic as defined in section 145.9268, subdivision 1.
(b) Effective for services rendered on or after July 1, 2013, payment rates for family planning services shall be increased by 20 percent over the rates in effect June 30, 2013, when these services are provided by a community clinic as defined in section 145.9268, subdivision 1. The commissioner shall adjust capitation rates to managed care and county-based purchasing plans to reflect this increase, and shall require plans to pass on the full amount of the rate increase to eligible community clinics, in the form of higher payment rates for family planning services.
(c) Effective for services provided on or after January 1, 2024, payment rates for family planning, when such services are provided by an eligible community clinic as defined in section 145.9268, subdivision 1, and abortion services shall be increased by 20 percent. This increase does not apply to federally qualified health centers, rural health centers, or Indian health services.
Sec. 9. Minnesota Statutes 2023 Supplement, section 256L.03, subdivision 1, is amended to read:
Subdivision 1. Covered
health services. (a) "Covered
health services" means the health services reimbursed under chapter 256B,
with the exception of special education services, home care nursing services, adult
dental care services other than services covered under section 256B.0625,
subdivision 9, orthodontic services, nonemergency
medical transportation services, personal care assistance and case management services, community first services and supports under section 256B.85, behavioral health home services under section 256B.0757, housing stabilization services under section 256B.051, and nursing home or intermediate care facilities services.
(b) Covered health services shall be expanded as provided in this section.
(c) For the purposes of covered health services under this section, "child" means an individual younger than 19 years of age.
Sec. 10. Minnesota Statutes 2022, section 524.3-801, as amended by Laws 2024, chapter 79, article 9, section 20, is amended to read:
524.3-801 NOTICE TO CREDITORS. (a) Unless notice has already been given under this section, upon appointment of a general personal representative in informal proceedings or upon the filing of a petition for formal appointment of a general personal representative, notice thereof, in the form prescribed by court rule, shall be given under the direction of the court administrator by publication once a week for two successive weeks in a legal newspaper in the county wherein the proceedings are pending giving the name and address of the general personal representative and notifying creditors of the estate to present their claims within four months after the date of the court administrator's notice which is subsequently published or be forever barred, unless they are entitled to further service of notice under paragraph (b) or (c).
(b) The personal representative shall, within three months after the date of the first publication of the notice, serve a copy of the notice upon each then known and identified creditor in the manner provided in paragraph (c). If the decedent or a predeceased spouse of the decedent received assistance for which a claim could be filed under section 246.53, 256B.15, 256D.16, or 261.04, notice to the commissioner of human services or direct care and treatment executive board, as applicable, must be given under paragraph (d) instead of under this paragraph or paragraph (c). A creditor is "known" if: (i) the personal representative knows that the creditor has asserted a claim that arose during the decedent's life against either the decedent or the decedent's estate; (ii) the creditor has asserted a claim that arose during the decedent's life and the fact is clearly disclosed in accessible financial records known and available to the personal representative; or (iii) the claim of the creditor would be revealed by a reasonably diligent search for creditors of the decedent in accessible financial records known and available to the personal representative. Under this section, a creditor is "identified" if the personal representative's knowledge of the name and address of the creditor will permit service of notice to be made under paragraph (c).
(c) Unless the claim has already been presented to the personal representative or paid, the personal representative shall serve a copy of the notice required by paragraph (b) upon each creditor of the decedent who is then known to the personal representative and identified either by delivery of a copy of the required notice to the creditor, or by mailing a copy of the notice to the creditor by certified, registered, or ordinary first class mail addressed to the creditor at the creditor's office or place of residence.
(d)(1) Effective for decedents dying on or after July 1, 1997, if the decedent or a predeceased spouse of the decedent received assistance for which a claim could be filed under section 246.53, 256B.15, 256D.16, or 261.04, the personal representative or the attorney for the personal representative shall serve the commissioner or executive board, as applicable, with notice in the manner prescribed in paragraph (c), or electronically in a manner prescribed by the commissioner, as soon as practicable after the appointment of the personal representative. The notice must state the decedent's full name, date of birth, and Social Security number and, to the extent then known after making a reasonably diligent inquiry, the full name, date of birth, and Social Security number for each of the decedent's predeceased spouses. The notice may also contain a statement that, after making a reasonably diligent inquiry, the personal representative has determined that the decedent did not have any predeceased spouses or that the personal representative has been unable to determine one or more of the previous items of information for a predeceased spouse of the decedent. A copy of the notice to creditors must be attached to and be a part of the notice to the commissioner or executive board.
(2) Notwithstanding a will or other instrument or law to the contrary, except as allowed in this paragraph, no property subject to administration by the estate may be distributed by the estate or the personal representative until 70 days after the date the notice is served on the commissioner or executive board as provided in paragraph (c), unless the local agency consents as provided for in clause (6). This restriction on distribution does not apply to the personal representative's sale of real or personal property, but does apply to the net proceeds the estate receives from these sales. The personal representative, or any person with personal knowledge of the facts, may provide an affidavit containing the description of any real or personal property affected by this paragraph and stating facts showing compliance with this paragraph. If the affidavit describes real property, it may be filed or recorded in the office of the county recorder or registrar of titles for the county where the real property is located. This paragraph does not apply to proceedings under sections 524.3-1203 and 525.31, or when a duly authorized agent of a county is acting as the personal representative of the estate.
(3) At any time before an order or decree is entered under section 524.3-1001 or 524.3-1002, or a closing statement is filed under section 524.3-1003, the personal representative or the attorney for the personal representative may serve an amended notice on the commissioner or executive board to add variations or other names of the decedent or a predeceased spouse named in the notice, the name of a predeceased spouse omitted from the notice, to add or correct the date of birth or Social Security number of a decedent or predeceased spouse named in the notice, or to correct any other deficiency in a prior notice. The amended notice must state the decedent's name, date of birth, and Social Security number, the case name, case number, and district court in which the estate is pending, and the date the notice being amended was served on the commissioner or executive board. If the amendment adds the name of a predeceased spouse omitted from the notice, it must also state that spouse's full name, date of birth, and Social Security number. The amended notice must be served on the commissioner or executive board in the same manner as the original notice. Upon service, the amended notice relates back to and is effective from the date the notice it amends was served, and the time for filing claims arising under section 246.53, 256B.15, 256D.16 or 261.04 is extended by 60 days from the date of service of the amended notice. Claims filed during the 60-day period are undischarged and unbarred claims, may be prosecuted by the entities entitled to file those claims in accordance with section 524.3-1004, and the limitations in section 524.3-1006 do not apply. The personal representative or any person with personal knowledge of the facts may provide and file or record an affidavit in the same manner as provided for in clause (1).
(4) Within one year after the date an order or decree is entered under section 524.3-1001 or 524.3-1002 or a closing statement is filed under section 524.3-1003, any person who has an interest in property that was subject to administration by the estate may serve an amended notice on the commissioner or executive board to add variations or other names of the decedent or a predeceased spouse named in the notice, the name of a predeceased spouse omitted from the notice, to add or correct the date of birth or Social Security number of a decedent or predeceased spouse named in the notice, or to correct any other deficiency in a prior notice. The amended notice must be served on the commissioner or executive board in the same manner as the original notice and must contain the information required for amendments under clause (3). If the amendment adds the name of a predeceased spouse omitted from the notice, it must also state that spouse's full name, date of birth, and Social Security number. Upon service, the amended notice relates back to and is effective from the date the notice it amends was served. If the amended notice adds the name of an omitted predeceased spouse or adds or corrects the Social Security number or date of birth of the decedent or a predeceased spouse already named in the notice, then, notwithstanding any other laws to the contrary, claims against the decedent's estate on account of those persons resulting from the amendment and arising under section 246.53, 256B.15, 256D.16, or 261.04 are undischarged and unbarred claims, may be prosecuted by the entities entitled to file those claims in accordance with section 524.3-1004, and the limitations in section 524.3-1006 do not apply. The person filing the amendment or any other person with personal knowledge of the facts may provide and file or record an affidavit describing affected real or personal property in the same manner as clause (1).
(5) After one year from the date an order or decree is entered under section 524.3-1001 or 524.3-1002, or a closing statement is filed under section 524.3-1003, no error, omission, or defect of any kind in the notice to the commissioner or executive board required under this paragraph or in the process of service of the notice on the
commissioner or executive board, or the failure to serve the commissioner or executive board with notice as required by this paragraph, makes any distribution of property by a personal representative void or voidable. The distributee's title to the distributed property shall be free of any claims based upon a failure to comply with this paragraph.
(6) The local agency may consent to a personal representative's request to distribute property subject to administration by the estate to distributees during the 70-day period after service of notice on the commissioner or executive board. The local agency may grant or deny the request in whole or in part and may attach conditions to its consent as it deems appropriate. When the local agency consents to a distribution, it shall give the estate a written certificate evidencing its consent to the early distribution of assets at no cost. The certificate must include the name, case number, and district court in which the estate is pending, the name of the local agency, describe the specific real or personal property to which the consent applies, state that the local agency consents to the distribution of the specific property described in the consent during the 70-day period following service of the notice on the commissioner or executive board, state that the consent is unconditional or list all of the terms and conditions of the consent, be dated, and may include other contents as may be appropriate. The certificate must be signed by the director of the local agency or the director's designees and is effective as of the date it is dated unless it provides otherwise. The signature of the director or the director's designee does not require any acknowledgment. The certificate shall be prima facie evidence of the facts it states, may be attached to or combined with a deed or any other instrument of conveyance and, when so attached or combined, shall constitute a single instrument. If the certificate describes real property, it shall be accepted for recording or filing by the county recorder or registrar of titles in the county in which the property is located. If the certificate describes real property and is not attached to or combined with a deed or other instrument of conveyance, it shall be accepted for recording or filing by the county recorder or registrar of titles in the county in which the property is located. The certificate constitutes a waiver of the 70-day period provided for in clause (2) with respect to the property it describes and is prima facie evidence of service of notice on the commissioner or executive board. The certificate is not a waiver or relinquishment of any claims arising under section 246.53, 256B.15, 256D.16, or 261.04, and does not otherwise constitute a waiver of any of the personal representative's duties under this paragraph. Distributees who receive property pursuant to a consent to an early distribution shall remain liable to creditors of the estate as provided for by law.
(7) All affidavits provided for under this paragraph:
(i) shall be provided by persons who have personal knowledge of the facts stated in the affidavit;
(ii) may be filed or recorded in the office of the county recorder or registrar of titles in the county in which the real property they describe is located for the purpose of establishing compliance with the requirements of this paragraph; and
(iii) are prima facie evidence of the facts stated in the affidavit.
(8) This paragraph applies to the estates of decedents dying on or after July 1, 1997. Clause (5) also applies with respect to all notices served on the commissioner of human services before July 1, 1997, under Laws 1996, chapter 451, article 2, section 55. All notices served on the commissioner before July 1, 1997, pursuant to Laws 1996, chapter 451, article 2, section 55, shall be deemed to be legally sufficient for the purposes for which they were intended, notwithstanding any errors, omissions or other defects.
ARTICLE 3
HEALTH CARE
Section 1. [62J.805]
DEFINITIONS.
Subdivision 1. Application. For purposes of sections 62J.805 to
62J.808, the following terms have the meanings given.
Subd. 2. Group
practice. "Group
practice" has the meaning given to health care provider group practice in
section 145D.01, subdivision 1.
Subd. 3. Health
care provider. "Health
care provider" means:
(1) a health
professional who is licensed or registered by the state to provide health
treatments and services within the professional's scope of practice and in
accordance with state law;
(2) a group practice; or
(3) a hospital.
Subd. 4. Health
plan. "Health plan"
has the meaning given in section 62A.011, subdivision 3.
Subd. 5. Hospital. "Hospital" means a health
care facility licensed as a hospital under sections 144.50 to 144.56.
Subd. 6. Medically
necessary. "Medically
necessary" means:
(1) safe and effective;
(2) not experimental or
investigational, except as provided in Code of Federal Regulations, title 42,
section 411.15(o);
(3) furnished in
accordance with acceptable medical standards of medical practice for the
diagnosis or treatment of the patient's condition or to improve the function of
a malformed body member;
(4) furnished in a
setting appropriate to the patient's medical need and condition;
(5) ordered and
furnished by qualified personnel;
(6) meets, but does not
exceed, the patient's medical need; and
(7) is at least as
beneficial as an existing and available medically appropriate alternative.
Subd. 7. Miscode. "Miscode" means a health
care provider or a health care provider's designee, using a coding system and
for billing purposes, assigns a numeric or alphanumeric code to a health
treatment or service provided to a patient and the code assigned does not
accurately reflect the health treatment or service provided based on factors
that include the patient's diagnosis and the complexity of the patient's
condition.
Subd. 8. Payment. "Payment" includes
co-payments and coinsurance and deductible payments made by a patient.
Sec. 2. [62J.806]
POLICY FOR COLLECTION OF MEDICAL DEBT.
Subdivision 1. Requirement. Each health care provider must make
available to the public the health care provider's policy for the collection of
medical debt from patients. This policy
must be made available by:
(1) clearly posting it on
the health care provider's website or, for health professionals, on the website
of the health clinic, group practice, or hospital at which the health
professional is employed or under contract; and
(2) providing a copy of
the policy to any individual who requests it.
Subd. 2. Content. A policy made available under this
section must at least specify the procedures followed by the health care
provider for:
(1) communicating with
patients about the medical debt owed and collecting medical debt;
(2) referring medical
debt to a collection agency or law firm for collection; and
(3) identifying medical
debt as uncollectible or satisfied, and ending collection activities.
Sec. 3. [62J.807]
DENIAL OF HEALTH TREATMENTS OR SERVICES DUE TO OUTSTANDING MEDICAL DEBT.
(a) A health care
provider must not deny medically necessary health treatments or services to a
patient or any member of the patient's family or household because of
outstanding medical debt owed by the patient or any member of the patient's
family or household to the health care provider, regardless of whether the
health treatment or service may be available from another health care provider.
(b) As a condition of
providing medically necessary health treatments or services in the
circumstances described in paragraph (a), a health care provider may require
the patient to enroll in a payment plan for the outstanding medical debt owed
to the health care provider.
Sec. 4. [62J.808]
BILLING AND PAYMENT FOR MISCODED HEALTH TREATMENTS AND SERVICES.
Subdivision 1. Participation
and cooperation required. Each
health care provider must participate in, and cooperate with, all processes and
investigations to identify, review, and correct the coding of health treatments
and services that are miscoded by the health care provider or a designee.
Subd. 2. Notice;
billing and payment during review. (a)
When a health care provider receives notice, other than notice from a health
plan company as provided in paragraph (b), or otherwise determines that a
health treatment or service may have been miscoded, the health care provider
must notify the health plan company administering the patient's health plan in
a timely manner of the potentially miscoded health treatment or service.
(b) When a health plan
company receives notice, other than notice from a health care provider as
provided in paragraph (a), or otherwise determines that a health treatment or
service may have been miscoded, the health plan company must notify the health care
provider who provided the health treatment or service of the potentially
miscoded health treatment or service.
(c) When a review of a
potentially miscoded health treatment or service is commenced, the health care
provider and health plan company must notify the patient that a miscoding
review is being conducted and that the patient will not be billed for any health
treatment or service subject to the review and is not required to submit
payments for any health treatment or service subject to the review until the
review is complete and any miscoded health treatments or services are correctly
coded.
(d) While a review of a
potentially miscoded health treatment or service is being conducted, the health
care provider and health plan company must not bill the patient for, or accept
payment from the patient for, any health treatment or service subject to the
review.
Subd. 3. Billing
and payment after completion of review.
The health care provider and health plan company may bill the
patient for, and accept payment from the patient for, the health treatment or
service that was subject to the miscoding review only after the review is
complete and any miscoded health treatments or services have been correctly
coded.
Sec. 5. Minnesota Statutes 2023 Supplement, section 144.587, subdivision 1, is amended to read:
Subdivision 1. Definitions. (a) The terms defined in this subdivision apply to this section and sections 144.588 to 144.589.
(b) "Charity care" means the provision of free or discounted care to a patient according to a hospital's financial assistance policies.
(c) "Hospital" means a private, nonprofit, or municipal hospital licensed under sections 144.50 to 144.56.
(d) "Insurance affordability program" has the meaning given in section 256B.02, subdivision 19.
(e) "Navigator" has the meaning given in section 62V.02, subdivision 9.
(f) "Presumptive eligibility" has the meaning given in section 256B.057, subdivision 12.
(g) "Revenue
recapture" means the use of the procedures in chapter 270A to
collect debt.
(h) (g) "Uninsured
service or treatment" means any service or treatment that is not covered
by:
(1) a health plan, contract, or policy that provides health coverage to a patient; or
(2) any other type of insurance coverage, including but not limited to no-fault automobile coverage, workers' compensation coverage, or liability coverage.
(i) (h) "Unreasonable
burden" includes requiring a patient to apply for enrollment in a state or
federal program for which the patient is obviously or categorically ineligible
or has been found to be ineligible in the previous 12 months.
Sec. 6. Minnesota Statutes 2023 Supplement, section 144.587, subdivision 4, is amended to read:
Subd. 4. Prohibited actions. (a) A hospital must not initiate one or more of the following actions until the hospital determines that the patient is ineligible for charity care or denies an application for charity care:
(1) offering to enroll or enrolling the patient in a payment plan;
(2) changing the terms of a patient's payment plan;
(3) offering the patient a loan or line of credit, application materials for a loan or line of credit, or assistance with applying for a loan or line of credit, for the payment of medical debt;
(4) referring a patient's debt
for collections, including in-house collections, third-party collections, revenue
recapture, or any other process for the collection of debt; or
(5) denying health care
services to the patient or any member of the patient's household because of
outstanding medical debt, regardless of whether the services are deemed
necessary or may be available from another provider; or
(6) (5) accepting
a credit card payment of over $500 for the medical debt owed to the hospital.
(b) A hospital is
subject to section 62J.807.
Sec. 7. Minnesota Statutes 2023 Supplement, section 151.555, subdivision 1, is amended to read:
Subdivision 1. Definitions. (a) For the purposes of this section, the terms defined in this subdivision have the meanings given.
(b) "Central repository" means a wholesale distributor that meets the requirements under subdivision 3 and enters into a contract with the Board of Pharmacy in accordance with this section.
(c) "Distribute" means to deliver, other than by administering or dispensing.
(d) "Donor" means:
(1) a health care
facility as defined in this subdivision an individual at least 18 years
of age, provided that the drug or medical
supply that is donated was obtained legally and meets the requirements of this
section for donation; or
(2) a skilled nursing
facility licensed under chapter 144A; any entity legally
authorized to possess medicine with a license or permit in good standing in the
state in which it is located, without further restrictions, including but not
limited to a health care facility, skilled nursing facility, assisted living facility,
pharmacy, wholesaler, and drug manufacturer.
(3) an assisted living
facility licensed under chapter 144G;
(4) a pharmacy licensed
under section 151.19, and located either in the state or outside the state;
(5) a drug wholesaler
licensed under section 151.47;
(6) a drug manufacturer
licensed under section 151.252; or
(7) an individual at
least 18 years of age, provided that the drug or medical supply that is donated
was obtained legally and meets the requirements of this section for donation.
(e) "Drug" means any prescription drug that has been approved for medical use in the United States, is listed in the United States Pharmacopoeia or National Formulary, and meets the criteria established under this section for donation; or any over-the-counter medication that meets the criteria established under this section for donation. This definition includes cancer drugs and antirejection drugs, but does not include controlled substances, as defined in section 152.01, subdivision 4, or a prescription drug that can only be dispensed to a patient registered with the drug's manufacturer in accordance with federal Food and Drug Administration requirements.
(f) "Health care facility" means:
(1) a physician's office or health care clinic where licensed practitioners provide health care to patients;
(2) a hospital licensed under section 144.50;
(3) a pharmacy licensed under section 151.19 and located in Minnesota; or
(4) a nonprofit community clinic, including a federally qualified health center; a rural health clinic; public health clinic; or other community clinic that provides health care utilizing a sliding fee scale to patients who are low‑income, uninsured, or underinsured.
(g) "Local repository" means a health care facility that elects to accept donated drugs and medical supplies and meets the requirements of subdivision 4.
(h) "Medical supplies" or "supplies" means any prescription or nonprescription medical supplies needed to administer a drug.
(i) "Original, sealed, unopened, tamper-evident packaging" means packaging that is sealed, unopened, and tamper-evident, including a manufacturer's original unit dose or unit-of-use container, a repackager's original unit dose or unit-of-use container, or unit-dose packaging prepared by a licensed pharmacy according to the standards of Minnesota Rules, part 6800.3750.
(j) "Practitioner" has the meaning given in section 151.01, subdivision 23, except that it does not include a veterinarian.
Sec. 8. Minnesota Statutes 2023 Supplement, section 151.555, subdivision 4, is amended to read:
Subd. 4. Local repository requirements. (a) To be eligible for participation in the medication repository program, a health care facility must agree to comply with all applicable federal and state laws, rules, and regulations pertaining to the medication repository program, drug storage, and dispensing. The facility must also agree to maintain in good standing any required state license or registration that may apply to the facility.
(b) A local repository may elect to participate in the program by submitting the following information to the central repository on a form developed by the board and made available on the board's website:
(1) the name, street address, and telephone number of the health care facility and any state-issued license or registration number issued to the facility, including the issuing state agency;
(2) the name and telephone number of a responsible pharmacist or practitioner who is employed by or under contract with the health care facility; and
(3) a statement signed and dated by the responsible pharmacist or practitioner indicating that the health care facility meets the eligibility requirements under this section and agrees to comply with this section.
(c) Participation in the
medication repository program is voluntary.
A local repository may withdraw from participation in the medication
repository program at any time by providing written notice to the central
repository on a form developed by the board and made available on the board's
website. The central repository shall
provide the board with a copy of the withdrawal notice within ten business days
from the date of receipt of the withdrawal notice.
Sec. 9. Minnesota Statutes 2023 Supplement, section 151.555, subdivision 5, is amended to read:
Subd. 5. Individual
eligibility and application requirements.
(a) To be eligible for the medication repository program At
the time of or before receiving donated drugs or supplies as a new eligible
patient, an individual must submit to a local repository an electronic
or physical intake application form that is signed by the individual and
attests that the individual:
(1) is a resident of Minnesota;
(2) is uninsured and is
not enrolled in the medical assistance program under chapter 256B or
the MinnesotaCare program under chapter 256L, has no prescription
drug coverage, or is underinsured;
(3) acknowledges that the drugs or medical supplies to be received
through the program may have been donated; and
(4) consents to a waiver of the child-resistant packaging requirements of the federal Poison Prevention Packaging Act.
(b) Upon determining
that an individual is eligible for the program, the local repository shall
furnish the individual with an identification card. The card shall be valid for one year from the
date of issuance and may be used at any local repository. A new identification card may be issued upon
expiration once the individual submits a new application form.
(c) (b) The
local repository shall send a copy of the intake application form to the
central repository by regular mail, facsimile, or secured email within ten days
from the date the application is approved by the local repository.
(d) (c) The
board shall develop and make available on the board's website an application
form and the format for the identification card.
Sec. 10. Minnesota Statutes 2023 Supplement, section 151.555, subdivision 6, is amended to read:
Subd. 6. Standards and procedures for accepting donations of drugs and supplies. (a) Notwithstanding any other law or rule, a donor may donate drugs or medical supplies to the central repository or a local repository if the drug or supply meets the requirements of this section as determined by a pharmacist or practitioner who is employed by or under contract with the central repository or a local repository.
(b) A drug is eligible for donation under the medication repository
program if the following requirements are met:
(1) the donation is
accompanied by a medication repository donor form described under paragraph (d)
that is signed by an individual who is authorized by the donor to attest to the
donor's knowledge in accordance with paragraph (d);
(2) (1) the
drug's expiration date is at least six months after the date the drug was
donated. If a donated drug bears an
expiration date that is less than six months from the donation date, the drug
may be accepted and distributed if the drug is in high demand and can be
dispensed for use by a patient before the drug's expiration date;
(3) (2) the
drug is in its original, sealed, unopened, tamper-evident packaging that
includes the expiration date. Single-unit-dose
drugs may be accepted if the single-unit-dose packaging is unopened;
(4) (3) the
drug or the packaging does not have any physical signs of tampering,
misbranding, deterioration, compromised integrity, or adulteration;
(5) (4) the drug does not require storage temperatures other than normal room temperature as specified by the manufacturer or United States Pharmacopoeia, unless the drug is being donated directly by its manufacturer, a wholesale drug distributor, or a pharmacy located in Minnesota; and
(6) (5) the
drug is not a controlled substance.
(c) A medical supply is eligible for donation under the medication repository program if the following requirements are met:
(1) the supply has no physical signs of tampering, misbranding, or alteration and there is no reason to believe it has been adulterated, tampered with, or misbranded;
(2) the supply is in its
original, unopened, sealed packaging; and
(3) the donation is
accompanied by a medication repository donor form described under paragraph (d)
that is signed by an individual who is authorized by the donor to attest to the
donor's knowledge in accordance with paragraph (d); and
(4) (3) if the
supply bears an expiration date, the date is at least six months later than the
date the supply was donated. If the
donated supply bears an expiration date that is less than six months from the
date the supply was donated, the supply may be accepted and distributed if the
supply is in high demand and can be dispensed for use by a patient before the
supply's expiration date.
(d) The board shall develop
the medication repository donor form and make it available on the board's
website. The form must state that to
the best of the donor's knowledge the donated drug or supply has been properly
stored under appropriate temperature and humidity conditions and that the drug
or supply has never been opened, used, tampered with, adulterated, or
misbranded. Prior to the first
donation from a new donor, a central repository or local repository shall verify
and record the following information on the donor form:
(1) the donor's name,
address, phone number, and license number, if applicable;
(2) that the donor will
only make donations in accordance with the program;
(3) to the best of the
donor's knowledge, only drugs or supplies that have been properly stored under
appropriate temperature and humidity conditions will be donated; and
(4) to the best of the
donor's knowledge, only drugs or supplies that have never been opened, used,
tampered with, adulterated, or misbranded will be donated.
(e) Notwithstanding any
other law or rule, a central repository or a local repository may receive
donated drugs from donors. Donated
drugs and supplies may be shipped or delivered to the premises of the central
repository or a local repository, and shall be inspected by a pharmacist or an
authorized practitioner who is employed by or under contract with the
repository and who has been designated by the repository to accept donations
prior to dispensing. A drop box
must not be used to deliver or accept donations.
(f) The central repository
and local repository shall maintain a written or electronic inventory of
all drugs and supplies donated to the repository upon acceptance of each
drug or supply. For each drug, the
inventory must include the drug's name, strength, quantity, manufacturer,
expiration date, and the date the drug was donated. For each medical supply, the inventory must
include a description of the supply, its manufacturer, the date the supply was
donated, and, if applicable, the supply's brand name and expiration date. The board may waive the requirement under
this paragraph if an entity is under common ownership or control with a central
repository or local repository and either the entity or the repository
maintains an inventory containing all the information required under this
paragraph.
Sec. 11. Minnesota Statutes 2023 Supplement, section 151.555, subdivision 7, is amended to read:
Subd. 7. Standards
and procedures for inspecting and storing donated drugs and supplies. (a) A pharmacist or authorized
practitioner who is employed by or under contract with the central repository
or a local repository shall inspect all donated drugs and supplies before the
drug or supply is dispensed to determine, to the extent reasonably possible in
the professional judgment of the pharmacist or practitioner, that the drug or
supply is not adulterated or misbranded, has not been tampered with, is safe and
suitable for dispensing, has not been subject to a recall, and meets the
requirements for donation. The
pharmacist or practitioner who inspects the drugs or supplies shall sign an
inspection record stating that the requirements for donation have been met. If a local repository receives drugs and
supplies from the central repository, the local repository does not need to
reinspect the drugs and supplies.
(b) The central repository and local repositories shall store donated drugs and supplies in a secure storage area under environmental conditions appropriate for the drug or supply being stored. Donated drugs and supplies may not be stored with nondonated inventory.
(c) The central repository and local repositories shall dispose of all drugs and medical supplies that are not suitable for donation in compliance with applicable federal and state statutes, regulations, and rules concerning hazardous waste.
(d) In the event that controlled substances or drugs that can only be dispensed to a patient registered with the drug's manufacturer are shipped or delivered to a central or local repository for donation, the shipment delivery must be documented by the repository and returned immediately to the donor or the donor's representative that provided the drugs.
(e) Each repository must develop drug and medical supply recall policies and procedures. If a repository receives a recall notification, the repository shall destroy all of the drug or medical supply in its inventory that is the subject of the recall and complete a record of destruction form in accordance with paragraph (f). If a drug or medical supply that is the subject of a Class I or Class II recall has been dispensed, the repository shall immediately notify the recipient of the recalled drug or medical supply. A drug that potentially is subject to a recall need not be destroyed if its packaging bears a lot number and that lot of the drug is not subject to the recall. If no lot number is on the drug's packaging, it must be destroyed.
(f) A record of destruction of donated drugs and supplies that are not dispensed under subdivision 8, are subject to a recall under paragraph (e), or are not suitable for donation shall be maintained by the repository for at least two years. For each drug or supply destroyed, the record shall include the following information:
(1) the date of destruction;
(2) the name, strength, and quantity of the drug destroyed; and
(3) the name of the person or firm that destroyed the drug.
No other record of destruction is required.
Sec. 12. Minnesota Statutes 2023 Supplement, section 151.555, subdivision 8, is amended to read:
Subd. 8. Dispensing requirements. (a) Donated prescription drugs and supplies may be dispensed if the drugs or supplies are prescribed by a practitioner for use by an eligible individual and are dispensed by a pharmacist or practitioner. A repository shall dispense drugs and supplies to eligible individuals in the following priority order: (1) individuals who are uninsured; (2) individuals with no prescription drug coverage; and (3) individuals who are
underinsured. A repository shall dispense donated drugs in compliance with applicable federal and state laws and regulations for dispensing drugs, including all requirements relating to packaging, labeling, record keeping, drug utilization review, and patient counseling.
(b) Before dispensing or administering a drug or supply, the pharmacist or practitioner shall visually inspect the drug or supply for adulteration, misbranding, tampering, and date of expiration. Drugs or supplies that have expired or appear upon visual inspection to be adulterated, misbranded, or tampered with in any way must not be dispensed or administered.
(c) Before a the
first drug or supply is dispensed or administered to an individual, the
individual must sign a an electronic or physical drug repository
recipient form acknowledging that the individual understands the information
stated on the form. The board shall
develop the form and make it available on the board's website. The form must include the following
information:
(1) that the drug or supply being dispensed or administered has been donated and may have been previously dispensed;
(2) that a visual inspection has been conducted by the pharmacist or practitioner to ensure that the drug or supply has not expired, has not been adulterated or misbranded, and is in its original, unopened packaging; and
(3) that the dispensing pharmacist, the dispensing or administering practitioner, the central repository or local repository, the Board of Pharmacy, and any other participant of the medication repository program cannot guarantee the safety of the drug or medical supply being dispensed or administered and that the pharmacist or practitioner has determined that the drug or supply is safe to dispense or administer based on the accuracy of the donor's form submitted with the donated drug or medical supply and the visual inspection required to be performed by the pharmacist or practitioner before dispensing or administering.
Sec. 13. Minnesota Statutes 2023 Supplement, section 151.555, subdivision 9, is amended to read:
Subd. 9. Handling fees. (a) The central or local repository may charge the individual receiving a drug or supply a handling fee of no more than 250 percent of the medical assistance program dispensing fee for each drug or medical supply dispensed or administered by that repository.
(b) A repository that dispenses or administers a drug or medical supply through the medication repository program shall not receive reimbursement under the medical assistance program or the MinnesotaCare program for that dispensed or administered drug or supply.
(c) A supply or handling
fee must not be charged to an individual enrolled in the medical assistance or
MinnesotaCare program.
Sec. 14. Minnesota Statutes 2023 Supplement, section 151.555, subdivision 11, is amended to read:
Subd. 11. Forms
and record-keeping requirements. (a)
The following forms developed for the administration of this program shall
be utilized by the participants of the program and shall be available on
the board's website:
(1) intake application form described under subdivision 5;
(2) local repository participation form described under subdivision 4;
(3) local repository withdrawal form described under subdivision 4;
(4) medication repository donor form described under subdivision 6;
(5) record of destruction form described under subdivision 7; and
(6) medication repository recipient form described under subdivision 8.
Participants may use substantively similar
electronic or physical forms.
(b) All records, including
drug inventory, inspection, and disposal of donated drugs and medical
supplies, must be maintained by a repository for a minimum of two years. Records required as part of this program must
be maintained pursuant to all applicable practice acts.
(c) Data collected by the medication repository program from all local repositories shall be submitted quarterly or upon request to the central repository. Data collected may consist of the information, records, and forms required to be collected under this section.
(d) The central repository shall submit reports to the board as required by the contract or upon request of the board.
Sec. 15. Minnesota Statutes 2023 Supplement, section 151.555, subdivision 12, is amended to read:
Subd. 12. Liability. (a) The manufacturer of a drug or supply is not subject to criminal or civil liability for injury, death, or loss to a person or to property for causes of action described in clauses (1) and (2). A manufacturer is not liable for:
(1) the intentional or unintentional alteration of the drug or supply by a party not under the control of the manufacturer; or
(2) the failure of a party not under the control of the manufacturer to transfer or communicate product or consumer information or the expiration date of the donated drug or supply.
(b) A health care facility
participating in the program, a pharmacist dispensing a drug or supply pursuant
to the program, a practitioner dispensing or administering a drug or supply
pursuant to the program, or a donor of a drug or medical supply, or a
person or entity that facilitates any of the above is immune from civil
liability for an act or omission that causes injury to or the death of an
individual to whom the drug or supply is dispensed and no disciplinary action
by a health-related licensing board shall be taken against a pharmacist or
practitioner person or entity so long as the drug or supply is
donated, accepted, distributed, and dispensed according to the requirements of
this section. This immunity does not
apply if the act or omission involves reckless, wanton, or intentional
misconduct, or malpractice unrelated to the quality of the drug or medical
supply.
Sec. 16. Minnesota Statutes 2023 Supplement, section 151.74, subdivision 3, is amended to read:
Subd. 3. Access to urgent-need insulin. (a) MNsure shall develop an application form to be used by an individual who is in urgent need of insulin. The application must ask the individual to attest to the eligibility requirements described in subdivision 2. The form shall be accessible through MNsure's website. MNsure shall also make the form available to pharmacies and health care providers who prescribe or dispense insulin, hospital emergency departments, urgent care clinics, and community health clinics. By submitting a completed, signed, and dated application to a pharmacy, the individual attests that the information contained in the application is correct.
(b) If the individual is in urgent need of insulin, the individual may present a completed, signed, and dated application form to a pharmacy. The individual must also:
(1) have a valid insulin prescription; and
(2) present the pharmacist with identification indicating Minnesota residency in the form of a valid Minnesota identification card, driver's license or permit, individual taxpayer identification number, or Tribal identification card as defined in section 171.072, paragraph (b). If the individual in urgent need of insulin is under the age of 18, the individual's parent or legal guardian must provide the pharmacist with proof of residency.
(c) Upon receipt of a completed and signed application, the pharmacist shall dispense the prescribed insulin in an amount that will provide the individual with a 30-day supply. The pharmacy must notify the health care practitioner who issued the prescription order no later than 72 hours after the insulin is dispensed.
(d) The pharmacy may submit to the manufacturer of the dispensed insulin product or to the manufacturer's vendor a claim for payment that is in accordance with the National Council for Prescription Drug Program standards for electronic claims processing, unless the manufacturer agrees to send to the pharmacy a replacement supply of the same insulin as dispensed in the amount dispensed. If the pharmacy submits an electronic claim to the manufacturer or the manufacturer's vendor, the manufacturer or vendor shall reimburse the pharmacy in an amount that covers the pharmacy's acquisition cost.
(e) The pharmacy may collect an insulin co-payment from the individual to cover the pharmacy's costs of processing and dispensing in an amount not to exceed $35 for the 30-day supply of insulin dispensed.
(f) The pharmacy shall also
provide each eligible individual with the information sheet described in
subdivision 7 and a list of trained navigators provided by the Board of
Pharmacy for the individual to contact if the individual is in need of
accessing needs to access ongoing insulin coverage options,
including assistance in:
(1) applying for medical assistance or MinnesotaCare;
(2) applying for a qualified health plan offered through MNsure, subject to open and special enrollment periods;
(3) accessing information on providers who participate in prescription drug discount programs, including providers who are authorized to participate in the 340B program under section 340b of the federal Public Health Services Act, United States Code, title 42, section 256b; and
(4) accessing insulin manufacturers' patient assistance programs, co-payment assistance programs, and other foundation-based programs.
(g) The pharmacist shall retain a copy of the application form submitted by the individual to the pharmacy for reporting and auditing purposes.
(h) A manufacturer may
submit to the commissioner of administration a request for reimbursement in an
amount not to exceed $35 for each 30-day supply of insulin the manufacturer
provides under paragraph (d). The
commissioner of administration shall determine the manner and format for
submitting and processing requests for reimbursement. After receiving a reimbursement request, the
commissioner of administration shall reimburse the manufacturer in an amount
not to exceed $35 for each 30-day supply of insulin the manufacturer provided
under paragraph (d).
EFFECTIVE DATE. This
section is effective July 1, 2024.
Sec. 17. Minnesota Statutes 2022, section 151.74, subdivision 6, is amended to read:
Subd. 6. Continuing safety net program; process. (a) The individual shall submit to a pharmacy the statement of eligibility provided by the manufacturer under subdivision 5, paragraph (b). Upon receipt of an individual's eligibility status, the pharmacy shall submit an order containing the name of the insulin product and the daily dosage amount as contained in a valid prescription to the product's manufacturer.
(b) The pharmacy must include with the order to the manufacturer the following information:
(1) the pharmacy's name and shipping address;
(2) the pharmacy's office telephone number, fax number, email address, and contact name; and
(3) any specific days or times when deliveries are not accepted by the pharmacy.
(c) Upon receipt of an order from a pharmacy and the information described in paragraph (b), the manufacturer shall send to the pharmacy a 90-day supply of insulin as ordered, unless a lesser amount is requested in the order, at no charge to the individual or pharmacy.
(d) Except as authorized under paragraph (e), the pharmacy shall provide the insulin to the individual at no charge to the individual. The pharmacy shall not provide insulin received from the manufacturer to any individual other than the individual associated with the specific order. The pharmacy shall not seek reimbursement for the insulin received from the manufacturer or from any third-party payer.
(e) The pharmacy may collect a co-payment from the individual to cover the pharmacy's costs for processing and dispensing in an amount not to exceed $50 for each 90-day supply if the insulin is sent to the pharmacy.
(f) The pharmacy may submit to a manufacturer a reorder for an individual if the individual's eligibility statement has not expired. Upon receipt of a reorder from a pharmacy, the manufacturer must send to the pharmacy an additional 90-day supply of the product, unless a lesser amount is requested, at no charge to the individual or pharmacy if the individual's eligibility statement has not expired.
(g) Notwithstanding paragraph (c), a manufacturer may send the insulin as ordered directly to the individual if the manufacturer provides a mail order service option.
(h) A manufacturer may
submit to the commissioner of administration a request for reimbursement in an
amount not to exceed $105 for each 90-day supply of insulin the manufacturer
provides under paragraphs (c) and (f). The
commissioner of administration shall determine the manner and format for
submitting and processing requests for reimbursement. After receiving a reimbursement request, the
commissioner of administration shall reimburse the manufacturer in an amount
not to exceed $105 for each 90-day supply of insulin the manufacturer provided
under paragraphs (c) and (f). If the
manufacturer provides less than a 90-day supply of insulin under paragraphs (c)
and (f), the manufacturer may submit a request for reimbursement not to exceed
$35 for each 30-day supply of insulin provided.
EFFECTIVE DATE. This
section is effective July 1, 2024.
Sec. 18. [151.741]
INSULIN MANUFACTURER REGISTRATION FEE.
Subdivision 1. Definitions. (a) For purposes of this section, the
following terms have the meanings given.
(b) "Board"
means the Minnesota Board of Pharmacy under section 151.02.
(c)
"Manufacturer" means a manufacturer licensed under section 151.252
and engaged in the manufacturing of prescription insulin.
Subd. 2. Assessment
of registration fee. (a) The
board shall assess each manufacturer an annual registration fee of $100,000,
except as provided in paragraph (b). The
board shall notify each manufacturer of this requirement beginning November 1,
2024, and each November 1 thereafter.
(b) A manufacturer may
request an exemption from the annual registration fee. The board shall exempt a manufacturer from
the annual registration fee if the manufacturer can demonstrate to the board,
in the form and manner specified by the board, that sales of prescription
insulin produced by that manufacturer and sold or delivered within or into the
state totaled $2,000,000 or less in the previous calendar year.
Subd. 3. Payment
of the registration fee; deposit of fee.
(a) Each manufacturer must pay the registration fee by March 1,
2025, and by each March 1 thereafter. In
the event of a change in ownership of the manufacturer, the new owner must pay
the registration fee that the original owner would have been assessed had the
original owner retained ownership. The
board may assess a late fee of ten percent per month or any portion of a month
that the registration fee is paid after the due date.
(b) The registration
fee, including any late fees, must be deposited in the insulin safety net
program account.
Subd. 4. Insulin
safety net program account. The
insulin safety net program account is established in the special revenue fund
in the state treasury. Money in the
account is appropriated each fiscal year to:
(1) the MNsure board in an amount sufficient to carry out assigned
duties under section 151.74, subdivision 7; and
(2) the Board of
Pharmacy in an amount sufficient to cover costs incurred by the board in
assessing and collecting the registration fee under this section and in
administering the insulin safety net program under section 151.74.
Subd. 5. Insulin
repayment account; annual transfer from health care access fund. (a) The insulin repayment account is
established in the special revenue fund in the state treasury. Money in the account is appropriated each
fiscal year to the commissioner of administration in an amount sufficient for
the commissioner to reimburse manufacturers for insulin dispensed under the
insulin safety net program in section 151.74, in accordance with section
151.74, subdivisions 3, paragraph (h), and 6, paragraph (h), and to cover costs
incurred by the commissioner in providing these reimbursement payments.
(b) The commissioner of
management and budget shall transfer from the health care access fund to the
insulin repayment account, beginning July 1, 2025, and each July 1 thereafter,
an amount sufficient for the commissioner of administration to implement paragraph
(a).
Subd. 6. Contingent
transfer by commissioner. If
subdivisions 2 and 3, or the application of subdivisions 2 and 3 to any person
or circumstance, are held invalid for any reason in a court of competent
jurisdiction, the validity of subdivisions 2 and 3 does not affect other
provisions of this act, and the commissioner of management and budget shall
annually transfer from the health care access fund to the insulin safety net
program account an amount sufficient to implement subdivision 4.
EFFECTIVE DATE. This
section is effective July 1, 2024.
Sec. 19. Minnesota Statutes 2023 Supplement, section 270A.03, subdivision 2, is amended to read:
Subd. 2. Claimant
agency. "Claimant agency"
means any state agency, as defined by section 14.02, subdivision 2, the regents
of the University of Minnesota, any district court of the state, any county,
any statutory or home rule charter city, including a city that is presenting a
claim for a municipal hospital or a public library or a municipal
ambulance service, a hospital district, any ambulance service licensed under
chapter 144E, any public
agency responsible for child support enforcement, any public agency responsible for the collection of court-ordered restitution, and any public agency established by general or special law that is responsible for the administration of a low-income housing program.
Sec. 20. [332.371]
MEDICAL DEBT CREDIT REPORTING PROHIBITED.
(a) A consumer reporting
agency is prohibited from making a consumer report containing an item of
information that the consumer reporting agency knows or should know concerns
(1) medical information; or (2) debt arising from: (i) the provision of medical care, treatment,
services, devices, or medicines; or (ii) procedures to maintain, diagnose, or
treat a person's physical or mental health.
(b) For purposes of this
section, "consumer report," "consumer reporting agency,"
and "medical information" have the meanings given in the Fair Credit
Reporting Act, United States Code, title 15, section 1681a.
Sec. 21. [332C.01]
DEFINITIONS.
Subdivision 1. Application. For purposes of this chapter, the
following terms have the meanings given.
Subd. 2. Collecting
party. "Collecting
party" means a party engaged in the collection of medical debt for any
account, bill, or other indebtedness, except as hereinafter provided.
Subd. 3. Debtor. "Debtor" means a person
obligated or alleged to be obligated to pay any debt.
Subd. 4. Medical
debt. "Medical
debt" means debt incurred primarily for necessary medical care and related
services. Medical debt does not include
debt charged to a credit card unless the credit card is issued under a credit
plan offered solely for the payment of health care treatment or services.
Subd. 5. Person. "Person" means any
individual, partnership, association, or corporation.
Sec. 22. [332C.02]
PROHIBITED PRACTICES.
No collecting party
shall:
(1) in a collection
letter, publication, invoice, or any oral or written communication, threaten
wage garnishment or legal suit by a particular lawyer, unless the collecting
party has actually retained the lawyer to do so;
(2) use or employ
sheriffs or any other officer authorized to serve legal papers in connection
with the collection of a claim, except when performing their legally authorized
duties;
(3) use or threaten to
use methods of collection which violate Minnesota law;
(4) furnish legal advice
to debtors or represent that the collecting party is competent or able to
furnish legal advice to debtors;
(5) communicate with
debtors in a misleading or deceptive manner by falsely using the stationery of
a lawyer, forms or instruments which only lawyers are authorized to prepare, or
instruments which simulate the form and appearance of judicial process;
(6) publish or cause to
be published any list of debtors, use shame cards or shame automobiles,
advertise or threaten to advertise for sale any claim as a means of forcing
payment thereof, or use similar devices or methods of intimidation;
(7) operate under a name or in
a manner which falsely implies the collecting party is a branch of or
associated with any department of federal, state, county, or local government
or an agency thereof;
(8) transact business or
hold itself out as a debt settlement company, debt management company, debt
adjuster, or any person who settles, adjusts, prorates, pools, liquidates, or
pays the indebtedness of a debtor, unless there is no charge to the debtor, or
the pooling or liquidation is done pursuant to court order or under the
supervision of a creditor's committee;
(9) unless an exemption
in the law exists, violate Code of Federal Regulations, title 12, part 1006,
while attempting to collect on any account, bill, or other indebtedness. For purposes of this section, Public Law
95-109 and Code of Federal Regulations, title 12, part 1006, apply to
collecting parties;
(10) communicate with a
debtor by use of an automatic telephone dialing system or an artificial or
prerecorded voice after the debtor expressly informs the collecting party to
cease communication utilizing an automatic telephone dialing system or an artificial
or prerecorded voice. For purposes of
this clause, an automatic telephone dialing system or an artificial or
prerecorded voice includes but is not limited to (i) artificial intelligence
chat bots, and (ii) the usage of the term under the Telephone Consumer
Protection Act, United States Code, title 47, section 227(b)(1)(A);
(11) in collection
letters or publications, or in any oral or written communication, imply or
suggest that medically necessary health treatment or services will be denied as
a result of a medical debt;
(12) when a debtor has a
listed telephone number, enlist the aid of a neighbor or third party to request
that the debtor contact the collecting party, except a person who resides with
the debtor or a third party with whom the debtor has authorized with the
collecting party to place the request. This
clause does not apply to a call back message left at the debtor's place of
employment which is limited solely to the collecting party's telephone number
and name;
(13) when attempting to
collect a medical debt, fail to provide the debtor with the full name of the
collecting party, as registered with the secretary of state;
(14) fail to return any
amount of overpayment from a debtor to the debtor or to the state of Minnesota
pursuant to the requirements of chapter 345;
(15) accept currency or
coin as payment for a medical debt without issuing an original receipt to the
debtor and maintaining a duplicate receipt in the debtor's payment records;
(16) attempt to collect
any amount, including any interest, fee, charge, or expense incidental to the
charge-off obligation, from a debtor unless the amount is expressly authorized
by the agreement creating the medical debt or is otherwise permitted by law;
(17) falsify any
documents with the intent to deceive;
(18) when initially
contacting a Minnesota debtor by mail to collect a medical debt, fail to
include a disclosure on the contact notice, in a type size or font which is
equal to or larger than the largest other type of type size or font used in the
text of the notice, that includes and identifies the Office of the Minnesota
Attorney General's general telephone number, and states: "You have the right to hire your own
attorney to represent you in this matter.";
(19) commence legal
action to collect a medical debt outside the limitations period set forth in
section 541.053;
(20) report to a credit
reporting agency any medical debt which the collecting party knows or should
know is or was originally owed to a health care provider, as defined in section
62J.805, subdivision 2; or
(21) challenge a
debtor's claim of exemption to garnishment or levy in a manner that is
baseless, frivolous, or otherwise in bad faith.
Sec. 23. [332C.04]
DEFENDING MEDICAL DEBT CASES.
A debtor who
successfully defends against a claim for payment of medical debt that is
alleged by a collecting party must be awarded the debtor's costs, including a
reasonable attorney fee, incurred in defending against the collecting party's
claim for debt payment.
Sec. 24. [332C.05]
ENFORCEMENT.
(a) The attorney general
may enforce this chapter under section 8.31.
(b) A collecting party
that violates this chapter is strictly liable to the debtor in question for the
sum of:
(1) actual damage
sustained by the debtor as a result of the violation;
(2) additional damages
as the court may allow, but not exceeding $1,000 per violation; and
(3) in the case of any
successful action to enforce the foregoing, the costs of the action, together
with a reasonable attorney fee as determined by the court.
(c) A collecting party
that willfully and maliciously violates this chapter is strictly liable to the
debtor for three times the sums allowable under paragraph (b), clauses (1) and
(2).
(d) The dollar amount
limit under paragraph (b), clause (2), changes on July 1 of each even-numbered
year in an amount equal to changes made in the Consumer Price Index, compiled
by the United States Bureau of Labor Statistics. The Consumer Price Index for December 2024 is
the reference base index. If the
Consumer Price Index is revised, the percentage of change made under this
section must be calculated on the basis of the revised Consumer Price Index. If a Consumer Price Index revision changes
the reference base index, a revised reference base index must be determined by
multiplying the reference base index that is effective at the time by the
rebasing factor furnished by the Bureau of Labor Statistics.
(e) If the Consumer
Price Index is superseded, the Consumer Price Index referred to in this section
is the Consumer Price Index represented by the Bureau of Labor Statistics as
most accurately reflecting changes in the prices paid by consumers for consumer
goods and services.
(f) The attorney general
must publish the base reference index under paragraph (c) in the State Register
no later than September 1, 2024. The
attorney general must calculate and then publish the revised Consumer Price
Index under paragraph (c) in the State Register no later than September 1 each
even-numbered year.
(g) An action brought
under this section benefits the public.
Sec. 25. Minnesota Statutes 2022, section 334.01, is amended by adding a subdivision to read:
Subd. 4. Contracts
for medical care. Interest
for any debt owed to a health care provider incurred in exchange for care,
treatment, services, devices, medicines, or procedures to maintain, diagnose,
or treat a person's physical or mental health shall be at a rate of $4 upon
$100 for a year.
Sec. 26. Minnesota Statutes 2022, section 519.05, is amended to read:
519.05 LIABILITY OF HUSBAND AND WIFE SPOUSES.
(a) A spouse is not liable
to a creditor for any debts of the other spouse. Where husband and wife are living
together, they Spouses shall be jointly and severally liable for necessary
medical services that have been furnished to either spouse, including any
claims arising under section 246.53, 256B.15, 256D.16, or 261.04, and
necessary household articles and supplies furnished to and used by the family. Notwithstanding this paragraph, in a
proceeding under chapter 518 the court may apportion such debt between the
spouses.
(b) Either spouse may close a credit card account or other unsecured consumer line of credit on which both spouses are contractually liable, by giving written notice to the creditor.
Sec. 27. Laws 2020, chapter 73, section 8, is amended to read:
Sec. 8. APPROPRIATIONS.
(a) $297,000 is
appropriated in fiscal year 2020 from the health care access fund to the Board
of Directors of MNsure to train navigators to assist individuals and provide
compensation as required for the insulin safety net program under
Minnesota Statutes, section 151.74, subdivision 7. Of this appropriation, $108,000 is for
implementing the training requirements for navigators and $189,000 is for
application assistance bonus payments.
This is a onetime appropriation and is available until December 31, 2024
June 30, 2027.
(b) $250,000 is appropriated in fiscal year 2020 from the health care access fund to the Board of Directors of MNsure for a public awareness campaign for the insulin safety net program established under Minnesota Statutes, section 151.74. This is a onetime appropriation and is available until December 31, 2024.
(c) $76,000 is appropriated in fiscal year 2021 from the health care access fund to the Board of Pharmacy to implement Minnesota Statutes, section 151.74. The base for this appropriation is $76,000 in fiscal year 2022; $76,000 in fiscal year 2023; $76,000 in fiscal year 2024; $38,000 in fiscal year 2025; and $0 in fiscal year 2026.
(d) $136,000 in fiscal year 2021 is appropriated from the health care access fund to the commissioner of health to implement the survey to assess program satisfaction in Minnesota Statutes, section 151.74, subdivision 12. The base for this appropriation is $80,000 in fiscal year 2022 and $0 in fiscal year 2023. This is a onetime appropriation.
Sec. 28. REPEALER;
SUNSET FOR THE LONG-TERM SAFETY NET INSULIN PROGRAM.
Minnesota Statutes 2022,
section 151.74, subdivision 16, is repealed.
EFFECTIVE DATE. This
section is effective the day following final enactment.
ARTICLE 4
HEALTH INSURANCE
Section 1. Minnesota Statutes 2022, section 62A.28, subdivision 2, is amended to read:
Subd. 2. Required
coverage. (a) Every policy,
plan, certificate, or contract referred to in subdivision 1 issued or
renewed after August 1, 1987, must provide coverage for scalp hair
prostheses, including all equipment and accessories necessary of regular use
of scalp hair prostheses, worn for hair loss suffered as a result of a
health condition, including, but not limited to, alopecia areata or the
treatment for cancer, unless there is a clinical basis for limitation.
(b) The coverage required by this section is subject to the co-payment, coinsurance, deductible, and other enrollee cost-sharing requirements that apply to similar types of items under the policy, plan, certificate, or contract and may be limited to one prosthesis per benefit year.
(c) The coverage
required by this section for scalp hair prostheses is limited to $1,000 per
benefit year.
(d) A scalp hair
prostheses must be prescribed by a doctor to be covered under this section.
EFFECTIVE DATE. This
section is effective January 1, 2025, and applies to all policies, plans,
certificates, and contracts offered, issued, or renewed on or after that date.
Sec. 2. [62A.3098]
RAPID WHOLE GENOME SEQUENCING; COVERAGE.
Subdivision 1. Definition. For purposes of this section,
"rapid whole genome sequencing" or "rWGS" means an
investigation of the entire human genome, including coding and noncoding
regions and mitochondrial deoxyribonucleic acid, to identify disease-causing
genetic changes that returns the final results in 14 days. Rapid whole genome sequencing includes
patient-only whole genome sequencing and duo and trio whole genome sequencing
of the patient and the patient's biological parent or parents.
Subd. 2. Required
coverage. A health plan that
provides coverage to Minnesota residents must cover rWGS testing if the
enrollee:
(1) is 21 years of age
or younger;
(2) has a complex or
acute illness of unknown etiology that is not confirmed to have been caused by
an environmental exposure, toxic ingestion, an infection with a normal response
to therapy, or trauma; and
(3) is receiving inpatient hospital services in an intensive care unit
or a neonatal or high acuity pediatric care unit.
Subd. 3. Coverage
criteria. Coverage may be
based on the following medical necessity criteria:
(1) the enrollee has
symptoms that suggest a broad differential diagnosis that would require an
evaluation by multiple genetic tests if rWGS testing is not performed;
(2) timely
identification of a molecular diagnosis is necessary in order to guide clinical
decision making, and the rWGS testing may aid in guiding the treatment or
management of the enrollee's condition; and
(3) the enrollee's
complex or acute illness of unknown etiology includes at least one of the
following conditions:
(i) congenital anomalies
involving at least two organ systems, or complex or multiple congenital
anomalies in one organ system;
(ii) specific organ
malformations that are highly suggestive of a genetic etiology;
(iii) abnormal
laboratory tests or abnormal chemistry profiles suggesting the presence of a
genetic disease, complex metabolic disorder, or inborn error of metabolism;
(iv) refractory or
severe hypoglycemia or hyperglycemia;
(v) abnormal response to
therapy related to an underlying medical condition affecting vital organs or
bodily systems;
(vi) severe muscle weakness,
rigidity, or spasticity;
(vii) refractory
seizures;
(viii) a high-risk
stratification on evaluation for a brief resolved unexplained event with any of
the following features:
(A) a recurrent event
without respiratory infection;
(B) a recurrent
seizure-like event; or
(C) a recurrent
cardiopulmonary resuscitation;
(ix) abnormal cardiac
diagnostic testing results that are suggestive of possible channelopathies,
arrhythmias, cardiomyopathies, myocarditis, or structural heart disease;
(x) abnormal diagnostic
imaging studies that are suggestive of underlying genetic condition;
(xi) abnormal
physiologic function studies that are suggestive of an underlying genetic
etiology; or
(xii) family genetic
history related to the patient's condition.
Subd. 4. Cost
sharing. Coverage provided in
this section is subject to the enrollee's health plan cost-sharing
requirements, including any deductibles, co-payments, or coinsurance
requirements that apply to diagnostic testing services.
Subd. 5. Payment
for services provided. If the
enrollee's health plan uses a capitated or bundled payment arrangement to
reimburse a provider for services provided in an inpatient setting,
reimbursement for services covered under this section must be paid separately
and in addition to any reimbursement otherwise payable to the provider under
the capitated or bundled payment arrangement, unless the health carrier and the
provider have negotiated an increased capitated or bundled payment rate that
includes the services covered under this section.
Subd. 6. Genetic
data. Genetic data generated
as a result of performing rWGS and covered under this section: (1) must be used for the primary purpose of
assisting the ordering provider and treating care team to diagnose and treat
the patient; (2) is protected health information as set forth under the Health
Insurance Portability and Accountability Act (HIPAA), the Health Information
Technology for Economic and Clinical Health Act, and any promulgated
regulations, including but not limited to Code of Federal Regulations, title
45, parts 160 and 164, subparts A and E; and (3) is a protected health record
under sections 144.291 to 144.298.
Subd. 7. Reimbursement. The commissioner of commerce must
reimburse health carriers for coverage under this section. Reimbursement is available only for coverage
that would not have been provided by the health carrier without the
requirements of this section. Each
fiscal year, an amount necessary to make payments to health carriers to defray
the cost of providing coverage under this section is appropriated to the
commissioner of commerce. Health
carriers must report to the commissioner quantified costs attributable to the
additional benefit under this section in a format developed by the commissioner. The commissioner must evaluate submissions
and make payments to health carriers as provided in Code of Federal
Regulations, title 45, section 155.170.
EFFECTIVE DATE. This
section is effective January 1, 2025, and applies to a health plan offered,
issued, or sold on or after that date.
Sec. 3. [62A.59]
COVERAGE OF SERVICE; PRIOR AUTHORIZATION.
Subdivision 1. Service
for which prior authorization not required.
A health carrier must not retrospectively deny or limit coverage
of a health care service for which prior authorization was not required by the
health carrier, unless there is evidence that the health care service was
provided based on fraud or misinformation.
Subd. 2. Service
for which prior authorization required but not obtained. A health carrier must not deny or
limit coverage of a health care service which the enrollee has already received
solely on the basis of lack of prior authorization if the service would
otherwise have been covered had the prior authorization been obtained.
EFFECTIVE DATE. This
section is effective January 1, 2026, and applies to health plans offered,
sold, issued, or renewed on or after that date.
Sec. 4. [62C.045]
APPLICATION OF OTHER LAW.
Sections 145D.30 to
145D.37 apply to service plan corporations operating under this chapter.
Sec. 5. Minnesota Statutes 2022, section 62D.02, subdivision 4, is amended to read:
Subd. 4. Health
maintenance organization. "Health
maintenance organization" means a foreign or domestic nonprofit
corporation organized under chapter 317A, or a local governmental unit
as defined in subdivision 11, controlled and operated as provided in sections
62D.01 to 62D.30, which provides, either directly or through arrangements with
providers or other persons, comprehensive health maintenance services, or
arranges for the provision of these services, to enrollees on the basis of a
fixed prepaid sum without regard to the frequency or extent of services
furnished to any particular enrollee.
Sec. 6. Minnesota Statutes 2022, section 62D.02, subdivision 7, is amended to read:
Subd. 7. Comprehensive
health maintenance services. "Comprehensive
health maintenance services" means a set of comprehensive health services
which the enrollees might reasonably require to be maintained in good health
including as a minimum, but not limited to, emergency care, emergency ground
ambulance transportation services, inpatient hospital and physician care,
outpatient health services and preventive health services. Elective, induced abortion, except as
medically necessary to prevent the death of the mother, whether performed in a
hospital, other abortion facility or the office of a physician, shall not be mandatory
for any health maintenance organization.
EFFECTIVE DATE. This
section is effective January 1, 2025, and applies to health plans offered,
sold, issued, or renewed on or after that date.
Sec. 7. Minnesota Statutes 2022, section 62D.03, subdivision 1, is amended to read:
Subdivision 1. Certificate
of authority required. Notwithstanding
any law of this state to the contrary, any foreign or domestic nonprofit
corporation organized to do so or a local governmental unit may apply to the
commissioner of health for a certificate of authority to establish and operate
a health maintenance organization in compliance with sections 62D.01 to 62D.30. No person shall establish or operate a health
maintenance organization in this state, nor sell or offer to sell, or solicit
offers to purchase or receive advance or periodic consideration in conjunction
with a health maintenance organization or health maintenance contract unless
the organization has a certificate of authority under sections 62D.01 to
62D.30.
Sec. 8. Minnesota Statutes 2022, section 62D.05, subdivision 1, is amended to read:
Subdivision 1. Authority granted. Any nonprofit corporation or local governmental unit may, upon obtaining a certificate of authority as required in sections 62D.01 to 62D.30, operate as a health maintenance organization.
Sec. 9. Minnesota Statutes 2022, section 62D.06, subdivision 1, is amended to read:
Subdivision 1. Governing body composition; enrollee advisory body. The governing body of any health maintenance organization which is a nonprofit corporation may include enrollees, providers, or other individuals; provided, however, that after a health maintenance organization which is a nonprofit corporation has been authorized under sections 62D.01 to 62D.30 for one year, at least 40 percent of the governing body shall be composed of enrollees and members elected by the enrollees and members from among the enrollees and members. For purposes of this section, "member" means a consumer who receives health care services through a self-insured contract that is administered by the health maintenance organization or its related third-party administrator. The number of members elected to the governing body shall not exceed the number of enrollees elected to the governing body. An enrollee or member elected to the governing board may not be a person:
(1) whose occupation involves, or before retirement involved, the administration of health activities or the provision of health services;
(2) who is or was employed by a health care facility as a licensed health professional; or
(3) who has or had a direct substantial financial or managerial interest in the rendering of a health service, other than the payment of a reasonable expense reimbursement or compensation as a member of the board of a health maintenance organization.
After a health maintenance organization which is a local governmental unit has been authorized under sections 62D.01 to 62D.30 for one year, an enrollee advisory body shall be established. The enrollees who make up this advisory body shall be elected by the enrollees from among the enrollees.
Sec. 10. Minnesota Statutes 2022, section 62D.12, subdivision 19, is amended to read:
Subd. 19. Coverage
of service. A health maintenance
organization may not deny or limit coverage of a service which the enrollee has
already received solely on the basis of lack of prior authorization or second
opinion, to the extent that the service would otherwise have been covered under
the member's contract by the health maintenance organization had prior
authorization or second opinion been obtained.
This subdivision expires December 31, 2025, for health plans offered,
sold, issued, or renewed on or after that date.
Sec. 11. Minnesota Statutes 2022, section 62D.19, is amended to read:
62D.19 UNREASONABLE EXPENSES.
No health maintenance organization shall incur or pay for any expense of any nature which is unreasonably high in relation to the value of the service or goods provided. The commissioner of health shall implement and enforce this section by rules adopted under this section.
In an effort to achieve the stated purposes of sections 62D.01 to 62D.30, in order to safeguard the underlying nonprofit status of health maintenance organizations, and in order to ensure that the payment of health maintenance organization money to major participating entities results in a corresponding benefit to the health maintenance organization and its enrollees, when determining whether an organization has incurred an unreasonable expense in relation to a major participating entity, due consideration shall be given to, in addition to any other appropriate
factors, whether the officers and trustees of the health maintenance organization have acted with good faith and in the best interests of the health maintenance organization in entering into, and performing under, a contract under which the health maintenance organization has incurred an expense. The commissioner has standing to sue, on behalf of a health maintenance organization, officers or trustees of the health maintenance organization who have breached their fiduciary duty in entering into and performing such contracts.
Sec. 12. Minnesota Statutes 2022, section 62D.20, subdivision 1, is amended to read:
Subdivision 1. Rulemaking. The commissioner of health may, pursuant
to chapter 14, promulgate such reasonable rules as are necessary or proper to
carry out the provisions of sections 62D.01 to 62D.30. Included among such rules shall be those
which provide minimum requirements for the provision of comprehensive health
maintenance services, as defined in section 62D.02, subdivision 7, and
reasonable exclusions therefrom. Nothing
in such rules shall force or require a health maintenance organization to provide
elective, induced abortions, except as medically necessary to prevent the death
of the mother, whether performed in a hospital, other abortion facility, or the
office of a physician; the rules shall provide every health maintenance
organization the option of excluding or including elective, induced abortions,
except as medically necessary to prevent the death of the mother, as part of
its comprehensive health maintenance services.
EFFECTIVE DATE. This
section is effective January 1, 2025, and applies to health plans offered,
sold, issued, or renewed on or after that date.
Sec. 13. Minnesota Statutes 2022, section 62D.22, subdivision 5, is amended to read:
Subd. 5. Other
state law. Except as otherwise
provided in sections 62A.01 to 62A.42 and 62D.01 to 62D.30, and except as
they eliminate elective, induced abortions, wherever performed, from health or
maternity benefits, provisions of the insurance laws and provisions of
nonprofit health service plan corporation laws shall not be applicable to any
health maintenance organization granted a certificate of authority under
sections 62D.01 to 62D.30.
EFFECTIVE DATE. This
section is effective January 1, 2025, and applies to health plans offered,
sold, issued, or renewed on or after that date.
Sec. 14. Minnesota Statutes 2022, section 62D.22, is amended by adding a subdivision to read:
Subd. 5a. Application
of other law. Sections
145D.30 to 145D.37 apply to nonprofit health maintenance organizations
operating under this chapter.
Sec. 15. [62D.221]
OVERSIGHT OF TRANSACTIONS.
Subdivision 1. Insurance
provisions applicable to health maintenance organizations. (a) Health maintenance organizations
are subject to sections 60A.135, 60A.136, 60A.137, 60A.16, 60A.161, 60D.17,
60D.18, and 60D.20 and must comply with the provisions of these sections
applicable to insurers. In applying
these sections to health maintenance organizations, "the
commissioner" means the commissioner of health. Health maintenance organizations are subject
to Minnesota Rules, chapter 2720, as applicable to sections 60D.17, 60D.18, and
60D.20, and must comply with those provisions of the chapter applicable to
insurers unless the commissioner of health adopts rules to implement this
subdivision.
(b) In addition to the
conditions in section 60D.17, subdivision 1, subjecting a health maintenance
organization to filing requirements, no person other than the issuer shall
acquire all or substantially all of the assets of a domestic nonprofit health maintenance
organization through any means unless at the time the offer, request, or
invitation is made or the agreement is entered into the person has filed with
the commissioner and has sent to the health
maintenance organization a
statement containing the information required in section 60D.17 and the offer,
request, invitation, agreement, or acquisition has been approved by the
commissioner of health in the manner prescribed in section 60D.17.
Subd. 2. Conversion
transactions. If a health
maintenance organization must notify or report a transaction to the
commissioner under subdivision 1, the health maintenance organization must
include information regarding the plan for a conversion benefit entity, in the
form and manner determined by the commissioner, if the reportable transaction
qualifies as a conversion transaction as defined in section 145D.30,
subdivision 5. The commissioner may
consider information regarding the conversion transaction and the conversion
benefit entity plan in any actions taken under subdivision 1, including in
decisions to approve or disapprove transactions, and may extend time frames to
a total of 90 days, with notice to the parties to the transaction.
Sec. 16. Minnesota Statutes 2022, section 62E.02, subdivision 3, is amended to read:
Subd. 3. Health maintenance organization. "Health maintenance organization" means a nonprofit corporation licensed and operated as provided in chapter 62D.
Sec. 17. Minnesota Statutes 2022, section 62M.01, subdivision 3, is amended to read:
Subd. 3. Scope. (a) Nothing in this chapter applies to review of claims after submission to determine eligibility for benefits under a health benefit plan. The appeal procedure described in section 62M.06 applies to any complaint as defined under section 62Q.68, subdivision 2, that requires a medical determination in its resolution.
(b) Effective January 1,
2026, this chapter does not apply applies to managed care
plans or county-based purchasing plans when the plan is providing coverage to
state public health care program enrollees under chapter 256B or 256L.
(c) Effective January 1,
2026, the following sections of this chapter apply to services delivered
through fee‑for‑service under chapters 256B and 256L: 62M.02, subdivisions 1 to 5, 7 to 12, 13, 14
to 18, and 21; 62M.04; 62M.05, subdivisions 1 to 4; 62M.06, subdivisions 1 to
3; 62M.07; 62M.072; 62M.09; 62M.10; 62M.12; and 62M.17, subdivision 2.
Sec. 18. Minnesota Statutes 2022, section 62M.02, subdivision 1a, is amended to read:
Subd. 1a. Adverse
determination. "Adverse
determination" means a decision by a utilization review organization
relating to an admission, extension of stay, or health care service that is
partially or wholly adverse to the enrollee, including:
(1) a decision to
deny an admission, extension of stay, or health care service on the basis that
it is not medically necessary; or
(2) an authorization for a health care service that is less intensive than the health care service specified in the original request for authorization.
EFFECTIVE DATE. This
section is effective the day following final enactment.
Sec. 19. Minnesota Statutes 2022, section 62M.02, subdivision 5, is amended to read:
Subd. 5. Authorization. "Authorization" means a determination by a utilization review organization that an admission, extension of stay, or other health care service has been reviewed and that, based on the information provided, it satisfies the utilization review requirements of the applicable health benefit plan and the health plan company or commissioner will then pay for the covered benefit, provided the preexisting limitation provisions, the general exclusion provisions, and any deductible, co-payment, coinsurance, or other policy requirements have been met.
Sec. 20. Minnesota Statutes 2022, section 62M.02, is amended by adding a subdivision to read:
Subd. 8a. Commissioner. "Commissioner" means,
effective January 1, 2026, for the sections specified in section 62M.01,
subdivision 3, paragraph (c), the commissioner of human services, unless
otherwise specified.
Sec. 21. Minnesota Statutes 2022, section 62M.02, subdivision 11, is amended to read:
Subd. 11. Enrollee. "Enrollee" means:
(1) an individual
covered by a health benefit plan and includes an insured policyholder,
subscriber, contract holder, member, covered person, or certificate holder;
or
(2) effective January 1, 2026, for the sections specified in section 62M.01, subdivision 3, paragraph (c), a recipient receiving coverage through fee-for-service under chapters 256B and 256L.
Sec. 22. Minnesota Statutes 2022, section 62M.02, subdivision 12, is amended to read:
Subd. 12. Health
benefit plan. (a)
"Health benefit plan" means:
(1) a policy,
contract, or certificate issued by a health plan company for the coverage of
medical, dental, or hospital benefits; or
(2) effective January 1, 2026, for the sections specified in section 62M.01, subdivision 3, paragraph (c), coverage of medical, dental, or hospital benefits through fee-for-service under chapters 256B and 256L, as specified by the commissioner on the agency's public website or through other forms of recipient and provider guidance.
(b) A health benefit plan does not include coverage that is:
(1) limited to disability or income protection coverage;
(2) automobile medical payment coverage;
(3) supplemental to liability insurance;
(4) designed solely to provide payments on a per diem, fixed indemnity, or nonexpense incurred basis;
(5) credit accident and health insurance issued under chapter 62B;
(6) blanket accident and sickness insurance as defined in section 62A.11;
(7) accident only coverage issued by a licensed and tested insurance agent; or
(8) workers' compensation.
Sec. 23. Minnesota Statutes 2022, section 62M.02, subdivision 21, is amended to read:
Subd. 21. Utilization review organization. "Utilization review organization" means an entity including but not limited to an insurance company licensed under chapter 60A to offer, sell, or issue a policy of accident and sickness insurance as defined in section 62A.01; a prepaid limited health service organization issued a certificate of authority and operating under sections 62A.451 to 62A.4528; a health service plan licensed under chapter 62C; a health maintenance organization licensed under chapter 62D; a community integrated service network licensed under
chapter 62N; an accountable provider network operating under chapter 62T; a fraternal benefit society operating under chapter 64B; a joint self-insurance employee health plan operating under chapter 62H; a multiple employer welfare arrangement, as defined in section 3 of the Employee Retirement Income Security Act of 1974 (ERISA), United States Code, title 29, section 1103, as amended; a third-party administrator licensed under section 60A.23, subdivision 8, which conducts utilization review and authorizes or makes adverse determinations regarding an admission, extension of stay, or other health care services for a Minnesota resident; effective January 1, 2026, for the sections specified in section 62M.01, subdivision 3, paragraph (c), the commissioner of human services for purposes of delivering services through fee-for-service under chapters 256B and 256L; any other entity that provides, offers, or administers hospital, outpatient, medical, prescription drug, or other health benefits to individuals treated by a health professional under a policy, plan, or contract; or any entity performing utilization review that is affiliated with, under contract with, or conducting utilization review on behalf of, a business entity in this state. Utilization review organization does not include a clinic or health care system acting pursuant to a written delegation agreement with an otherwise regulated utilization review organization that contracts with the clinic or health care system. The regulated utilization review organization is accountable for the delegated utilization review activities of the clinic or health care system.
Sec. 24. Minnesota Statutes 2022, section 62M.04, subdivision 1, is amended to read:
Subdivision 1. Responsibility for obtaining authorization. A health benefit plan that includes utilization review requirements must specify the process for notifying the utilization review organization in a timely manner and obtaining authorization for health care services. Each health plan company must provide a clear and concise description of this process to an enrollee as part of the policy, subscriber contract, or certificate of coverage. Effective January 1, 2026, the commissioner must provide a clear and concise description of this process to fee‑for‑service recipients receiving services under chapters 256B and 256L, through the agency's public website or through other forms of recipient guidance. In addition to the enrollee, the utilization review organization must allow any provider or provider's designee, or responsible patient representative, including a family member, to fulfill the obligations under the health benefit plan.
A claims administrator that contracts directly with providers for the provision of health care services to enrollees may, through contract, require the provider to notify the review organization in a timely manner and obtain authorization for health care services.
Sec. 25. Minnesota Statutes 2022, section 62M.05, subdivision 3a, is amended to read:
Subd. 3a. Standard
review determination. (a) Notwithstanding
subdivision 3b, a standard review determination on all requests for utilization
review must be communicated to the provider and enrollee in accordance with
this subdivision within five business days after receiving the request if the
request is received electronically, or within six business days if received
through nonelectronic means, provided that all information reasonably necessary
to make a determination on the request has been made available to the
utilization review organization. Effective
January 1, 2022, A standard review determination on all requests for
utilization review must be communicated to the provider and enrollee in
accordance with this subdivision within five business days after receiving the
request, regardless of how the request was received, provided that all
information reasonably necessary to make a determination on the request has
been made available to the utilization review organization.
(b) When a determination is made to authorize, notification must be provided promptly by telephone to the provider. The utilization review organization shall send written notification to the provider or shall maintain an audit trail of the determination and telephone notification. For purposes of this subdivision, "audit trail" includes documentation of the telephone notification, including the date; the name of the person spoken to; the enrollee; the service, procedure, or admission authorized; and the date of the service, procedure, or admission. If the utilization review organization indicates authorization by use of a number, the number must be called the "authorization number." For purposes of this subdivision, notification may also be made by facsimile to a verified number or by electronic mail to a secure electronic mailbox. These electronic forms of notification satisfy the "audit trail" requirement of this paragraph.
(c) When an adverse determination is made, notification must be provided within the time periods specified in paragraph (a) by telephone, by facsimile to a verified number, or by electronic mail to a secure electronic mailbox to the attending health care professional and hospital or physician office as applicable. Written notification must also be sent to the hospital or physician office as applicable and attending health care professional if notification occurred by telephone. For purposes of this subdivision, notification may be made by facsimile to a verified number or by electronic mail to a secure electronic mailbox. Written notification must be sent to the enrollee and may be sent by United States mail, facsimile to a verified number, or by electronic mail to a secure mailbox. The written notification must include all reasons relied on by the utilization review organization for the determination and the process for initiating an appeal of the determination. Upon request, the utilization review organization shall provide the provider or enrollee with the criteria used to determine the necessity, appropriateness, and efficacy of the health care service and identify the database, professional treatment parameter, or other basis for the criteria. Reasons for an adverse determination may include, among other things, the lack of adequate information to authorize after a reasonable attempt has been made to contact the provider or enrollee.
(d) When an adverse determination is made, the written notification must inform the enrollee and the attending health care professional of the right to submit an appeal to the internal appeal process described in section 62M.06 and the procedure for initiating the internal appeal. The written notice shall be provided in a culturally and linguistically appropriate manner consistent with the provisions of the Affordable Care Act as defined under section 62A.011, subdivision 1a.
EFFECTIVE DATE. This
section is effective the day following final enactment.
Sec. 26. Minnesota Statutes 2022, section 62M.07, subdivision 2, is amended to read:
Subd. 2. Prior
authorization of emergency certain services prohibited. No utilization review organization,
health plan company, or claims administrator may conduct or require prior
authorization of:
(1) emergency
confinement or an emergency service. The
enrollee or the enrollee's authorized representative may be required to notify
the health plan company, claims administrator, or utilization review
organization as soon as reasonably possible after the beginning of the
emergency confinement or emergency service.;
(2) oral buprenorphine
to treat a substance use disorder;
(3) outpatient mental
health treatment or outpatient substance use disorder treatment, except for
treatment which is: (i) a medication;
and (ii) not otherwise listed in this subdivision. Prior authorizations required for medications
used for outpatient mental health treatment or outpatient substance use
disorder treatment, and not otherwise listed in this subdivision, must be
processed according to section 62M.05, subdivision 3b, for initial
determinations, and according to section 62M.06, subdivision 2, for appeals;
(4) antineoplastic
cancer treatment that is consistent with guidelines of the National
Comprehensive Cancer Network, except for treatment which is: (i) a medication; and (ii) not otherwise
listed in this subdivision. Prior
authorizations required for medications used for antineoplastic cancer
treatment, and not otherwise listed in this subdivision, must be processed
according to section 62M.05, subdivision 3b, for initial determinations, and
according to section 62M.06, subdivision 2, for appeals;
(5) services that
currently have a rating of A or B from the United States Preventive Services
Task Force, immunizations recommended by the Advisory Committee on Immunization
Practices of the Centers for Disease Control and Prevention, or preventive services
and screenings provided to women as described in Code of Federal Regulations,
title 45, section 147.130;
(6) pediatric hospice
services provided by a hospice provider licensed under sections 144A.75 to
144A.755; and
(7) treatment delivered
through a neonatal abstinence program operated by pediatric pain or palliative
care subspecialists.
Clauses (2) to (7) are effective January 1,
2026, and apply to health benefit plans offered, sold, issued, or renewed on or
after that date.
Sec. 27. Minnesota Statutes 2022, section 62M.07, subdivision 4, is amended to read:
Subd. 4. Submission of prior authorization requests. (a) If prior authorization for a health care service is required, the utilization review organization, health plan company, or claim administrator must allow providers to submit requests for prior authorization of the health care services without unreasonable delay by telephone, facsimile, or voice mail or through an electronic mechanism 24 hours a day, seven days a week. This subdivision does not apply to dental service covered under MinnesotaCare or medical assistance.
(b) Effective January 1,
2027, for health benefit plans offered, sold, issued, or renewed on or after
that date, utilization review organizations, health plan companies, and claims
administrators must have and maintain a prior authorization application programming
interface (API) that automates the prior authorization process for health care
services, excluding prescription drugs and medications. The API must allow providers to determine
whether a prior authorization is required for health care services, identify
prior authorization information and documentation requirements, and facilitate
the exchange of prior authorization requests and determinations from provider
electronic health records or practice management systems. The API must use the Health Level Seven (HL7)
Fast Healthcare Interoperability Resources (FHIR) standard in accordance with
Code of Federal Regulations, title 45, section 170.215(a)(1), and the most
recent standards and guidance adopted by the United States Department of Health
and Human Services to implement that section.
Prior authorization submission requests for prescription drugs and
medications must comply with the requirements of section 62J.497.
Sec. 28. Minnesota Statutes 2022, section 62M.07, is amended by adding a subdivision to read:
Subd. 5. Treatment
of a chronic condition. This
subdivision is effective January 1, 2026, and applies to health benefit plans
offered, sold, issued, or renewed on or after that date. An authorization for treatment of a chronic
health condition does not expire unless the standard of treatment for that
health condition changes. A chronic
health condition is a condition that is expected to last one year or more and:
(1) requires ongoing
medical attention to effectively manage the condition or prevent an adverse
health event; or
(2) limits one or more
activities of daily living.
Sec. 29. Minnesota Statutes 2022, section 62M.10, subdivision 7, is amended to read:
Subd. 7. Availability of criteria. (a) For utilization review determinations other than prior authorization, a utilization review organization shall, upon request, provide to an enrollee, a provider, and the commissioner of commerce the criteria used to determine the medical necessity, appropriateness, and efficacy of a procedure or service and identify the database, professional treatment guideline, or other basis for the criteria.
(b) For prior authorization
determinations, a utilization review organization must submit the
organization's current prior authorization requirements and restrictions,
including written, evidence-based, clinical criteria used to make an
authorization or adverse determination, to all health plan companies for which
the organization performs utilization review.
A health plan company must post on its public website the prior
authorization requirements and restrictions of any utilization review
organization that performs utilization review for the health plan company. These prior authorization requirements and
restrictions must be detailed and written in language that is easily
understandable to providers. This
paragraph does not apply to the commissioner of human services when delivering
services through fee-for-service under chapters 256B and 256L.
(c) Effective January 1, 2026,
the commissioner of human services must post on the department's public website
the prior authorization requirements and restrictions, including written,
evidence-based, clinical criteria used to make an authorization or adverse
determination, that apply to prior authorization determinations for
fee-for-service under chapters 256B and 256L.
These prior authorization requirements and restrictions must be detailed
and written in language that is easily understandable to providers.
Sec. 30. Minnesota Statutes 2022, section 62M.10, subdivision 8, is amended to read:
Subd. 8. Notice;
new prior authorization requirements or restrictions; change to existing
requirement or restriction. (a)
Before a utilization review organization may implement a new prior
authorization requirement or restriction or amend an existing prior
authorization requirement or restriction, the utilization review organization
must submit the new or amended requirement or restriction to all health plan
companies for which the organization performs utilization review. A health plan company must post on its
website the new or amended requirement or restriction. This paragraph does not apply to the
commissioner of human services when delivering services through fee-for-service
under chapters 256B and 256L.
(b) At least 45 days before
a new prior authorization requirement or restriction or an amended existing
prior authorization requirement or restriction is implemented, the utilization
review organization, health plan company, or claims administrator must provide
written or electronic notice of the new or amended requirement or restriction
to all Minnesota-based, in-network attending health care professionals who are
subject to the prior authorization requirements and restrictions. This paragraph does not apply to the
commissioner of human services when delivering services through fee-for-service
under chapters 256B and 256L.
(c) Effective January 1,
2026, before the commissioner of human services may implement a new prior
authorization requirement or restriction or amend an existing prior
authorization requirement or restriction, the commissioner, at least 45 days
before the new or amended requirement or restriction takes effect, must provide
written or electronic notice of the new or amended requirement or restriction,
to all health care professionals participating as fee-for-service providers
under chapters 256B and 256L who are subject to the prior authorization
requirements and restrictions.
Sec. 31. Minnesota Statutes 2022, section 62M.17, subdivision 2, is amended to read:
Subd. 2. Effect of change in prior authorization clinical criteria. (a) If, during a plan year, a utilization review organization changes coverage terms for a health care service or the clinical criteria used to conduct prior authorizations for a health care service, the change in coverage terms or change in clinical criteria shall not apply until the next plan year for any enrollee who received prior authorization for a health care service using the coverage terms or clinical criteria in effect before the effective date of the change.
(b) Paragraph (a) does not apply if a utilization review organization changes coverage terms for a drug or device that has been deemed unsafe by the United States Food and Drug Administration (FDA); that has been withdrawn by either the FDA or the product manufacturer; or when an independent source of research, clinical guidelines, or evidence-based standards has issued drug- or device-specific warnings or recommended changes in drug or device usage.
(c) Paragraph (a) does not
apply if a utilization review organization changes coverage terms for a service
or the clinical criteria used to conduct prior authorizations for a service
when an independent source of research, clinical guidelines, or evidence-based
standards has recommended changes in usage of the service for reasons related
to patient harm. This paragraph
expires December 31, 2025, for health benefit plans offered, sold, issued, or
renewed on or after that date.
(d) Effective January 1, 2026,
and applicable to health benefit plans offered, sold, issued, or renewed on or
after that date, paragraph (a) does not apply if a utilization review
organization changes coverage terms for a service or the clinical criteria used
to conduct prior authorizations for a service when an independent source of
research, clinical guidelines, or evidence-based standards has recommended
changes in usage of the service for reasons related to previously unknown and
imminent patient harm.
(d) (e) Paragraph
(a) does not apply if a utilization review organization removes a brand name
drug from its formulary or places a brand name drug in a benefit category that increases
the enrollee's cost, provided the utilization review organization (1) adds to
its formulary a generic or multisource brand name drug rated as therapeutically
equivalent according to the FDA Orange Book, or a biologic drug rated as
interchangeable according to the FDA Purple Book, at a lower cost to the
enrollee, and (2) provides at least a 60-day notice to prescribers,
pharmacists, and affected enrollees.
Sec. 32. [62M.19]
ANNUAL REPORT TO COMMISSIONER OF HEALTH; PRIOR AUTHORIZATIONS.
On or before September 1
each year, each utilization review organization must report to the commissioner
of health, in a form and manner specified by the commissioner, information on
prior authorization requests for the previous calendar year. The report submitted under this subdivision
must include the following data:
(1) the total number of
prior authorization requests received;
(2) the number of prior
authorization requests for which an authorization was issued;
(3) the number of prior
authorization requests for which an adverse determination was issued;
(4) the number of
adverse determinations reversed on appeal;
(5) the 25 codes with
the highest number of prior authorization requests and the percentage of
authorizations for each of these codes;
(6) the 25 codes with
the highest percentage of prior authorization requests for which an
authorization was issued and the total number of the requests;
(7) the 25 codes with
the highest percentage of prior authorization requests for which an adverse
determination was issued but which was reversed on appeal and the total number
of the requests;
(8) the 25 codes with
the highest percentage of prior authorization requests for which an adverse
determination was issued and the total number of the requests; and
(9) the reasons an
adverse determination to a prior authorization request was issued, expressed as
a percentage of all adverse determinations.
The reasons listed may include but are not limited to:
(i) the patient did not
meet prior authorization criteria;
(ii) incomplete
information was submitted by the provider to the utilization review
organization;
(iii) the treatment
program changed; and
(iv) the patient is no
longer covered by the health benefit plan.
Sec. 33. Minnesota Statutes 2022, section 62Q.14, is amended to read:
62Q.14 RESTRICTIONS ON ENROLLEE SERVICES.
No health plan company may restrict the choice of an enrollee as to
where the enrollee receives services related to:
(1) the voluntary planning
of the conception and bearing of children, provided that this clause does
not refer to abortion services;
(2) the diagnosis of infertility;
(3) the testing and treatment of a sexually transmitted disease; and
(4) the testing for AIDS or other HIV-related conditions.
EFFECTIVE DATE. This
section is effective January 1, 2025, and applies to health plans offered,
sold, issued, or renewed on or after that date.
Sec. 34. Minnesota Statutes 2022, section 62Q.1841, subdivision 2, is amended to read:
Subd. 2. Prohibition
on use of prior authorization or step therapy protocols. A health plan that provides coverage for
the treatment of stage four advanced metastatic cancer or associated conditions
must not limit or exclude coverage for a drug approved by the United States
Food and Drug Administration that is on the health plan's prescription drug
formulary by mandating that an enrollee with stage four advanced metastatic
cancer or associated conditions obtain a
prior authorization or follow a step therapy protocol if the use of the
approved drug is consistent with:
(1) a United States Food and Drug Administration-approved indication; and
(2) a clinical practice guideline published by the National Comprehensive Care Network.
EFFECTIVE DATE. This
section is effective January 1, 2025, and applies to health plans offered,
sold, issued, or renewed on or after that date.
Sec. 35. Minnesota Statutes 2022, section 62Q.19, subdivision 3, is amended to read:
Subd. 3. Health
plan company affiliation. A health
plan company must offer a provider contract to any all designated
essential community provider providers located within the area
served by the health plan company. A
health plan company must include all essential community providers that have
accepted a contract in each of the company's provider networks. A health plan company shall not restrict
enrollee access to services designated to be provided by the essential
community provider for the population that the essential community provider is
certified to serve. A health plan
company may also make other providers available for these services. A health plan company may require an
essential community provider to meet all data requirements, utilization review,
and quality assurance requirements on the same basis as other health plan
providers.
EFFECTIVE DATE. This
section is effective January 1, 2025, and applies to health plans offered,
issued, or renewed on or after that date.
Sec. 36. Minnesota Statutes 2022, section 62Q.19, is amended by adding a subdivision to read:
Subd. 4a. Contract
payment rates; private. An
essential community provider and a health plan company may negotiate the
payment rate for covered services provided by the essential community provider. This rate must be at least the same rate per
unit of service as is paid by the health plan company to the essential
community provider under the provider contract between the two with the highest
number of enrollees receiving health care services from the provider or, if
there is no provider contract between the health plan company and the essential
community provider, the rate must be at least the same rate per unit of service
as is paid to other plan providers for the same or similar services. The provider contract used to set the rate
under this subdivision must be in relation to an individual, small group, or
large group health plan. This
subdivision applies only to provider contracts in relation to individual, small
employer, and large group health plans.
Sec. 37. Minnesota Statutes 2022, section 62Q.19, subdivision 5, is amended to read:
Subd. 5. Contract
payment rates; public. An
essential community provider and a health plan company may negotiate the
payment rate for covered services provided by the essential community provider. This rate must be at least the same rate per
unit of service as is paid to other health plan providers for the same or
similar services. This subdivision
applies only to provider contracts in relation to health plans offered through
the State Employee Group Insurance Program, medical assistance, and MinnesotaCare.
Sec. 38. Minnesota Statutes 2023 Supplement, section 62Q.522, subdivision 1, is amended to read:
Subdivision 1. Definitions. (a) The definitions in this subdivision apply to this section.
(b) "Closely held for-profit
entity" means an entity that:
(1) is not a nonprofit
entity;
(2) has more than 50
percent of the value of its ownership interest owned directly or indirectly by
five or fewer owners; and
(3) has no publicly
traded ownership interest.
For purposes of this paragraph:
(i) ownership interests
owned by a corporation, partnership, limited liability company, estate, trust,
or similar entity are considered owned by that entity's shareholders, partners,
members, or beneficiaries in proportion to their interest held in the corporation,
partnership, limited liability company, estate, trust, or similar entity;
(ii) ownership interests
owned by a nonprofit entity are considered owned by a single owner;
(iii) ownership
interests owned by all individuals in a family are considered held by a single
owner. For purposes of this item,
"family" means brothers and sisters, including half-brothers and
half-sisters, a spouse, ancestors, and lineal descendants; and
(iv) if an individual or
entity holds an option, warrant, or similar right to purchase an ownership
interest, the individual or entity is considered to be the owner of those
ownership interests.
(c) (b) "Contraceptive
method" means a drug, device, or other product approved by the Food and
Drug Administration to prevent unintended pregnancy.
(d) (c) "Contraceptive service" means consultation, examination, procedures, and medical services related to the prevention of unintended pregnancy, excluding vasectomies. This includes but is not limited to voluntary sterilization procedures, patient education, counseling on contraceptives, and follow-up services related to contraceptive methods or services, management of side effects, counseling for continued adherence, and device insertion or removal.
(e) "Eligible
organization" means an organization that opposes providing coverage for
some or all contraceptive methods or services on account of religious
objections and that is:
(1) organized as a
nonprofit entity and holds itself out to be religious; or
(2) organized and
operates as a closely held for-profit entity, and the organization's owners or
highest governing body has adopted, under the organization's applicable rules
of governance and consistent with state law, a resolution or similar action establishing
that the organization objects to covering some or all contraceptive methods or
services on account of the owners' sincerely held religious beliefs.
(f) "Exempt
organization" means an organization that is organized and operates as a
nonprofit entity and meets the requirements of section 6033(a)(3)(A)(i) or
(iii) of the Internal Revenue Code of 1986, as amended.
(g) (d) "Medical
necessity" includes but is not limited to considerations such as severity
of side effects, difference in permanence and reversibility of a contraceptive
method or service, and ability to adhere to the appropriate use of the
contraceptive method or service, as determined by the attending provider.
(h) (e) "Therapeutic
equivalent version" means a drug, device, or product that can be expected
to have the same clinical effect and safety
profile when administered to a patient under the conditions specified in the
labeling, and that:
(1) is approved as safe and effective;
(2) is a pharmaceutical equivalent: (i) containing identical amounts of the same active drug ingredient in the same dosage form and route of administration; and (ii) meeting compendial or other applicable standards of strength, quality, purity, and identity;
(3) is bioequivalent in that:
(i) the drug, device, or product does not present a known or potential bioequivalence problem and meets an acceptable in vitro standard; or
(ii) if the drug, device, or product does present a known or potential bioequivalence problem, it is shown to meet an appropriate bioequivalence standard;
(4) is adequately labeled; and
(5) is manufactured in compliance with current manufacturing practice regulations.
EFFECTIVE DATE. This
section is effective January 1, 2025, and applies to health plans offered,
sold, issued, or renewed on of after that date.
Sec. 39. Minnesota Statutes 2023 Supplement, section 62Q.523, subdivision 1, is amended to read:
Subdivision 1. Scope
of coverage. Except as otherwise
provided in section 62Q.522 62Q.679, subdivisions 2 and 3 and
4, all health plans that provide prescription coverage must comply with the
requirements of this section.
EFFECTIVE DATE. This
section is effective January 1, 2025, and applies to health plans offered,
sold, issued, or renewed on or after that date.
Sec. 40. [62Q.524]
COVERAGE OF ABORTIONS AND ABORTION-RELATED SERVICES.
Subdivision 1. Definition. For purposes of this section,
"abortion" means any medical treatment intended to induce the
termination of a pregnancy with a purpose other than producing a live birth.
Subd. 2. Required
coverage; cost-sharing. (a) A
health plan must provide coverage for abortions and abortion-related services,
including preabortion services and follow-up services.
(b) A health plan must
not impose on the coverage under this section any co-payment, coinsurance,
deductible, or other enrollee cost-sharing that is greater than the
cost-sharing that applies to similar services covered under the health plan.
(c) A health plan must
not impose any limitation on the coverage under this section, including but not
limited to any utilization review, prior authorization, referral requirements,
restrictions, or delays, that is not generally applicable to other coverages
under the plan.
Subd. 3. Exclusion. This section does not apply to managed
care organizations or county-based purchasing plans when the plan provides
coverage to public health care program enrollees under chapter 256B or 256L.
Subd. 4. Reimbursement. The commissioner of commerce must
reimburse health plan companies for coverage under this section. Reimbursement is available only for coverage
that would not have been provided by the health plan company without the
requirements of this section. Each
fiscal year, an amount necessary to make payments to health plan companies to
defray the cost of providing coverage under this section is appropriated to the
commissioner of commerce. Health plan
companies must report to the commissioner quantified costs attributable to the
additional benefit under this section in a format developed by the commissioner. The commissioner must evaluate submissions
and make payments to health plan companies as provided in Code of Federal
Regulations, title 45, section 155.170.
EFFECTIVE DATE. This
section is effective January 1, 2025, and applies to health plans offered,
sold, issued, or renewed on or after that date.
Sec. 41. [62Q.531]
AMINO ACID-BASED FORMULA COVERAGE.
Subdivision 1. Definition. (a) For purposes of this section, the
following term has the meaning given.
(b) "Formula"
means an amino acid-based elemental formula.
Subd. 2. Required
coverage. A health plan
company must provide coverage for formula when formula is medically necessary.
Subd. 3. Covered
conditions. Conditions for
which formula is medically necessary include but are not limited to:
(1) cystic fibrosis;
(2) amino acid, organic
acid, and fatty acid metabolic and malabsorption disorders;
(3) IgE mediated
allergies to food proteins;
(4) food protein-induced
enterocolitis syndrome;
(5) eosinophilic
esophagitis;
(6) eosinophilic
gastroenteritis;
(7) eosinophilic
colitis; and
(8) mast cell activation
syndrome.
EFFECTIVE DATE. This
section is effective January 1, 2025, and applies to health plans offered,
issued, or sold on or after that date.
Sec. 42. [62Q.585]
GENDER-AFFIRMING CARE COVERAGE; MEDICALLY NECESSARY CARE.
Subdivision 1. Requirement. No health plan that covers physical or
mental health services may be offered, sold, issued, or renewed in this state
that:
(1) excludes coverage
for medically necessary gender-affirming care; or
(2) requires
gender-affirming treatments to satisfy a definition of "medically
necessary care," "medical necessity," or any similar term that
is more restrictive than the definition provided in subdivision 2.
Subd. 2. Minimum
definition. "Medically
necessary care" means health care services appropriate in terms of type,
frequency, level, setting, and duration to the enrollee's diagnosis or
condition and diagnostic testing and preventive services. Medically necessary care must be consistent
with generally accepted practice parameters as determined by health care
providers in the same or similar general specialty as typically manages the
condition, procedure, or treatment at issue and must:
(1) help restore or
maintain the enrollee's health; or
(2) prevent
deterioration of the enrollee's condition.
Subd. 3. Definitions. (a) For purposes of this section, the
following terms have the meanings given.
(b)
"Gender-affirming care" means all medical, surgical, counseling, or
referral services, including telehealth services, that an individual may
receive to support and affirm the individual's gender identity or gender
expression and that are legal under the laws of this state.
(c) "Health
plan" has the meaning given in section 62Q.01, subdivision 3, but includes
the coverages listed in section 62A.011, subdivision 3, clauses (7) and (10).
Sec. 43. [62Q.665]
COVERAGE FOR ORTHOTIC AND PROSTHETIC DEVICES.
Subdivision 1. Definitions. (a) For the purposes of this section,
the following terms have the meanings given.
(b) "Accredited
facility" means any entity that is accredited to provide comprehensive
orthotic or prosthetic devices or services by a Centers for Medicare and
Medicaid Services approved accrediting agency.
(c) "Orthosis"
means:
(1) an external medical
device that is:
(i) custom-fabricated or
custom-fitted to a specific patient based on the patient's unique physical
condition;
(ii) applied to a part of the
body to correct a deformity, provide support and protection, restrict motion,
improve function, or relieve symptoms of a disease, syndrome, injury, or
postoperative condition; and
(iii) deemed medically
necessary by a prescribing physician or licensed health care provider who has
authority in Minnesota to prescribe orthotic and prosthetic devices, supplies,
and services; and
(2) any provision, repair, or replacement of a device that is furnished or performed by:
(i) an accredited facility in comprehensive orthotic services; or
(ii) a health care
provider licensed in Minnesota and operating within the provider's scope of
practice which allows the provider to provide orthotic or prosthetic devices,
supplies, or services.
(d) "Orthotics"
means:
(1) the science and
practice of evaluating, measuring, designing, fabricating, assembling, fitting,
adjusting, or servicing and providing the initial training necessary to
accomplish the fitting of an orthotic device for the support, correction, or
alleviation of a neuromuscular or musculoskeletal dysfunction, disease, injury,
or deformity;
(2) evaluation,
treatment, and consultation related to an orthotic device;
(3) basic observation of
gait and postural analysis;
(4) assessing and
designing orthosis to maximize function and provide support and alignment
necessary to prevent or correct a deformity or to improve the safety and
efficiency of mobility and locomotion;
(5) continuing patient
care to assess the effect of an orthotic device on the patient's tissues; and
(6) proper fit and
function of the orthotic device by periodic evaluation.
(e)
"Prosthesis" means:
(1) an external medical
device that is:
(i) used to replace or
restore a missing limb, appendage, or other external human body part; and
(ii) deemed medically
necessary by a prescribing physician or licensed health care provider who has
authority in Minnesota to prescribe orthotic and prosthetic devices, supplies,
and services; and
(2) any provision,
repair, or replacement of a device that is furnished or performed by:
(i) an accredited facility in comprehensive prosthetic services; or
(ii) a health care
provider licensed in Minnesota and operating within the provider's scope of
practice which allows the provider to provide orthotic or prosthetic devices,
supplies, or services.
(f)
"Prosthetics" means:
(1) the science and
practice of evaluating, measuring, designing, fabricating, assembling, fitting,
aligning, adjusting, or servicing, as well as providing the initial training
necessary to accomplish the fitting of, a prosthesis through the replacement of
external parts of a human body lost due to amputation or congenital deformities
or absences;
(2) the generation of an
image, form, or mold that replicates the patient's body segment and that
requires rectification of dimensions, contours, and volumes for use in the
design and fabrication of a socket to accept a residual anatomic limb to, in
turn, create an artificial appendage that is designed either to support body
weight or to improve or restore function or anatomical appearance, or both;
(3) observational gait
analysis and clinical assessment of the requirements necessary to refine and
mechanically fix the relative position of various parts of the prosthesis to
maximize function, stability, and safety of the patient;
(4) providing and continuing patient care in order to assess the
prosthetic device's effect on the patient's tissues; and
(5) assuring proper fit
and function of the prosthetic device by periodic evaluation.
Subd. 2. Coverage. (a) A health plan must provide coverage for orthotic and prosthetic devices, supplies, and services, including repair and replacement, at least equal to the coverage provided under federal law for health insurance for the aged and disabled under sections 1832, 1833, and 1834 of the Social Security Act, United States Code, title 42, sections 1395k, 1395l, and 1395m, but only to the extent consistent with this section.
(b) A health plan must
not subject orthotic and prosthetic benefits to separate financial requirements
that apply only with respect to those benefits.
A health plan may impose co-payment and coinsurance amounts on those
benefits, except that any financial requirements that apply to such benefits
must not be more restrictive than the financial requirements that apply to the
health plan's medical and surgical benefits, including those for internal
restorative devices.
(c) A health plan may
limit the benefits for, or alter the financial requirements for, out-of-network
coverage of prosthetic and orthotic devices, except that the restrictions and
requirements that apply to those benefits must not be more restrictive than the
financial requirements that apply to the out-of-network coverage for the health
plan's medical and surgical benefits.
(d) A health plan must
cover orthoses and prostheses when furnished under an order by a prescribing
physician or licensed health care prescriber who has authority in Minnesota to
prescribe orthoses and prostheses, and that coverage for orthotic and prosthetic
devices, supplies, accessories, and services must include those devices or
device systems, supplies, accessories, and services that are customized to the
covered individual's needs.
(e) A health plan must
cover orthoses and prostheses determined by the enrollee's provider to be the
most appropriate model that meets the medical needs of the enrollee for
purposes of performing physical activities, as applicable, including but not
limited to running, biking, and swimming, and maximizing the enrollee's limb
function.
(f) A health plan must
cover orthoses and prostheses for showering or bathing.
Subd. 3. Prior
authorization. A health plan
may require prior authorization for orthotic and prosthetic devices, supplies,
and services in the same manner and to the same extent as prior authorization
is required for any other covered benefit.
Subd. 4. Reimbursement. The commissioner of commerce must
reimburse health plan companies for coverage under this section. Reimbursement is available only for coverage
that would not have been provided by the health plan company without the
requirements of this section. Each
fiscal year, an amount necessary to make payments to health plan companies to
defray the cost of providing coverage under this section is appropriated to the
commissioner of commerce. Health plan
companies must report to the commissioner quantified costs attributable to the
additional benefit under this section in a format developed by the commissioner. The commissioner must evaluate submissions
and make payments to health plan companies as provided in Code of Federal
Regulations, title 45, section 155.170.
EFFECTIVE DATE. This
section is effective January 1, 2025, and applies to all health plans offered,
issued, or renewed on or after that date.
Sec. 44. [62Q.666]
MEDICAL NECESSITY AND NONDISCRIMINATION STANDARDS FOR COVERAGE OF PROSTHETICS
OR ORTHOTICS.
(a) When performing a
utilization review for a request for coverage of prosthetic or orthotic
benefits, a health plan company shall apply the most recent version of
evidence-based treatment and fit criteria as recognized by relevant clinical
specialists.
(b) A health plan company shall render utilization review determinations in a nondiscriminatory manner and shall not deny coverage for habilitative or rehabilitative benefits, including prosthetics or orthotics, solely on the basis of an enrollee's actual or perceived disability.
(c) A health plan
company shall not deny a prosthetic or orthotic benefit for an individual with
limb loss or absence that would otherwise be covered for a nondisabled person
seeking medical or surgical intervention to restore or maintain the ability to perform
the same physical activity.
(d) A health plan offered, issued, or renewed in Minnesota that offers coverage for prosthetics and custom orthotic devices shall include language describing an enrollee's rights pursuant to paragraphs (b) and (c) in its evidence of coverage and any benefit denial letters.
(e) A health plan that provides coverage for prosthetic or orthotic services shall ensure access to medically necessary clinical care and to prosthetic and custom orthotic devices and technology from not less than two distinct prosthetic and custom orthotic providers in the plan's provider network located in Minnesota. In the event that medically necessary covered orthotics and prosthetics are not available from an in-network provider, the health plan company shall provide processes to refer a member to an out-of-network provider and shall fully reimburse the out‑of-network provider at a mutually agreed upon rate less member cost sharing determined on an in-network basis.
(f) If coverage for
prosthetic or custom orthotic devices is provided, payment shall be made for
the replacement of a prosthetic or custom orthotic device or for the
replacement of any part of the devices, without regard to continuous use or
useful lifetime restrictions, if an ordering health care provider determines
that the provision of a replacement device, or a replacement part of a device,
is necessary because:
(1) of a change in the
physiological condition of the patient;
(2) of an irreparable change in the condition of the device or in a part of the device; or
(3) the condition of the
device, or the part of the device, requires repairs and the cost of the repairs
would be more than 60 percent of the cost of a replacement device or of the
part being replaced.
(g) Confirmation from a
prescribing health care provider may be required if the prosthetic or custom
orthotic device or part being replaced is less than three years old.
EFFECTIVE DATE. This
section is effective January 1, 2025, and applies to all health plans offered,
issued, or renewed on or after that date.
Sec. 45. [62Q.679]
RELIGIOUS OBJECTIONS.
Subdivision 1. Definitions. (a) The definitions in this
subdivision apply to this section.
(b) "Closely held
for-profit entity" means an entity that is not a nonprofit entity, has
more than 50 percent of the value of its ownership interest owned directly or
indirectly by five or fewer owners, and has no publicly traded ownership interest. For purposes of this paragraph:
(1) ownership interests owned
by a corporation, partnership, limited liability company, estate, trust, or
similar entity are considered owned by that entity's shareholders, partners,
members, or beneficiaries in proportion to their interest held in the corporation,
partnership, limited liability company, estate, trust, or similar entity;
(2) ownership interests
owned by a nonprofit entity are considered owned by a single owner;
(3) ownership interests
owned by all individuals in a family are considered held by a single owner. For purposes of this clause,
"family" means brothers and sisters, including half-brothers and
half-sisters, a spouse, ancestors, and lineal descendants; and
(4) if an individual or
entity holds an option, warrant, or similar right to purchase an ownership
interest, the individual or entity is considered to be the owner of those
ownership interests.
(c) "Eligible
organization" means an organization that opposes covering some or all
health benefits under section 62Q.522, 62Q.524, or 62Q.585 on account of
religious objections and that is:
(1) organized as a
nonprofit entity and holds itself out to be religious; or
(2) organized and
operates as a closely held for-profit entity, and the organization's owners or
highest governing body has adopted, under the organization's applicable rules
of governance and consistent with state law, a resolution or similar action establishing
that the organization objects to covering some or all health benefits under
section 62Q.522, 62Q.524, or 62Q.585 on account of the owners' sincerely held
religious beliefs.
(d) "Exempt
organization" means an organization that is organized and operates as a
nonprofit entity and meets the requirements of section 6033(a)(3)(A)(i) or
(iii) of the Internal Revenue Code of 1986, as amended.
Subd. 2. Exemption. (a) An exempt organization is not
required to provide coverage under section 62Q.522, 62Q.524, or 62Q.585 if the
exempt organization has religious objections to the coverage. An exempt organization that chooses to not
provide coverage pursuant to this paragraph must notify employees as part of
the hiring process and must notify all employees at least 30 days before:
(1) an employee enrolls
in the health plan; or
(2) the effective date
of the health plan, whichever occurs first.
(b) If the exempt
organization provides partial coverage under section 62Q.522, 62Q.524, or
62Q.585, the notice required under paragraph (a) must provide a list of the
portions of such coverage which the organization refuses to cover.
Subd. 3. Accommodation
for eligible organizations. (a)
A health plan established or maintained by an eligible organization complies
with the coverage requirements of section 62Q.522, 62Q.524, or 62Q.585, with
respect to the health benefits identified in the notice under this paragraph,
if the eligible organization provides notice to any health plan company with
which the eligible organization contracts that it is an eligible organization
and that the eligible organization has a religious objection to coverage for
all or a subset of the health benefits under section 62Q.522, 62Q.524, or
62Q.585.
(b) The notice from an
eligible organization to a health plan company under paragraph (a) must
include: (1) the name of the eligible
organization; (2) a statement that it objects to coverage for some or all of
the health benefits under section 62Q.522, 62Q.524, or 62Q.585, including a
list of the health benefits to which the eligible organization objects, if
applicable; and (3) the health plan name.
The notice must be executed by a person authorized to provide notice on
behalf of the eligible organization.
(c) An eligible organization
must provide a copy of the notice under paragraph (a) to prospective employees
as part of the hiring process and to all employees at least 30 days before:
(1) an employee enrolls
in the health plan; or
(2) the effective date
of the health plan, whichever occurs first.
(d) A health plan
company that receives a copy of the notice under paragraph (a) with respect to
a health plan established or maintained by an eligible organization must, for
all future enrollments in the health plan:
(1) expressly exclude
coverage for those health benefits identified in the notice under paragraph (a)
from the health plan; and
(2) provide separate
payments for any health benefits required to be covered under section 62Q.522,
62Q.524, or 62Q.585 for enrollees as long as the enrollee remains enrolled in
the health plan.
(e) The health plan
company must not impose any cost-sharing requirements, including co-pays,
deductibles, or coinsurance, or directly or indirectly impose any premium, fee,
or other charge for the health benefits under section 62Q.522 on the enrollee. The health plan company must not directly or
indirectly impose any premium, fee, or other charge
for the health benefits under section 62Q.522, 62Q.524, or 62Q.585 on the
eligible organization or health plan.
(f) On January 1, 2024,
and every year thereafter a health plan company must notify the commissioner,
in a manner determined by the commissioner, of the number of eligible
organizations granted an accommodation under this subdivision.
EFFECTIVE DATE. This
section is effective January 1, 2025, and applies to health plans offered,
sold, issued, or renewed on or after that date.
Sec. 46. Minnesota Statutes 2022, section 62Q.73, subdivision 2, is amended to read:
Subd. 2. Exception. (a) This section does not apply to
governmental programs except as permitted under paragraph (b). For purposes of this subdivision,
"governmental programs" means the prepaid medical assistance program,;
effective January 1, 2026, the medical assistance fee-for-service program;
the MinnesotaCare program,; the demonstration project for people
with disabilities,; and the federal Medicare program.
(b) In the course of a recipient's appeal of a medical determination to the commissioner of human services under section 256.045, the recipient may request an expert medical opinion be arranged by the external review entity under contract to provide independent external reviews under this section. If such a request is made, the cost of the review shall be paid by the commissioner of human services. Any medical opinion obtained under this paragraph shall only be used by a state human services judge as evidence in the recipient's appeal to the commissioner of human services under section 256.045.
(c) Nothing in this subdivision shall be construed to limit or restrict the appeal rights provided in section 256.045 for governmental program recipients.
Sec. 47. Minnesota Statutes 2022, section 62V.05, subdivision 12, is amended to read:
Subd. 12. Reports
on interagency agreements and intra-agency transfers. The MNsure Board shall provide quarterly
reports to the chairs and ranking minority members of the legislative
committees with jurisdiction over health and human services policy and finance
on: legislative reports on
interagency agreements and intra-agency transfers according to section 15.0395.
(1) interagency agreements or
service-level agreements and any renewals or extensions of existing interagency
or service-level agreements with a state department under section 15.01, state
agency under section 15.012, or the Department of Information Technology
Services, with a value of more than $100,000, or related agreements with the
same department or agency with a cumulative value of more than $100,000; and
(2) transfers of
appropriations of more than $100,000 between accounts within or between
agencies.
The report must include the statutory
citation authorizing the agreement, transfer or dollar amount, purpose, and
effective date of the agreement, the duration of the agreement, and a copy of
the agreement.
EFFECTIVE DATE. This
section is effective the day following final enactment.
Sec. 48. Minnesota Statutes 2022, section 62V.08, is amended to read:
62V.08 REPORTS.
(a) MNsure shall submit a
report to the legislature by January 15, 2015 March 31, 2025, and
each January 15 March 31 thereafter, on: (1) the performance of MNsure operations; (2)
meeting MNsure responsibilities; (3) an accounting of MNsure budget activities;
(4) practices and procedures that have been implemented to ensure compliance
with data practices laws, and a description of any violations of data practices
laws or procedures; and (5) the effectiveness of the outreach and
implementation activities of MNsure in reducing the rate of uninsurance.
(b) MNsure must publish its administrative and operational costs on a website to educate consumers on those costs. The information published must include: (1) the amount of premiums and federal premium subsidies collected; (2) the amount and source of revenue received under section 62V.05, subdivision 1, paragraph (b), clause (3); (3) the amount and source of any other fees collected for purposes of supporting operations; and (4) any misuse of funds as identified in accordance with section 3.975. The website must be updated at least annually.
Sec. 49. Minnesota Statutes 2022, section 62V.11, subdivision 4, is amended to read:
Subd. 4. Review
of costs. The board shall submit for
review the annual budget of MNsure for the next fiscal year by March 15 31
of each year, beginning March 15, 2014 31, 2025.
Sec. 50. Minnesota Statutes 2023 Supplement, section 145D.01, subdivision 1, is amended to read:
Subdivision 1. Definitions. (a) For purposes of this chapter section
and section 145D.02, the following terms have the meanings given.
(b) "Captive professional entity" means a professional corporation, limited liability company, or other entity formed to render professional services in which a beneficial owner is a health care provider employed by, controlled by, or subject to the direction of a hospital or hospital system.
(c) "Commissioner" means the commissioner of health.
(d) "Control," including the terms "controlling," "controlled by," and "under common control with," means the possession, direct or indirect, of the power to direct or cause the direction of the management and policies of a health care entity, whether through the ownership of voting securities, membership in an entity formed under chapter 317A, by contract other than a commercial contract for goods or nonmanagement services, or otherwise, unless the power is the result of an official position with, corporate office held by, or court appointment of, the person. Control is presumed to exist if any person, directly or indirectly, owns, controls, holds with the power to
vote, or holds proxies representing 40 percent or more of the voting securities of any other person, or if any person, directly or indirectly, constitutes 40 percent or more of the membership of an entity formed under chapter 317A. The attorney general may determine that control exists in fact, notwithstanding the absence of a presumption to that effect.
(e) "Health care entity" means:
(1) a hospital;
(2) a hospital system;
(3) a captive professional entity;
(4) a medical foundation;
(5) a health care provider group practice;
(6) an entity organized or controlled by an entity listed in clauses (1) to (5); or
(7) an entity that owns or exercises control over an entity listed in clauses (1) to (5).
(f) "Health care provider" means a physician licensed under chapter 147, a physician assistant licensed under chapter 147A, or an advanced practice registered nurse as defined in section 148.171, subdivision 3, who provides health care services, including but not limited to medical care, consultation, diagnosis, or treatment.
(g) "Health care provider group practice" means two or more health care providers legally organized in a partnership, professional corporation, limited liability company, medical foundation, nonprofit corporation, faculty practice plan, or other similar entity:
(1) in which each health care provider who is a member of the group provides services that a health care provider routinely provides, including but not limited to medical care, consultation, diagnosis, and treatment, through the joint use of shared office space, facilities, equipment, or personnel;
(2) for which substantially all services of the health care providers who are group members are provided through the group and are billed in the name of the group practice and amounts so received are treated as receipts of the group; or
(3) in which the overhead expenses of, and the income from, the group are distributed in accordance with methods previously determined by members of the group.
An entity that otherwise meets the definition of health care provider group practice in this paragraph shall be considered a health care provider group practice even if its shareholders, partners, members, or owners include a professional corporation, limited liability company, or other entity in which any beneficial owner is a health care provider and that is formed to render professional services.
(h) "Hospital" means a health care facility licensed as a hospital under sections 144.50 to 144.56.
(i) "Medical foundation" means a nonprofit legal entity through which health care providers perform research or provide medical services.
(j) "Transaction" means a single action, or a series of actions within a five-year period, which occurs in part within the state of Minnesota or involves a health care entity formed or licensed in Minnesota, that constitutes:
(1) a merger or exchange of a health care entity with another entity;
(2) the sale, lease, or transfer of 40 percent or more of the assets of a health care entity to another entity;
(3) the granting of a security interest of 40 percent or more of the property and assets of a health care entity to another entity;
(4) the transfer of 40 percent or more of the shares or other ownership of a health care entity to another entity;
(5) an addition, removal, withdrawal, substitution, or other modification of one or more members of the health care entity's governing body that transfers control, responsibility for, or governance of the health care entity to another entity;
(6) the creation of a new health care entity;
(7) an agreement or series of agreements that results in the sharing of 40 percent or more of the health care entity's revenues with another entity, including affiliates of such other entity;
(8) an addition, removal, withdrawal, substitution, or other modification of the members of a health care entity formed under chapter 317A that results in a change of 40 percent or more of the membership of the health care entity; or
(9) any other transfer of control of a health care entity to, or acquisition of control of a health care entity by, another entity.
(k) A transaction as defined in paragraph (j) does not include:
(1) an action or series of actions that meets one or more of the criteria set forth in paragraph (j), clauses (1) to (9), if, immediately prior to all such actions, the health care entity directly, or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with, all other parties to the action or series of actions;
(2) a mortgage or other secured loan for business improvement purposes entered into by a health care entity that does not directly affect delivery of health care or governance of the health care entity;
(3) a clinical affiliation of health care entities formed solely for the purpose of collaborating on clinical trials or providing graduate medical education;
(4) the mere offer of employment to, or hiring of, a health care provider by a health care entity;
(5) contracts between a health care entity and a health care provider primarily for clinical services; or
(6) a single action or series of actions within a five-year period involving only entities that operate solely as a nursing home licensed under chapter 144A; a boarding care home licensed under sections 144.50 to 144.56; a supervised living facility licensed under sections 144.50 to 144.56; an assisted living facility licensed under chapter 144G; a foster care setting licensed under Minnesota Rules, parts 9555.5105 to 9555.6265, for a physical location that is not the primary residence of the license holder; a community residential setting as defined in section 245D.02, subdivision 4a; or a home care provider licensed under sections 144A.471 to 144A.483.
Sec. 51. [145D.30]
DEFINITIONS.
Subdivision 1. Application. For purposes of sections 145D.30 to
145D.37, the following terms have the meanings given unless the context clearly
indicates otherwise.
Subd. 2. Commissioner"Commissioner"
means the commissioner of commerce for a nonprofit health coverage entity that
is a nonprofit health service plan corporation operating under chapter 62C or
the commissioner of health for a nonprofit
health coverage entity that is a nonprofit health maintenance organization
operating under chapter 62D.
Subd. 3. Control. "Control," including the
terms "controlling," "controlled by," and "under
common control with," means the possession, direct or indirect, of the
power to direct or cause the direction of the management and policies of a
nonprofit health coverage entity, whether through the ownership of voting
securities, through membership in an entity formed under chapter 317A, by
contract other than a commercial contract for goods or nonmanagement services,
or otherwise, unless the power is the result of an official position with,
corporate office held by, or court appointment of the person. Control is presumed to exist if any person,
directly or indirectly, owns, controls, holds with the power to vote, or holds
proxies representing 40 percent or more of the voting securities of any other
person or if any person, directly or indirectly, constitutes 40 percent or more
of the membership of an entity formed under chapter 317A. The attorney general may determine that
control exists in fact, notwithstanding the absence of a presumption to that
effect.
Subd. 4. Conversion
benefit entity. "Conversion
benefit entity" means a foundation, corporation, limited liability
company, trust, partnership, or other entity that receives, in connection with
a conversion transaction, the value of any public benefit asset in accordance
with section 145D.32, subdivision 5.
Subd. 5. Conversion
transaction. "Conversion
transaction" means a transaction otherwise permitted under applicable law
in which a nonprofit health coverage entity:
(1) merges, consolidates,
converts, or transfers all or substantially all of its assets to any entity
except a corporation that is exempt under United States Code, title 26, section
501(c)(3);
(2) makes a series of
separate transfers within a 60-month period that in the aggregate constitute a
transfer of all or substantially all of the nonprofit health coverage entity's
assets to any entity except a corporation that is exempt under United States
Code, title 26, section 501(c)(3); or
(3) adds or substitutes
one or more directors or officers that effectively transfer the control of,
responsibility for, or governance of the nonprofit health coverage entity to
any entity except a corporation that is exempt under United States Code, title
26, section 501(c)(3).
Subd. 6. Corporation. "Corporation" has the
meaning given in section 317A.011, subdivision 6, and also includes a nonprofit
limited liability company organized under section 322C.1101.
Subd. 7. Director. "Director" has the meaning
given in section 317A.011, subdivision 7.
Subd. 8. Family
member. "Family
member" means a spouse, parent, child, spouse of a child, brother, sister,
or spouse of a brother or sister.
Subd. 9. Full
and fair value. "Full
and fair value" means at least the amount that the public benefit assets
of the nonprofit health coverage entity would be worth if the assets were equal
to stock in the nonprofit health coverage entity, if the nonprofit health
coverage entity was a for-profit corporation and if the nonprofit health
coverage entity had 100 percent of its stock authorized by the corporation and
available for purchase without transfer restrictions. The valuation shall consider market value,
investment or earning value, net asset value, goodwill, amount of donations
received, and control premium, if any.
Subd. 10. Key
employee. "Key
employee" means an individual, regardless of title, who:
(1) has
responsibilities, power, or influence over an organization similar to those of
an officer or director;
(2) manages a discrete
segment or activity of the organization that represents ten percent or more of
the activities, assets, income, or expenses of the organization, as compared to
the organization as a whole; or
(3) has or shares
authority to control or determine ten percent or more of the organization's
capital expenditures, operating budget, or compensation for employees.
Subd. 11. Nonprofit
health coverage entity. "Nonprofit
health coverage entity" means a nonprofit health service plan corporation
operating under chapter 62C or a nonprofit health maintenance organization
operating under chapter 62D.
Subd. 12. Officer. "Officer" has the meaning
given in section 317A.011, subdivision 15.
Subd. 13. Public
benefit assets. "Public
benefit assets" means the entirety of a nonprofit health coverage entity's
assets, whether tangible or intangible, including but not limited to its
goodwill and anticipated future revenue.
Subd. 14. Related
organization. "Related
organization" has the meaning given in section 317A.011, subdivision 18.
Sec. 52. [145D.31]
CERTAIN CONVERSION TRANSACTIONS PROHIBITED.
A nonprofit health
coverage entity must not enter into a conversion transaction if:
(1) doing so would
result in less than the full and fair market value of all public benefit assets
remaining dedicated to the public benefit; or
(2) an individual who
has been an officer, director, or other executive of the nonprofit health
coverage entity or of a related organization, or a family member of such an
individual:
(i) has held or will
hold, whether guaranteed or contingent, an ownership stake, stock, securities,
investment, or other financial interest in an entity to which the nonprofit
health coverage entity transfers public benefit assets in connection with the conversion
transaction;
(ii) has received or
will receive any type of compensation or other financial benefit from an entity
to which the nonprofit health coverage entity transfers public benefit assets
in connection with the conversion transaction;
(iii) has held or will
hold, whether guaranteed or contingent, an ownership stake, stock, securities,
investment, or other financial interest in an entity that has or will have a
business relationship with an entity to which the nonprofit health coverage
entity transfers public benefit assets in connection with the conversion
transaction; or
(iv) has received or
will receive any type of compensation or other financial benefit from an entity
that has or will have a business relationship with an entity to which the
nonprofit health coverage entity transfers public benefit assets in connection with
the conversion transaction.
Sec. 53. [145D.32]
REQUIREMENTS FOR NONPROFIT HEALTH COVERAGE ENTITY CONVERSION TRANSACTIONS.
Subdivision 1. Notice. (a) Before entering into a conversion
transaction, a nonprofit health coverage entity must notify the attorney
general according to section 317A.811. In
addition to the elements listed in section 317A.811, subdivision 1, the notice
required by this subdivision must also include:
(1) an itemization of the nonprofit health coverage entity's public
benefit assets and an independent third-party valuation of the nonprofit health
coverage entity's public benefit assets; (2) a proposed plan to distribute the
value of those public benefit assets to a conversion benefit entity that meets
the requirements of section 145D.33; and (3) other information contained in
forms provided by the attorney general.
(b) When the nonprofit
health coverage entity provides the attorney general with the notice and other
information required under paragraph (a), the nonprofit health coverage entity
must also provide a copy of this notice and other information to the applicable
commissioner.
Subd. 2. Nonprofit
health coverage entity requirements.
Before entering into a conversion transaction, a nonprofit health
coverage entity must ensure that:
(1) the proposed
conversion transaction complies with chapters 317A and 501B and other
applicable laws;
(2) the proposed
conversion transaction does not involve or constitute a breach of charitable
trust;
(3) the nonprofit health
coverage entity shall receive full and fair value for its public benefit
assets;
(4) the value of the
public benefit assets to be transferred has not been manipulated in a manner
that causes or caused the value of the assets to decrease;
(5) the proceeds of the
proposed conversion transaction shall be used in a manner consistent with the
public benefit for which the assets are held by the nonprofit health coverage
entity;
(6) the proposed
conversion transaction shall not result in a breach of fiduciary duty; and
(7) the conversion
benefit entity that receives the value of the nonprofit health coverage
entity's public benefit assets meets the requirements in section 145D.33.
Subd. 3. Listening
sessions and public comment. The
attorney general or the commissioner may hold public listening sessions or
forums and may solicit public comments regarding the proposed conversion
transaction, including on the formation of a conversion benefit entity under
section 145D.33.
Subd. 4. Waiting
period. (a) Subject to
paragraphs (b) and (c), a nonprofit health coverage entity must not enter into
a conversion transaction until 90 days after the nonprofit health coverage
entity has given written notice as required in subdivision 1.
(b) The attorney general
may waive all or part of the waiting period or may extend the waiting period
for an additional 90 days by notifying the nonprofit health coverage entity of
the extension in writing.
(c) The time periods
specified in this subdivision shall be suspended while an investigation into
the conversion transaction is pending or while a request from the attorney
general for additional information is outstanding.
Subd. 5. Transfer
of value of assets required. As
part of a conversion transaction for which notice is provided under subdivision
1, the nonprofit health coverage entity must transfer the entirety of the full
and fair value of its public benefit assets to one or more conversion benefit
entities that meet the requirements in section 145D.33.
Subd. 6. Funds
restricted for a particular purpose.
Nothing in this section relieves a nonprofit health coverage
entity from complying with requirements for funds that are restricted for a
particular purpose. Funds restricted for
a particular purpose must continue to be used in accordance with the purpose
for which they were restricted under sections 317A.671 and 501B.31. A nonprofit health coverage entity may not
convert assets that would conflict with their restricted purpose.
Sec. 54. [145D.33]
CONVERSION BENEFIT ENTITY REQUIREMENTS.
Subdivision 1. Requirements. In order to receive the value of a
nonprofit health coverage entity's public benefit assets as part of a
conversion transaction, a conversion benefit entity must:
(1) be: (i) an existing or new domestic, nonprofit
corporation operating under chapter 317A, a nonprofit limited liability company
operating under chapter 322C, or a wholly owned subsidiary thereof; and (ii)
exempt under United States Code, title 26, section 501(c)(3);
(2) have in place
procedures and policies to prohibit conflicts of interest, including but not
limited to conflicts of interest relating to any grant-making activities that
may benefit:
(i) the officers,
directors, or key employees of the conversion benefit entity;
(ii) any entity to which
the nonprofit health coverage entity transfers public benefit assets in
connection with a conversion transaction; or
(iii) any officers,
directors, or key employees of an entity to which the nonprofit health coverage
entity transfers public benefit assets in connection with a conversion
transaction;
(3) operate to benefit
the health of the people in this state;
(4) have in place
procedures and policies that prohibit:
(i) an officer,
director, or key employee of the nonprofit health coverage entity from serving
as an officer, director, or key employee of the conversion benefit entity for
the five-year period following the conversion transaction;
(ii) an officer,
director, or key employee of the nonprofit health coverage entity or of the
conversion benefit entity from directly or indirectly benefiting from the
conversion transaction; and
(iii) elected or
appointed public officials from serving as an officer, director, or key
employee of the conversion benefit entity;
(5) not make grants or
payments or otherwise provide financial benefit to an entity to which a
nonprofit health coverage entity transfers public benefit assets as part of a
conversion transaction or to a related organization of the entity to which the nonprofit health coverage
entity transfers public benefit assets as part of a conversion transaction; and
(6) not have as an
officer director, or key employee any individual who has been an officer,
director, or key employee of an entity that receives public benefit assets as
part of a conversion transaction.
Subd. 2. Review
and approval. The
commissioner must review and approve a conversion benefit entity before the
conversion benefit entity receives the value of public benefit assets from a nonprofit
health coverage entity. In order to be
approved under this subdivision, the conversion benefit entity's governance
must be broadly based in the community served by the nonprofit health coverage
entity and must be independent of the entity to which the nonprofit health
coverage entity transfers public benefit assets as part of the conversion
transaction. As part of the review of
the conversion benefit entity's governance, the commissioner may hold a public
hearing. The public hearing, if held by
the commissioner of health, may be held concurrently with the hearing
authorized under section 62D.31. If the
commissioner finds it necessary, a portion of the value of the public benefit
assets must be used to develop a community-based plan for use by the conversion
benefit entity.
Subd. 3. Community
advisory committee. The
commissioner must establish a community advisory committee for a conversion
benefit entity receiving the value of public benefit assets. The members of the community advisory
committee must be selected to represent the diversity of the community
previously served by the nonprofit health coverage entity. The community advisory committee must:
(1) provide a slate of
three nominees for each vacancy on the governing board of the conversion
benefit entity, from which the remaining board members must select new members
to the board;
(2) provide the
conversion benefit entity's governing board with guidance on the health needs
of the community previously served by the nonprofit health coverage entity; and
(3) promote dialogue and
information sharing between the conversion benefit entity and the community
previously served by the nonprofit health coverage entity.
Sec. 55. [145D.34]
ENFORCEMENT AND REMEDIES.
Subdivision 1. Investigation. The attorney general has the powers in
section 8.31. Nothing in this
subdivision limits the powers, remedies, or responsibilities of the attorney
general under this chapter; chapter 8, 309, 317A, or 501B; or any other chapter. For purposes of this section, an approval by
the commissioner for regulatory purposes does not impair or inform the attorney
general's authority.
Subd. 2. Enforcement
and penalties. (a) The
attorney general may bring an action in district court to enjoin or unwind a
conversion transaction or seek other equitable relief necessary to protect the
public interest if:
(1) a nonprofit health
coverage entity or conversion transaction violates sections 145D.30 to 145D.33;
or
(2) the conversion
transaction is contrary to the public interest.
In seeking injunctive relief, the attorney
general must not be required to establish irreparable harm but must instead
establish that a violation of sections 145D.30 to 145D.33 occurred or that the
requested order promotes the public interest.
(b) Factors informing
whether a conversion transaction is contrary to the public interest include but
are not limited to whether:
(1) the conversion
transaction shall result in increased health care costs for patients; and
(2) the conversion
transaction shall adversely impact provider cost trends and containment of
total health care spending.
(c) The attorney general
may enforce sections 145D.30 to 145D.33 under section 8.31.
(d) Failure of the entities
involved in a conversion transaction to provide timely information as required
by the attorney general or the commissioner shall be an independent and
sufficient ground for a court to enjoin or unwind the transaction or provide
other equitable relief, provided the attorney general notifies the entities of
the inadequacy of the information provided and provides the entities with a
reasonable opportunity to remedy the inadequacy.
(e) An officer,
director, or other executive found to have violated sections 145D.30 to 145D.33
shall be subject to a civil penalty of up to $100,000 for each violation. A corporation or other entity which is a
party to or materially participated in a conversion transaction found to have
violated sections 145D.30 to 145D.33 shall be subject to a civil penalty of up
to $1,000,000. A court may also award
reasonable attorney fees and costs of investigation and litigation.
Subd. 3. Commissioner
of health; data and research. The
commissioner of health must provide the attorney general, upon request, with
data and research on broader market trends, impacts on prices and outcomes,
public health and population health considerations, and health care access, for
the attorney general to use when evaluating whether a conversion transaction is
contrary to public interest. The
commissioner may share with the attorney general, according to section 13.05,
subdivision 9, any not public data, as defined in section 13.02, subdivision
8a, held by the commissioner to aid in the investigation and review of the
conversion transaction, and the attorney general must maintain this data with
the same classification according to section 13.03, subdivision 4, paragraph
(c).
Subd. 4. Failure
to take action. Failure by
the attorney general to take action with respect to a conversion transaction
under this section does not constitute approval of the conversion transaction
or waiver, nor shall failure prevent the attorney general from taking action in
the same, similar, or subsequent circumstances.
Sec. 56. [145D.35]
DATA PRACTICES.
Section 13.65 applies to
data provided by a nonprofit health coverage entity or the commissioner to the
attorney general under sections 145D.30 to 145D.33. Section 13.39 applies to data provided by a
nonprofit health coverage entity to the commissioner under sections 145D.30 to
145D.33. The attorney general or the
commissioner may make any data classified as confidential or protected
nonpublic under this section accessible to any civil or criminal law
enforcement agency if the attorney general or commissioner determines that the
access aids the law enforcement process.
Sec. 57. [145D.36]
COMMISSIONER OF HEALTH; REPORTS AND ANALYSIS.
Notwithstanding any law
to the contrary, the commissioner of health may use data or information
submitted under sections 60A.135 to 60A.137, 60A.17, 60D.18, 60D.20, 62D.221,
and 145D.32 to conduct analyses of the aggregate impact of transactions within
nonprofit health coverage entities and organizations which include nonprofit
health coverage entities or their affiliates on access to or the cost of health
care services, health care market consolidation, and health care quality. The commissioner of health must issue
periodic public reports on the number and types of conversion transactions
subject to sections 145D.30 to 145D.35 and on the aggregate impact of
conversion transactions on health care costs, quality, and competition in
Minnesota.
Sec. 58. [145D.37]
RELATION TO OTHER LAW.
(a) Sections 145D.30 to
145D.36 are in addition to and do not affect or limit any power, remedy, or responsibility
of a health maintenance organization, a service plan corporation, a conversion
benefit entity, the attorney general, the commissioner of health, or the
commissioner of commerce under this chapter; chapter 8, 62C, 62D, 309, 317A, or
501B; or other law.
(b) Nothing in sections
145D.03 to 145D.36 authorizes a nonprofit health coverage entity to enter into
a conversion transaction not otherwise permitted under chapter 317A or 501B or
other law.
Sec. 59. Minnesota Statutes 2022, section 256B.0625, subdivision 12, is amended to read:
Subd. 12. Eyeglasses,
dentures, and prosthetic and orthotic devices. (a) Medical assistance covers
eyeglasses, dentures, and prosthetic and orthotic devices if prescribed
by a licensed practitioner.
(b) For purposes of
prescribing prosthetic and orthotic devices, "licensed practitioner"
includes a physician, an advanced practice registered nurse, a physician
assistant, or a podiatrist.
EFFECTIVE DATE. This
section is effective January 1, 2025, or upon federal approval, whichever is
later. The commissioner of human
services shall notify the revisor of statutes when federal approval is
obtained.
Sec. 60. Minnesota Statutes 2023 Supplement, section 256B.0625, subdivision 16, is amended to read:
Subd. 16. Abortion
services. Medical assistance covers abortion
services determined to be medically necessary by the treating provider and
delivered in accordance with all applicable Minnesota laws abortions and
abortion‑related services, including preabortion services and follow-up
services.
EFFECTIVE DATE. This
section is effective January 1, 2025, or upon federal approval, whichever is
later. The commissioner of human
services shall notify the revisor of statutes when federal approval is
obtained.
Sec. 61. Minnesota Statutes 2022, section 256B.0625, is amended by adding a subdivision to read:
Subd. 25c. Applicability
of utilization review provisions. Effective
January 1, 2026, the following provisions of chapter 62M apply to the
commissioner when delivering services through fee-for-service under chapters
256B and 256L: 62M.02, subdivisions 1 to
5, 7 to 12, 13, 14 to 18, and 21; 62M.04; 62M.05, subdivisions 1 to 4; 62M.06,
subdivisions 1 to 3; 62M.07; 62M.072; 62M.09; 62M.10; 62M.12; and 62M.17,
subdivision 2.
Sec. 62. Minnesota Statutes 2022, section 256B.0625, subdivision 32, is amended to read:
Subd. 32. Nutritional products. Medical assistance covers nutritional products needed for nutritional supplementation because solid food or nutrients thereof cannot be properly absorbed by the body or needed for treatment of phenylketonuria, hyperlysinemia, maple syrup urine disease, a combined allergy to human milk, cow's milk, and soy formula, or any other childhood or adult diseases, conditions, or disorders identified by the commissioner as requiring a similarly necessary nutritional product. Medical assistance covers amino acid-based elemental formulas in the same manner as is required under section 62Q.531. Nutritional products needed for the treatment of a combined allergy to human milk, cow's milk, and soy formula require prior authorization. Separate payment shall not be made for nutritional products for residents of long-term care facilities. Payment for dietary requirements is a component of the per diem rate paid to these facilities.
EFFECTIVE DATE. This
section is effective January 1, 2025.
Sec. 63. Minnesota Statutes 2022, section 256B.0625, is amended by adding a subdivision to read:
Subd. 72. Orthotic
and prosthetic devices. Medical
assistance covers orthotic and prosthetic devices, supplies, and services
according to section 256B.066.
EFFECTIVE DATE. This
section is effective January 1, 2025, or upon federal approval, whichever is
later. The commissioner of human
services shall notify the revisor of statutes when federal approval is
obtained.
Sec. 64. Minnesota Statutes 2022, section 256B.0625, is amended by adding a subdivision to read:
Subd. 73. Rapid
whole genome sequencing. Medical
assistance covers rapid whole genome sequencing (rWGS) testing. Coverage and eligibility for rWGS testing,
and the use of genetic data, must meet the requirements specified in section
62A.3098, subdivisions 1 to 3 and 6.
EFFECTIVE DATE. This
section is effective January 1, 2025.
Sec. 65. Minnesota Statutes 2022, section 256B.0625, is amended by adding a subdivision to read:
Subd. 74. Scalp
hair prostheses. Medical
assistance covers scalp hair prostheses prescribed for hair loss suffered as a
result of treatment for cancer. Medical
assistance must meet the requirements that would otherwise apply to a health
plan under section 62A.28, except for the limitation on coverage required per
benefit year set forth in section 62A.28, subdivision 2, paragraph (c).
EFFECTIVE DATE. This
section is effective January 1, 2025.
Sec. 66. [256B.066]
ORTHOTIC AND PROSTHETIC DEVICES, SUPPLIES, AND SERVICES.
Subdivision 1. Definitions. All terms used in this section have
the meanings given them in section 62Q.665, subdivision 1.
Subd. 2. Coverage
requirements. (a) Medical
assistance covers orthotic and prosthetic devices, supplies, and services:
(1) furnished under an
order by a prescribing physician or licensed health care prescriber who has
authority in Minnesota to prescribe orthoses and prostheses. Coverage for orthotic and prosthetic devices,
supplies, accessories, and services under this clause includes those devices or
device systems, supplies, accessories, and services that are customized to the
enrollee's needs;
(2) determined by the
enrollee's provider to be the most appropriate model that meets the medical
needs of the enrollee for purposes of performing physical activities, as
applicable, including but not limited to running, biking, and swimming, and
maximizing the enrollee's limb function; or
(3) for showering or
bathing.
(b) The coverage set
forth in paragraph (a) includes the repair and replacement of those orthotic
and prosthetic devices, supplies, and services described therein.
(c) Coverage of a
prosthetic or orthotic benefit must not be denied for an individual with limb
loss or absence that would otherwise be covered for a nondisabled person
seeking medical or surgical intervention to restore or maintain the ability to
perform the same physical activity.
(d) If coverage for
prosthetic or custom orthotic devices is provided, payment must be made for the
replacement of a prosthetic or custom orthotic device or for the replacement of
any part of the devices, without regard to useful lifetime restrictions, if an
ordering health care provider determines that the provision of a replacement
device, or a replacement part of a device, is necessary because:
(1) of a change in the
physiological condition of the enrollee;
(2) of an irreparable
change in the condition of the device or in a part of the device; or
(3) the condition of the
device, or the part of the device, requires repairs and the cost of the repairs
would be more than 60 percent of the cost of a replacement device or of the
part being replaced.
Subd. 3. Restrictions
on coverage. (a) Prior
authorization may be required for orthotic and prosthetic devices, supplies,
and services.
(b) A utilization review
for a request for coverage of prosthetic or orthotic benefits must apply the
most recent version of evidence-based treatment and fit criteria as recognized
by relevant clinical specialists.
(c) Utilization review
determinations must be rendered in a nondiscriminatory manner and must not deny
coverage for habilitative or rehabilitative benefits, including prosthetics or
orthotics, solely on the basis of an enrollee's actual or perceived disability.
(d) Evidence of coverage
and any benefit denial letters must include language describing an enrollee's
rights pursuant to paragraphs (b) and (c).
(e) Confirmation from a
prescribing health care provider may be required if the prosthetic or custom
orthotic device or part being replaced is less than three years old.
Subd. 4. Managed care plan access to care. (a) Managed care plans and county-based purchasing plans subject to this section must ensure access to medically necessary clinical care and to prosthetic and custom orthotic devices and technology from at least two distinct prosthetic and custom orthotic providers in the plan's provider network located in Minnesota.
(b) In the event that
medically necessary covered orthotics and prosthetics are not available from an
in-network provider, the plan must provide processes to refer an enrollee to an
out-of-network provider and must fully reimburse the out-of-network provider at
a mutually agreed upon rate less enrollee cost sharing determined on an in‑network
basis.
EFFECTIVE DATE. This
section is effective January 1, 2025, or upon federal approval, whichever is
later. The commissioner of human
services shall notify the revisor of statutes when federal approval is
obtained.
Sec. 67. Minnesota Statutes 2022, section 317A.811, subdivision 1, is amended to read:
Subdivision 1. When required. (a) Except as provided in subdivision 6, the following corporations shall notify the attorney general of their intent to dissolve, merge, consolidate, or convert, or to transfer all or substantially all of their assets:
(1) a corporation that
holds assets for a charitable purpose as defined in section 501B.35,
subdivision 2; or
(2) a corporation that is
exempt under section 501(c)(3) of the Internal Revenue Code of 1986, or any
successor section.; or
(3) a nonprofit health
coverage entity as defined in section 145D.30.
(b) The notice must include:
(1) the purpose of the corporation that is giving the notice;
(2) a list of assets owned or held by the corporation for charitable purposes;
(3) a description of restricted assets and purposes for which the assets were received;
(4) a description of debts, obligations, and liabilities of the corporation;
(5) a description of tangible assets being converted to cash and the manner in which they will be sold;
(6) anticipated expenses of the transaction, including attorney fees;
(7) a list of persons to whom assets will be transferred, if known, or the name of the converted organization;
(8) the purposes of persons receiving the assets or of the converted organization; and
(9) the terms, conditions, or restrictions, if any, to be imposed on the transferred or converted assets.
The notice must be signed on behalf of the corporation by an authorized person.
Sec. 68. COMMISSIONER
OF HEALTH; ANALYSIS AND REPORT TO THE LEGISLATURE.
(a) The commissioner of
health must use the data submitted by utilization review organizations under
Minnesota Statutes, section 62M.19, and other data available to the
commissioner to analyze the use of utilization management tools, including
prior authorization, in health care. The
analysis must evaluate the effect utilization management tools have on patient
access to care, the administrative burden the use of utilization management
tools places on health care providers, and system costs. The commissioner must also develop
recommendations on how to simplify health insurance prior authorization
standards and processes to improve health care access, reduce delays in care,
reduce the administrative burden on health care providers, and maximize quality
of care, including recommendations for a prior authorization exemption process
for providers and group practices that have an authorization rate for all
submitted requests for authorization at or above a level determined by the
commissioner as qualifying for the exemption.
When conducting the analysis and developing recommendations, the
commissioner must consult, as appropriate, with physicians, other providers,
health plan companies, consumers, and other health care experts.
(b) The commissioner
must issue a report to the legislature by December 15, 2026, containing the
commissioner's analysis and recommendations under paragraph (a).
Sec. 69. INITIAL
REPORTS TO COMMISSIONER OF HEALTH; UTILIZATION MANAGEMENT TOOLS.
Utilization review
organizations must submit initial reports to the commissioner of health under
Minnesota Statutes, section 62M.19, by September 1, 2025.
Sec. 70. TRANSITION.
(a) A health maintenance
organization that has a certificate of authority under Minnesota Statutes,
chapter 62D, but that is not a nonprofit corporation organized under Minnesota
Statutes, chapter 317A, or a local governmental unit, as defined in Minnesota
Statutes, section 62D.02, subdivision 11:
(1) must not offer,
sell, issue, or renew any health maintenance contracts on or after August 1,
2024;
(2) may otherwise
continue to operate as a health maintenance organization until December 31,
2025; and
(3) must provide notice to the
health maintenance organization's enrollees as of August 1, 2024, of the date
the health maintenance organization will cease to operate in this state and any
plans to transition enrollee coverage to another insurer. This notice must be provided by October 1,
2024.
(b) The commissioner of
health must not issue or renew a certificate of authority to operate as a
health maintenance organization on or after August 1, 2024, unless the entity
seeking the certificate of authority meets the requirements for a health maintenance
organization under Minnesota Statutes, chapter 62D, in effect on or after
August 1, 2024.
Sec. 71. REPEALER.
(a) Minnesota Statutes
2022, section 62A.041, subdivision 3, is repealed.
(b) Minnesota Statutes
2023 Supplement, section 62Q.522, subdivisions 3 and 4, are repealed.
EFFECTIVE DATE. This
section is effective January 1, 2025, and applies to health plans offered,
sold, issued, or renewed on or after that date.
ARTICLE 5
DEPARTMENT OF HEALTH FINANCE
Section 1. Minnesota Statutes 2022, section 62D.14, subdivision 1, is amended to read:
Subdivision 1. Examination
authority. The commissioner of
health may make an examination of the affairs of any health maintenance
organization and its contracts, agreements, or other arrangements with any
participating entity as often as the commissioner of health deems necessary for
the protection of the interests of the people of this state, but not less
frequently than once every three five years. Examinations of participating entities
pursuant to this subdivision shall be limited to their dealings with the health
maintenance organization and its enrollees, except that examinations of major
participating entities may include inspection of the entity's financial
statements kept in the ordinary course of business. The commissioner may require major
participating entities to submit the financial statements directly to the
commissioner. Financial statements of
major participating entities are subject to the provisions of section 13.37,
subdivision 1, clause (b), upon request of the major participating entity or
the health maintenance organization with which it contracts.
Sec. 2. Minnesota Statutes 2022, section 103I.621, subdivision 1, is amended to read:
Subdivision 1. Permit. (a) Notwithstanding any department or agency rule to the contrary, the commissioner shall issue, on request by the owner of the property and payment of the permit fee, permits for the reinjection of water by a properly constructed well into the same aquifer from which the water was drawn for the operation of a groundwater thermal exchange device.
(b) As a condition of the permit, an applicant must agree to allow inspection by the commissioner during regular working hours for department inspectors.
(c) Not more than 200
permits may be issued for small systems having maximum capacities of 20 gallons
per minute or less and that are compliant with the natural resource
water-use requirements under subdivision 2.
The small systems are subject to inspection twice a year.
(d) Not more than ten
100 permits may be issued for larger systems having maximum capacities from
over 20 to 50 gallons per minute and are compliant with the
natural resource water-use requirements under subdivision 2. The larger systems are subject to
inspection four times a year.
(e) A person issued a permit
must comply with this section and permit conditions deemed necessary to
protect public health and safety of groundwater for the permit to be
valid. The permit conditions may
include but are not limited to requirements for:
(1) notification to the
commissioner at intervals specified in the permit conditions;
(2) system operation and
maintenance;
(3) system location and
construction;
(4) well location and construction;
(5) signage;
(6) reports of system
construction, performance, operation, and maintenance;
(7) removal of the
system upon termination of its use or system failure;
(8) disclosure of the
system at the time of property transfer;
(9) obtaining approval
from the commissioner prior to deviation from the approval plan and conditions;
(10) groundwater level
monitoring; or
(11) groundwater quality
monitoring.
(f) The property owner
or the property owner's agent must submit to the commissioner a permit
application on a form provided by the commissioner, or in a format approved by
the commissioner, that provides any information necessary to protect public
health and safety of groundwater.
(g) A permit granted
under this section is not valid if a water-use permit is required for the
project and is not approved by the commissioner of natural resources.
EFFECTIVE DATE. This
section is effective the day following final enactment.
Sec. 3. Minnesota Statutes 2022, section 103I.621, subdivision 2, is amended to read:
Subd. 2. Water-use
requirements apply. Water-use permit
requirements and penalties under chapter 103F 103G and related
rules adopted and enforced by the commissioner of natural resources apply to
groundwater thermal exchange permit recipients.
A person who violates a provision of this section is subject to
enforcement or penalties for the noncomplying activity that are available to
the commissioner and the Pollution Control Agency.
EFFECTIVE DATE. This
section is effective the day following final enactment.
Sec. 4. Minnesota Statutes 2022, section 144.05, subdivision 6, is amended to read:
Subd. 6. Reports
on interagency agreements and intra-agency transfers. The commissioner of health shall provide quarterly
reports to the chairs and ranking minority members of the legislative
committees with jurisdiction over health and human services policy and finance
on: the interagency agreements
and intra-agency transfers report per section 15.0395.
(1) interagency agreements or
service-level agreements and any renewals or extensions of existing interagency
or service-level agreements with a state department under section 15.01, state
agency under section 15.012, or the Department of Information Technology
Services, with a value of more than $100,000, or related agreements with the
same department or agency with a cumulative value of more than $100,000; and
(2) transfers of
appropriations of more than $100,000 between accounts within or between
agencies.
The report must include the statutory
citation authorizing the agreement, transfer or dollar amount, purpose, and
effective date of the agreement, duration of the agreement, and a copy of the
agreement.
Sec. 5. Minnesota Statutes 2023 Supplement, section 144.1501, subdivision 2, is amended to read:
Subd. 2. Creation
of account Availability. (a)
A health professional education loan forgiveness program account is
established. The commissioner of
health shall use money from the account to establish a appropriated
for health professional education loan forgiveness program in
this section:
(1) for medical residents, physicians, mental health professionals, and alcohol and drug counselors agreeing to practice in designated rural areas or underserved urban communities or specializing in the area of pediatric psychiatry;
(2) for midlevel practitioners agreeing to practice in designated rural areas or to teach at least 12 credit hours, or 720 hours per year in the nursing field in a postsecondary program at the undergraduate level or the equivalent at the graduate level;
(3) for nurses who agree to practice in a Minnesota nursing home; in an intermediate care facility for persons with developmental disability; in a hospital if the hospital owns and operates a Minnesota nursing home and a minimum of 50 percent of the hours worked by the nurse is in the nursing home; in an assisted living facility as defined in section 144G.08, subdivision 7; or for a home care provider as defined in section 144A.43, subdivision 4; or agree to teach at least 12 credit hours, or 720 hours per year in the nursing field in a postsecondary program at the undergraduate level or the equivalent at the graduate level;
(4) for other health care technicians agreeing to teach at least 12 credit hours, or 720 hours per year in their designated field in a postsecondary program at the undergraduate level or the equivalent at the graduate level. The commissioner, in consultation with the Healthcare Education-Industry Partnership, shall determine the health care fields where the need is the greatest, including, but not limited to, respiratory therapy, clinical laboratory technology, radiologic technology, and surgical technology;
(5) for pharmacists, advanced dental therapists, dental therapists, and public health nurses who agree to practice in designated rural areas;
(6) for dentists agreeing to
deliver at least 25 percent of the dentist's yearly patient encounters to state
public program enrollees or patients receiving sliding fee schedule discounts
through a formal sliding fee schedule meeting the standards established by the
United States Department of Health and Human Services under Code of Federal
Regulations, title 42, section 51, chapter 303 51c.303; and
(7) for nurses employed as a hospital nurse by a nonprofit hospital and providing direct care to patients at the nonprofit hospital.
(b) Appropriations made to
the account for health professional education loan forgiveness in this
section do not cancel and are available until expended, except that at the
end of each biennium, any remaining balance in the account that is not
committed by contract and not needed to fulfill existing commitments shall
cancel to the fund.
Sec. 6. Minnesota Statutes 2022, section 144.1501, subdivision 5, is amended to read:
Subd. 5. Penalty
for nonfulfillment. If a participant
does not fulfill the required minimum commitment of service according to
subdivision 3, the commissioner of health shall collect from the participant
the total amount paid to the participant under the loan forgiveness program
plus interest at a rate established according to section 270C.40. The commissioner shall deposit the money
collected in the health care access fund to be credited to a
dedicated account in the special revenue fund.
The balance of the account is appropriated annually to the commissioner
for the health professional education loan forgiveness program account
established in subdivision 2. The
commissioner shall allow waivers of all or part of the money owed the
commissioner as a result of a nonfulfillment penalty if emergency circumstances
prevented fulfillment of the minimum service commitment.
Sec. 7. Minnesota Statutes 2023 Supplement, section 144.1505, subdivision 2, is amended to read:
Subd. 2. Programs. (a) For advanced practice provider
clinical training expansion grants, the commissioner of health shall award
health professional training site grants to eligible physician assistant,
advanced practice registered nurse, pharmacy, dental therapy, and mental health
professional programs to plan and implement expanded clinical training. A planning grant shall not exceed $75,000,
and a three-year training grant shall not exceed $150,000 for the
first year, $100,000 for the second year, and $50,000 for the third year $300,000
per program project. The
commissioner may provide a one-year, no-cost extension for grants.
(b) For health professional rural and underserved clinical rotations grants, the commissioner of health shall award health professional training site grants to eligible physician, physician assistant, advanced practice registered nurse, pharmacy, dentistry, dental therapy, and mental health professional programs to augment existing clinical training programs to add rural and underserved rotations or clinical training experiences, such as credential or certificate rural tracks or other specialized training. For physician and dentist training, the expanded training must include rotations in primary care settings such as community clinics, hospitals, health maintenance organizations, or practices in rural communities.
(c) Funds may be used for:
(1) establishing or expanding rotations and clinical training;
(2) recruitment, training, and retention of students and faculty;
(3) connecting students with appropriate clinical training sites, internships, practicums, or externship activities;
(4) travel and lodging for students;
(5) faculty, student, and preceptor salaries, incentives, or other financial support;
(6) development and implementation of cultural competency training;
(7) evaluations;
(8) training site improvements, fees, equipment, and supplies required to establish, maintain, or expand a training program; and
(9) supporting clinical education in which trainees are part of a primary care team model.
Sec. 8. Minnesota Statutes 2022, section 144.555, subdivision 1a, is amended to read:
Subd. 1a. Notice
of closing, curtailing operations, relocating services, or ceasing to offer
certain services; hospitals. (a) The
controlling persons of a hospital licensed under sections 144.50 to 144.56 or a
hospital campus must notify the commissioner of health and, the
public, and others at least 120 182 days before the
hospital or hospital campus voluntarily plans to implement one of the following
scheduled actions:
(1) cease operations;
(2) curtail operations to the extent that patients must be relocated;
(3) relocate the provision of health services to another hospital or another hospital campus; or
(4) cease offering maternity care and newborn care services, intensive care unit services, inpatient mental health services, or inpatient substance use disorder treatment services.
(b) A notice required
under this subdivision must comply with the requirements in subdivision 1d.
(b) (c) The
commissioner shall cooperate with the controlling persons and advise them about
relocating the patients.
Sec. 9. Minnesota Statutes 2022, section 144.555, subdivision 1b, is amended to read:
Subd. 1b. Public
hearing. Within 45 30
days after receiving notice under subdivision 1a, the commissioner shall
conduct a public hearing on the scheduled cessation of operations, curtailment
of operations, relocation of health services, or cessation in offering health
services. The commissioner must provide
adequate public notice of the hearing in a time and manner determined by the
commissioner. The controlling persons of
the hospital or hospital campus must participate in the public hearing. The public hearing must be held at a
location that is within 30 miles of the hospital or hospital campus and that is
provided or arranged by the hospital or hospital campus. A hospital or hospital campus is encouraged
to hold the public hearing at a location that is within ten miles of the
hospital or hospital campus. Video
conferencing technology must be used to allow members of the public to view and
participate in the hearing. The public
hearing must include:
(1) an explanation by the controlling persons of the reasons for ceasing or curtailing operations, relocating health services, or ceasing to offer any of the listed health services;
(2) a description of the actions that controlling persons will take to ensure that residents in the hospital's or campus's service area have continued access to the health services being eliminated, curtailed, or relocated;
(3) an opportunity for public testimony on the scheduled cessation or curtailment of operations, relocation of health services, or cessation in offering any of the listed health services, and on the hospital's or campus's plan to ensure continued access to those health services being eliminated, curtailed, or relocated; and
(4) an opportunity for the controlling persons to respond to questions from interested persons.
Sec. 10. Minnesota Statutes 2022, section 144.555, is amended by adding a subdivision to read:
Subd. 1d. Methods
of providing notice; content of notice.
(a) A notice required under subdivision 1a must be provided to
patients, hospital personnel, the public, local units of government, and the
commissioner of health using at least the following methods:
(1) posting a notice of
the proposed cessation of operations, curtailment, relocation of health
services, or cessation in offering health services at the main public entrance
of the hospital or hospital campus;
(2) providing written notice
to the commissioner of health, to the city council in the city where the
hospital or hospital campus is located, and to the county board in the county
where the hospital or hospital campus is located;
(3) providing written
notice to the local health department as defined in section 145A.02,
subdivision 8b, for the community where the hospital or hospital campus is
located;
(4) providing notice to
the public through a written public announcement which must be distributed to
local media outlets;
(5) providing written
notice to existing patients of the hospital or hospital campus; and
(6) notifying all
personnel currently employed in the unit, hospital, or hospital campus impacted
by the proposed cessation, curtailment, or relocation.
(b) A notice required
under subdivision 1a must include:
(1) a description of the
proposed cessation of operations, curtailment, relocation of health services,
or cessation in offering health services.
The description must include:
(i) the number of beds,
if any, that will be eliminated, repurposed, reassigned, or otherwise
reconfigured to serve populations or patients other than those currently
served;
(ii) the current number
of beds in the impacted unit, hospital, or hospital campus, and the number of
beds in the impacted unit, hospital, or hospital campus after the proposed
cessation, curtailment, or relocation takes place;
(iii) the number of
existing patients who will be impacted by the proposed cessation, curtailment,
or relocation;
(iv) any decrease in
personnel, or relocation of personnel to a different unit, hospital, or
hospital campus, caused by the proposed cessation, curtailment, or relocation;
(v) a description of the
health services provided by the unit, hospital, or hospital campus impacted by
the proposed cessation, curtailment, or relocation; and
(vi) identification of
the three nearest available health care facilities where patients may obtain
the health services provided by the unit, hospital, or hospital campus impacted
by the proposed cessation, curtailment, or relocation, and any potential
barriers to seamlessly transition patients to receive services at one of these
facilities. If the unit, hospital, or
hospital campus impacted by the proposed cessation, curtailment, or relocation
serves medical assistance or Medicare enrollees, the information required under
this item must specify whether any of the three nearest available facilities
serves medical assistance or Medicare enrollees; and
(2) a telephone number,
email address, and address for each of the following, to which interested
parties may offer comments on the proposed cessation, curtailment, or
relocation:
(i) the hospital or
hospital campus; and
(ii) the parent entity,
if any, or the entity under contract, if any, that acts as the corporate
administrator of the hospital or hospital campus.
Sec. 11. Minnesota Statutes 2022, section 144.555, subdivision 2, is amended to read:
Subd. 2. Penalty;
facilities other than hospitals. Failure
to notify the commissioner under subdivision 1, 1a, or 1c or failure to
participate in a public hearing under subdivision 1b may result in issuance
of a correction order under section 144.653, subdivision 5.
Sec. 12. Minnesota Statutes 2022, section 144.555, is amended by adding a subdivision to read:
Subd. 3. Penalties;
hospitals. (a) Failure to
participate in a public hearing under subdivision 1b or failure to notify the
commissioner under subdivision 1c may result in issuance of a correction order
under section 144.653, subdivision 5.
(b) Notwithstanding any
law to the contrary, the commissioner must impose on the controlling persons of
a hospital or hospital campus a fine of $20,000 for each failure to provide
notice to an individual or entity or at a location required under subdivision
1d, paragraph (a), with the total fine amount imposed not to exceed $60,000 for
failures to comply with the notice requirements for a single scheduled action. The commissioner is not required to issue a
correction order before imposing a fine under this paragraph. Section 144.653, subdivision 8, applies to
fines imposed under this paragraph.
Sec. 13. [144.556]
RIGHT OF FIRST REFUSAL; SALE OF HOSPITAL OR HOSPITAL CAMPUS.
(a) The controlling
persons of a hospital licensed under sections 144.50 to 144.56 or a hospital
campus must not sell or convey the hospital or hospital campus, offer to sell
or convey the hospital or hospital campus to a person other than a local unit
of government listed in this paragraph, or voluntarily cease operations of the
hospital or hospital campus unless the controlling persons have first made a
good faith offer to sell or convey the hospital or hospital campus to the home
rule charter or statutory city, county, town, or hospital district in which the
hospital or hospital campus is located.
(b) The offer to sell or
convey the hospital or hospital campus to a local unit of government under
paragraph (a) must be at a price that does not exceed the current fair market
value of the hospital or hospital campus.
A party to whom an offer is made under paragraph (a) must accept or
decline the offer within 60 days of receipt.
If the party to whom the offer is made fails to respond within 60 days
of receipt, the offer is deemed declined.
Sec. 14. Minnesota Statutes 2022, section 144A.70, subdivision 3, is amended to read:
Subd. 3. Controlling
person. "Controlling
person" means a business entity or entities, officer, program
administrator, or director, whose responsibilities include the
direction of the management or policies of a supplemental nursing services
agency the management and decision-making authority to establish or
control business policy and all other policies of a supplemental nursing
services agency. Controlling person
also means an individual who, directly or indirectly, beneficially owns an
interest in a corporation, partnership, or other business association that is a
controlling person.
Sec. 15. Minnesota Statutes 2022, section 144A.70, subdivision 5, is amended to read:
Subd. 5. Person. "Person" includes an
individual, firm, corporation, partnership, limited liability
company, or association.
Sec. 16. Minnesota Statutes 2022, section 144A.70, subdivision 6, is amended to read:
Subd. 6. Supplemental
nursing services agency. "Supplemental
nursing services agency" means a person, firm, corporation,
partnership, limited liability company, or association engaged for hire
in the business of providing or procuring temporary employment in health care
facilities for nurses, nursing assistants, nurse aides, and orderlies.
Supplemental nursing services agency does not include an individual who only engages in providing the individual's services on a temporary basis to health care facilities. Supplemental nursing services agency does not include a professional home care agency licensed under section 144A.471 that only provides staff to other home care providers.
Sec. 17. Minnesota Statutes 2022, section 144A.70, subdivision 7, is amended to read:
Subd. 7. Oversight. The commissioner is responsible for the
oversight of supplemental nursing services agencies through annual semiannual
unannounced surveys and follow-up surveys, complaint investigations
under sections 144A.51 to 144A.53, and other actions necessary to ensure
compliance with sections 144A.70 to 144A.74.
Sec. 18. Minnesota Statutes 2022, section 144A.71, subdivision 2, is amended to read:
Subd. 2. Application information and fee. The commissioner shall establish forms and procedures for processing each supplemental nursing services agency registration application. An application for a supplemental nursing services agency registration must include at least the following:
(1) the names and addresses
of the owner or owners all owners and controlling persons of the
supplemental nursing services agency;
(2) if the owner is a corporation, copies of its articles of incorporation and current bylaws, together with the names and addresses of its officers and directors;
(3) satisfactory proof
of compliance with section 144A.72, subdivision 1, clauses (5) to (7) if
the owner is a limited liability company, copies of its articles of
organization and operating agreement, together with the names and addresses of
its officers and directors;
(4) documentation that
the supplemental nursing services agency has medical malpractice insurance to
insure against the loss, damage, or expense of a claim arising out of the death
or injury of any person as the result of negligence or malpractice in the
provision of health care services by the supplemental nursing services agency
or by any employee of the agency;
(5) documentation that
the supplemental nursing services agency has an employee dishonesty bond in the
amount of $10,000;
(6) documentation that
the supplemental nursing services agency has insurance coverage for workers'
compensation for all nurses, nursing assistants, nurse aides, and orderlies
provided or procured by the agency;
(7) documentation that
the supplemental nursing services agency filed with the commissioner of
revenue: (i) the name and address of the
bank, savings bank, or savings association in which the supplemental nursing
services agency deposits all employee income tax withholdings; and (ii) the
name and address of any nurse, nursing assistant, nurse aide, or orderly whose
income is derived from placement by the agency, if the agency purports the
income is not subject to withholding;
(4) (8) any
other relevant information that the commissioner determines is necessary to
properly evaluate an application for registration;
(5) (9) a
policy and procedure that describes how the supplemental nursing services
agency's records will be immediately available at all times to the commissioner
and facility; and
(6) (10) a nonrefundable
registration fee of $2,035.
If a supplemental nursing services agency fails to provide the items in this subdivision to the department, the commissioner shall immediately suspend or refuse to issue the supplemental nursing services agency registration. The supplemental nursing services agency may appeal the commissioner's findings according to section 144A.475, subdivisions 3a and 7, except that the hearing must be conducted by an administrative law judge within 60 calendar days of the request for hearing assignment.
Sec. 19. Minnesota Statutes 2022, section 144A.71, is amended by adding a subdivision to read:
Subd. 2a. Renewal
applications. An applicant
for registration renewal must complete the registration application form
supplied by the department. An
application must be submitted at least 60 days before the expiration of the
current registration.
Sec. 20. [144A.715]
PENALTIES.
Subdivision 1. Authority. The fines imposed under this section
are in accordance with section 144.653, subdivision 6.
Subd. 2. Fines. Each violation of sections 144A.70 to
144A.74, not corrected at the time of a follow-up survey, is subject to a fine. A fine must be assessed according to the
schedules established in the sections violated.
Subd. 3. Failure
to correct. If, upon a
subsequent follow-up survey after a fine has been imposed under subdivision 2,
a violation is still not corrected, another fine shall be assessed. The fine shall be double the amount of the
previous fine.
Subd. 4. Payment
of fines. Payment of fines is
due 15 business days from the registrant's receipt of notice of the fine from
the department.
Sec. 21. Minnesota Statutes 2022, section 144A.72, subdivision 1, is amended to read:
Subdivision 1. Minimum criteria. (a) The commissioner shall require that, as a condition of registration:
(1) all owners and
controlling persons must complete a background study under section 144.057 and
receive a clearance or set aside of any disqualification;
(1) (2) the
supplemental nursing services agency shall document that each temporary
employee provided to health care facilities currently meets the minimum
licensing, training, and continuing education standards for the position in
which the employee will be working and verifies competency for the position. A violation of this provision may be subject
to a fine of $3,000;
(2) (3) the
supplemental nursing services agency shall comply with all pertinent
requirements relating to the health and other qualifications of personnel
employed in health care facilities;
(3) (4) the
supplemental nursing services agency must not restrict in any manner the
employment opportunities of its employees;. A violation of this provision may be subject
to a fine of $3,000;
(4) the supplemental
nursing services agency shall carry medical malpractice insurance to insure
against the loss, damage, or expense incident to a claim arising out of the
death or injury of any person as the result of negligence or malpractice in the
provision of health care services by the supplemental nursing services agency
or by any employee of the agency;
(5) the supplemental
nursing services agency shall carry an employee dishonesty bond in the amount
of $10,000;
(6) the supplemental nursing
services agency shall maintain insurance coverage for workers' compensation for
all nurses, nursing assistants, nurse aides, and orderlies provided or procured
by the agency;
(7) the supplemental
nursing services agency shall file with the commissioner of revenue: (i) the name and address of the bank, savings
bank, or savings association in which the supplemental nursing services agency
deposits all employee income tax withholdings; and (ii) the name and address of
any nurse, nursing assistant, nurse aide, or orderly whose income is derived
from placement by the agency, if the agency purports the income is not subject
to withholding;
(8) (5) the
supplemental nursing services agency must not, in any contract with any
employee or health care facility, require the payment of liquidated damages,
employment fees, or other compensation should the employee be hired as a
permanent employee of a health care facility;. A violation of this provision may be subject
to a fine of $3,000;
(9) (6) the
supplemental nursing services agency shall document that each temporary
employee provided to health care facilities is an employee of the agency and is
not an independent contractor; and
(10) (7) the
supplemental nursing services agency shall retain all records for five calendar
years. All records of the supplemental
nursing services agency must be immediately available to the department.
(b) In order to retain
registration, the supplemental nursing services agency must provide services to
a health care facility during the year in Minnesota within the past
12 months preceding the supplemental nursing services agency's registration
renewal date.
Sec. 22. Minnesota Statutes 2022, section 144A.73, is amended to read:
144A.73 COMPLAINT SYSTEM.
The commissioner shall
establish a system for reporting complaints against a supplemental nursing
services agency or its employees. Complaints
may be made by any member of the public.
Complaints against a supplemental nursing services agency shall be
investigated by the Office of Health Facility Complaints commissioner
of health under sections 144A.51 to 144A.53.
Sec. 23. Minnesota Statutes 2023 Supplement, section 145.561, subdivision 4, is amended to read:
Subd. 4. 988
telecommunications fee. (a) In
compliance with the National Suicide Hotline Designation Act of 2020, the
commissioner shall impose a monthly statewide fee on each subscriber of a
wireline, wireless, or IP‑enabled voice service at a rate that
provides must pay a monthly fee to provide for the robust creation,
operation, and maintenance of a statewide 988 suicide prevention and crisis
system.
(b) The commissioner
shall annually recommend to the Public Utilities Commission an adequate and
appropriate fee to implement this section.
The amount of the fee must comply with the limits in paragraph (c). The commissioner shall provide
telecommunication service providers and carriers a minimum of 45 days' notice
of each fee change.
(c) (b) The
amount of the 988 telecommunications fee must not be more than 25 is
12 cents per month on or after January 1, 2024, for each consumer
access line, including trunk equivalents as designated by the commission
Public Utilities Commission pursuant to section 403.11, subdivision 1. The 988 telecommunications fee must be the
same for all subscribers.
(d) (c) Each wireline, wireless, and IP-enabled voice telecommunication service provider shall collect the 988 telecommunications fee and transfer the amounts collected to the commissioner of public safety in the same manner as provided in section 403.11, subdivision 1, paragraph (d).
(e) (d) The
commissioner of public safety shall deposit the money collected from the 988
telecommunications fee to the 988 special revenue account established in
subdivision 3.
(f) (e) All
988 telecommunications fee revenue must be used to supplement, and not
supplant, federal, state, and local funding for suicide prevention.
(g) (f) The
988 telecommunications fee amount shall be adjusted as needed to provide for
continuous operation of the lifeline centers and 988 hotline, volume increases,
and maintenance.
(h) (g) The
commissioner shall annually report to the Federal Communications Commission on
revenue generated by the 988 telecommunications fee.
EFFECTIVE DATE. This
section is effective September 1, 2024.
Sec. 24. Minnesota Statutes 2022, section 149A.02, subdivision 3, is amended to read:
Subd. 3. Arrangements
for disposition. "Arrangements
for disposition" means any action normally taken by a funeral provider in
anticipation of or preparation for the entombment, burial in a cemetery,
alkaline hydrolysis, or cremation, or, effective July 1, 2025,
natural organic reduction of a dead human body.
Sec. 25. Minnesota Statutes 2022, section 149A.02, subdivision 16, is amended to read:
Subd. 16. Final
disposition. "Final
disposition" means the acts leading to and the entombment, burial in a cemetery, alkaline hydrolysis, or cremation,
or, effective July 1, 2025, natural organic reduction of a dead human body.
Sec. 26. Minnesota Statutes 2022, section 149A.02, subdivision 26a, is amended to read:
Subd. 26a. Inurnment. "Inurnment" means placing
hydrolyzed or cremated remains in a hydrolyzed or cremated remains container
suitable for placement, burial, or shipment.
Effective July 1, 2025, inurnment also includes placing naturally
reduced remains in a naturally reduced remains container suitable for
placement, burial, or shipment.
Sec. 27. Minnesota Statutes 2022, section 149A.02, subdivision 27, is amended to read:
Subd. 27. Licensee. "Licensee" means any person or
entity that has been issued a license to practice mortuary science, to operate
a funeral establishment, to operate an alkaline hydrolysis facility, or
to operate a crematory, or, effective July 1, 2025, to operate a natural
organic reduction facility by the Minnesota commissioner of health.
Sec. 28. Minnesota Statutes 2022, section 149A.02, is amended by adding a subdivision to read:
Subd. 30b. Natural
organic reduction or naturally reduce.
"Natural organic reduction" or "naturally
reduce" means the contained,
accelerated conversion of a dead human body to soil. This subdivision is effective July 1, 2025.
Sec. 29. Minnesota Statutes 2022, section 149A.02, is amended by adding a subdivision to read:
Subd. 30c. Natural
organic reduction facility. "Natural
organic reduction facility" means a structure, room, or other space in a
building or real property where natural organic reduction of a dead human body
occurs. This subdivision is effective
July 1, 2025.
Sec. 30. Minnesota Statutes 2022, section 149A.02, is amended by adding a subdivision to read:
Subd. 30d. Natural
organic reduction vessel. "Natural
organic reduction vessel" means the enclosed container in which natural
organic reduction takes place. This
subdivision is effective July 1, 2025.
Sec. 31. Minnesota Statutes 2022, section 149A.02, is amended by adding a subdivision to read:
Subd. 30e. Naturally
reduced remains. "Naturally
reduced remains" means the soil remains following the natural organic
reduction of a dead human body and the accompanying plant material. This subdivision is effective July 1, 2025.
Sec. 32. Minnesota Statutes 2022, section 149A.02, is amended by adding a subdivision to read:
Subd. 30f. Naturally
reduced remains container. "Naturally
reduced remains container" means a receptacle in which naturally reduced
remains are placed. This subdivision is
effective July 1, 2025.
Sec. 33. Minnesota Statutes 2022, section 149A.02, subdivision 35, is amended to read:
Subd. 35. Processing. "Processing" means the removal
of foreign objects, drying or cooling, and the reduction of the hydrolyzed or
remains, cremated remains, or, effective July 1, 2025, naturally
reduced remains by mechanical means including, but not limited to,
grinding, crushing, or pulverizing, to a granulated appearance appropriate for
final disposition.
Sec. 34. Minnesota Statutes 2022, section 149A.02, subdivision 37c, is amended to read:
Subd. 37c. Scattering. "Scattering" means the
authorized dispersal of hydrolyzed or remains, cremated remains,
or, effective July 1, 2025, naturally reduced remains in a defined area of
a dedicated cemetery or in areas where no local prohibition exists provided
that the hydrolyzed or, cremated, or naturally reduced
remains are not distinguishable to the public, are not in a container, and that
the person who has control over disposition of the hydrolyzed or,
cremated, or naturally reduced remains has obtained written permission
of the property owner or governing agency to scatter on the property.
Sec. 35. Minnesota Statutes 2022, section 149A.03, is amended to read:
149A.03 DUTIES OF COMMISSIONER.
The commissioner shall:
(1) enforce all laws and adopt and enforce rules relating to the:
(i) removal, preparation, transportation, arrangements for disposition, and final disposition of dead human bodies;
(ii) licensure and professional conduct of funeral directors, morticians, interns, practicum students, and clinical students;
(iii) licensing and operation of a funeral establishment;
(iv) licensing and operation
of an alkaline hydrolysis facility; and
(v) licensing and operation of
a crematory; and
(vi) effective July 1,
2025, licensing and operation of a natural organic reduction facility;
(2) provide copies of the requirements for licensure and permits to all applicants;
(3) administer examinations and issue licenses and permits to qualified persons and other legal entities;
(4) maintain a record of the name and location of all current licensees and interns;
(5) perform periodic compliance reviews and premise inspections of licensees;
(6) accept and investigate complaints relating to conduct governed by this chapter;
(7) maintain a record of all current preneed arrangement trust accounts;
(8) maintain a schedule of application, examination, permit, and licensure fees, initial and renewal, sufficient to cover all necessary operating expenses;
(9) educate the public about the existence and content of the laws and rules for mortuary science licensing and the removal, preparation, transportation, arrangements for disposition, and final disposition of dead human bodies to enable consumers to file complaints against licensees and others who may have violated those laws or rules;
(10) evaluate the laws, rules, and procedures regulating the practice of mortuary science in order to refine the standards for licensing and to improve the regulatory and enforcement methods used; and
(11) initiate proceedings to address and remedy deficiencies and inconsistencies in the laws, rules, or procedures governing the practice of mortuary science and the removal, preparation, transportation, arrangements for disposition, and final disposition of dead human bodies.
Sec. 36. [149A.56]
LICENSE TO OPERATE A NATURAL ORGANIC REDUCTION FACILITY.
Subdivision 1. License
requirement. This section is
effective July 1, 2025. Except as
provided in section 149A.01, subdivision 3, no person shall maintain, manage,
or operate a place or premises devoted to or used in the holding and natural
organic reduction of a dead human body without possessing a valid license to
operate a natural organic reduction facility issued by the commissioner of
health.
Subd. 2. Requirements
for natural organic reduction facility.
(a) A natural organic reduction facility licensed under this
section must consist of:
(1) a building or
structure that complies with applicable local and state building codes, zoning
laws and ordinances, and environmental standards, and that contains one or more
natural organic reduction vessels for the natural organic reduction of dead human
bodies;
(2) a motorized
mechanical device for processing naturally reduced remains; and
(3) an appropriate
refrigerated holding facility for dead human bodies awaiting natural organic
reduction.
(b) A natural organic
reduction facility licensed under this section may also contain a display room
for funeral goods.
Subd. 3. Application
procedure; documentation; initial inspection. (a) An applicant for a license to
operate a natural organic reduction facility shall submit a completed
application to the commissioner. A
completed application includes:
(1) a completed
application form, as provided by the commissioner;
(2) proof of business
form and ownership; and
(3) proof of liability
insurance coverage or other financial documentation, as determined by the
commissioner, that demonstrates the applicant's ability to respond in damages
for liability arising from the ownership, maintenance, management, or operation
of a natural organic reduction facility.
(b) Upon receipt of the
application and appropriate fee, the commissioner shall review and verify all
information. Upon completion of the
verification process and resolution of any deficiencies in the application
information, the commissioner shall conduct an initial inspection of the
premises to be licensed. After the
inspection and resolution of any deficiencies found and any reinspections as
may be necessary, the commissioner shall make a determination, based on all the
information available, to grant or deny licensure. If the commissioner's determination is to
grant the license, the applicant shall be notified and the license shall issue
and remain valid for a period prescribed on the license, but not to exceed one
calendar year from the date of issuance of the license. If the commissioner's determination is to
deny the license, the commissioner must notify the applicant, in writing, of
the denial and provide the specific reason for denial.
Subd. 4. Nontransferability
of license. A license to
operate a natural organic reduction facility is not assignable or transferable
and shall not be valid for any entity other than the one named. Each license issued to operate a natural
organic reduction facility is valid only for the location identified on the
license. A 50 percent or more change in
ownership or location of the natural organic reduction facility automatically
terminates the license. Separate
licenses shall be required of two or more persons or other legal entities
operating from the same location.
Subd. 5. Display
of license. Each license to
operate a natural organic reduction facility must be conspicuously displayed in
the natural organic reduction facility at all times. Conspicuous display means in a location where
a member of the general public within the natural organic reduction facility is
able to observe and read the license.
Subd. 6. Period
of licensure. All licenses to
operate a natural organic reduction facility issued by the commissioner are
valid for a period of one calendar year beginning on July 1 and ending on June
30, regardless of the date of issuance.
Subd. 7. Reporting
changes in license information. Any
change of license information must be reported to the commissioner, on forms
provided by the commissioner, no later than 30 calendar days after the change
occurs. Failure to report changes is
grounds for disciplinary action.
Subd. 8. Licensing
information. Section 13.41
applies to data collected and maintained by the commissioner pursuant to this
section.
Sec. 37. [149A.57]
RENEWAL OF LICENSE TO OPERATE A NATURAL ORGANIC REDUCTION FACILITY.
Subdivision 1. Renewal
required. This section is
effective July 1, 2025. All licenses to
operate a natural organic reduction facility issued by the commissioner expire
on June 30 following the date of issuance of the license and must be renewed to
remain valid.
Subd. 2. Renewal
procedure and documentation. (a)
Licensees who wish to renew their licenses must submit to the commissioner a
completed renewal application no later than June 30 following the date the
license was issued. A completed renewal
application includes:
(1) a completed renewal
application form, as provided by the commissioner; and
(2) proof of liability
insurance coverage or other financial documentation, as determined by the
commissioner, that demonstrates the applicant's ability to respond in damages
for liability arising from the ownership, maintenance, management, or operation
of a natural organic reduction facility.
(b) Upon receipt of the
completed renewal application, the commissioner shall review and verify the
information. Upon completion of the
verification process and resolution of any deficiencies in the renewal
application information, the commissioner shall make a determination, based on
all the information available, to reissue or refuse to reissue the license. If the commissioner's determination is to
reissue the license, the applicant shall be notified and the license shall
issue and remain valid for a period prescribed on the license, but not to
exceed one calendar year from the date of issuance of the license. If the commissioner's determination is to
refuse to reissue the license, section 149A.09, subdivision 2, applies.
Subd. 3. Penalty
for late filing. Renewal
applications received after the expiration date of a license will result in the
assessment of a late filing penalty. The
late filing penalty must be paid before the reissuance of the license and
received by the commissioner no later than 31 calendar days after the
expiration date of the license.
Subd. 4. Lapse
of license. A license to
operate a natural organic reduction facility shall automatically lapse when a
completed renewal application is not received by the commissioner within 31
calendar days after the expiration date of a license, or a late filing penalty
assessed under subdivision 3 is not received by the commissioner within 31
calendar days after the expiration of a license.
Subd. 5. Effect
of lapse of license. Upon the
lapse of a license, the person to whom the license was issued is no longer
licensed to operate a natural organic reduction facility in Minnesota. The commissioner shall issue a cease and
desist order to prevent the lapsed license holder from operating a natural
organic reduction facility in Minnesota and may pursue any additional lawful
remedies as justified by the case.
Subd. 6. Restoration
of lapsed license. The
commissioner may restore a lapsed license upon receipt and review of a
completed renewal application, receipt of the late filing penalty, and
reinspection of the premises, provided that the receipt is made within one
calendar year from the expiration date of the lapsed license and the cease and
desist order issued by the commissioner has not been violated. If a lapsed license is not restored within
one calendar year from the expiration date of the lapsed license, the holder of
the lapsed license cannot be relicensed until the requirements in section
149A.56 are met.
Subd. 7. Reporting
changes in license information. Any
change of license information must be reported to the commissioner, on forms
provided by the commissioner, no later than 30 calendar days after the change
occurs. Failure to report changes is
grounds for disciplinary action.
Subd. 8. Licensing
information. Section 13.41
applies to data collected and maintained by the commissioner pursuant to this
section.
Sec. 38. Minnesota Statutes 2022, section 149A.65, is amended by adding a subdivision to read:
Subd. 6a. Natural
organic reduction facilities. This
subdivision is effective July 1, 2025. The
initial and renewal fee for a natural organic reduction facility is $425. The late fee charge for a license renewal is
$100.
Sec. 39. Minnesota Statutes 2022, section 149A.70, subdivision 1, is amended to read:
Subdivision 1. Use of
titles. Only a person holding a
valid license to practice mortuary science issued by the commissioner may use
the title of mortician, funeral director, or any other title implying that the
licensee is engaged in the business or practice of mortuary science. Only the holder of a valid license to operate
an alkaline hydrolysis facility issued by the commissioner may use the title of
alkaline hydrolysis facility, water cremation, water‑reduction,
biocremation, green-cremation, resomation, dissolution, or any other title,
word, or term implying that the licensee operates an alkaline hydrolysis
facility. Only the holder of a valid
license to operate a funeral establishment issued by the commissioner may use
the title of funeral home, funeral chapel, funeral service, or any other title,
word, or term implying that the licensee is engaged in the business or practice
of mortuary science. Only the holder of
a valid license to operate a crematory issued by the commissioner may use the
title of crematory, crematorium, green-cremation, or any other title, word, or
term implying that the licensee operates a crematory or crematorium. Effective July 1, 2025, only the holder of
a valid license to operate a natural organic reduction facility issued by the
commissioner may use the title of natural organic reduction facility, human
composting, or any other title, word, or term implying that the licensee
operates a natural organic reduction facility.
Sec. 40. Minnesota Statutes 2022, section 149A.70, subdivision 2, is amended to read:
Subd. 2. Business
location. A funeral establishment,
alkaline hydrolysis facility, or crematory, or, effective July 1,
2025, natural organic reduction facility shall not do business in a
location that is not licensed as a funeral establishment, alkaline hydrolysis
facility, or crematory, or natural organic reduction facility and
shall not advertise a service that is available from an unlicensed location.
Sec. 41. Minnesota Statutes 2022, section 149A.70, subdivision 3, is amended to read:
Subd. 3. Advertising. No licensee, clinical student, practicum student, or intern shall publish or disseminate false, misleading, or deceptive advertising. False, misleading, or deceptive advertising includes, but is not limited to:
(1) identifying, by using the names or pictures of, persons who are not licensed to practice mortuary science in a way that leads the public to believe that those persons will provide mortuary science services;
(2) using any name other than
the names under which the funeral establishment, alkaline hydrolysis facility, or
crematory, or, effective July 1, 2025, natural organic reduction facility
is known to or licensed by the commissioner;
(3) using a surname not
directly, actively, or presently associated with a licensed funeral
establishment, alkaline hydrolysis facility, or crematory, or,
effective July 1, 2025, natural organic reduction facility, unless the
surname had been previously and continuously used by the licensed funeral
establishment, alkaline hydrolysis facility, or crematory, or natural
organic reduction facility; and
(4) using a founding or
establishing date or total years of service not directly or continuously
related to a name under which the funeral establishment, alkaline hydrolysis
facility, or crematory, or, effective July 1, 2025, natural organic
reduction facility is currently or was previously licensed.
Any advertising or other
printed material that contains the names or pictures of persons affiliated with
a funeral establishment, alkaline hydrolysis facility, or crematory,
or, effective July 1, 2025, natural organic reduction facility shall state
the position held by the persons and shall identify each person who is licensed
or unlicensed under this chapter.
Sec. 42. Minnesota Statutes 2022, section 149A.70, subdivision 5, is amended to read:
Subd. 5. Reimbursement
prohibited. No licensee, clinical
student, practicum student, or intern shall offer, solicit, or accept a
commission, fee, bonus, rebate, or other reimbursement in consideration for
recommending or causing a dead human body to be disposed of by a specific body
donation program, funeral establishment, alkaline hydrolysis facility,
crematory, mausoleum, or cemetery, or, effective July 1, 2025,
natural organic reduction facility.
Sec. 43. Minnesota Statutes 2022, section 149A.71, subdivision 2, is amended to read:
Subd. 2. Preventive
requirements. (a) To prevent unfair
or deceptive acts or practices, the requirements of this subdivision must be
met. This subdivision applies to
natural organic reduction and naturally reduced remains goods and services
effective July 1, 2025.
(b) Funeral providers must tell persons who ask by telephone about the funeral provider's offerings or prices any accurate information from the price lists described in paragraphs (c) to (e) and any other readily available information that reasonably answers the questions asked.
(c) Funeral providers must make available for viewing to people who inquire in person about the offerings or prices of funeral goods or burial site goods, separate printed or typewritten price lists using a ten-point font or larger. Each funeral provider must have a separate price list for each of the following types of goods that are sold or offered for sale:
(1) caskets;
(2) alternative containers;
(3) outer burial containers;
(4) alkaline hydrolysis containers;
(5) cremation containers;
(6) hydrolyzed remains containers;
(7) cremated remains containers;
(8) markers; and
(9) headstones.;
and
(10) naturally reduced
remains containers.
(d) Each separate price list
must contain the name of the funeral provider's place of business, address, and
telephone number and a caption describing the list as a price list for one of
the types of funeral goods or burial site goods described in paragraph (c),
clauses (1) to (9) (10). The
funeral provider must offer the list upon beginning discussion of, but in any
event before showing, the specific funeral goods or burial site goods and must
provide a photocopy of the price list, for retention, if so asked by the
consumer. The list must contain, at
least, the retail prices of all the specific funeral goods and burial site
goods offered which do not require special ordering, enough information to
identify each, and the effective date for the price list. However, funeral providers are not required
to make a specific price list available if the funeral providers place the
information required by this paragraph on the general price list described in
paragraph (e).
(e) Funeral providers must give a printed price list, for retention, to persons who inquire in person about the funeral goods, funeral services, burial site goods, or burial site services or prices offered by the funeral provider. The funeral provider must give the list upon beginning discussion of either the prices of or the overall type of funeral service or disposition or specific funeral goods, funeral services, burial site goods, or burial site services offered by the provider. This requirement applies whether the discussion takes place in the funeral establishment or elsewhere. However, when the deceased is removed for transportation to the funeral establishment, an in-person request for authorization to embalm does not, by itself, trigger the requirement to offer the general price list. If the provider, in making an in-person request for authorization to embalm, discloses that embalming is not required by law except in certain special cases, the provider is not required to offer the general price list. Any other discussion during that time about prices or the selection of funeral goods, funeral services, burial site goods, or burial site services triggers the requirement to give the consumer a general price list. The general price list must contain the following information:
(1) the name, address, and telephone number of the funeral provider's place of business;
(2) a caption describing the list as a "general price list";
(3) the effective date for the price list;
(4) the retail prices, in any order, expressed either as a flat fee or as the prices per hour, mile, or other unit of computation, and other information described as follows:
(i) forwarding of remains to another funeral establishment, together with a list of the services provided for any quoted price;
(ii) receiving remains from another funeral establishment, together with a list of the services provided for any quoted price;
(iii) separate prices for
each alkaline hydrolysis, natural organic reduction, or cremation
offered by the funeral provider, with the price including an alternative
container or shroud or alkaline hydrolysis facility or cremation
container,; any alkaline hydrolysis, natural organic reduction
facility, or crematory charges,; and a description of the
services and container included in the price, where applicable, and the price
of alkaline hydrolysis or cremation where the purchaser provides the container;
(iv) separate prices for each immediate burial offered by the funeral provider, including a casket or alternative container, and a description of the services and container included in that price, and the price of immediate burial where the purchaser provides the casket or alternative container;
(v) transfer of remains to the funeral establishment or other location;
(vi) embalming;
(vii) other preparation of the body;
(viii) use of facilities, equipment, or staff for viewing;
(ix) use of facilities, equipment, or staff for funeral ceremony;
(x) use of facilities, equipment, or staff for memorial service;
(xi) use of equipment or staff for graveside service;
(xii) hearse or funeral coach;
(xiii) limousine; and
(xiv) separate prices for all cemetery-specific goods and services, including all goods and services associated with interment and burial site goods and services and excluding markers and headstones;
(5) the price range for the caskets offered by the funeral provider, together with the statement "A complete price list will be provided at the funeral establishment or casket sale location." or the prices of individual caskets, as disclosed in the manner described in paragraphs (c) and (d);
(6) the price range for the alternative containers or shrouds offered by the funeral provider, together with the statement "A complete price list will be provided at the funeral establishment or alternative container sale location." or the prices of individual alternative containers, as disclosed in the manner described in paragraphs (c) and (d);
(7) the price range for the outer burial containers offered by the funeral provider, together with the statement "A complete price list will be provided at the funeral establishment or outer burial container sale location." or the prices of individual outer burial containers, as disclosed in the manner described in paragraphs (c) and (d);
(8) the price range for the alkaline hydrolysis container offered by the funeral provider, together with the statement "A complete price list will be provided at the funeral establishment or alkaline hydrolysis container sale location." or the prices of individual alkaline hydrolysis containers, as disclosed in the manner described in paragraphs (c) and (d);
(9) the price range for the hydrolyzed remains container offered by the funeral provider, together with the statement "A complete price list will be provided at the funeral establishment or hydrolyzed remains container sale location." or the prices of individual hydrolyzed remains container, as disclosed in the manner described in paragraphs (c) and (d);
(10) the price range for the cremation containers offered by the funeral provider, together with the statement "A complete price list will be provided at the funeral establishment or cremation container sale location." or the prices of individual cremation containers, as disclosed in the manner described in paragraphs (c) and (d);
(11) the price range for the cremated remains containers offered by the funeral provider, together with the statement, "A complete price list will be provided at the funeral establishment or cremated remains container sale location," or the prices of individual cremation containers as disclosed in the manner described in paragraphs (c) and (d);
(12) the price range for
the naturally reduced remains containers offered by the funeral provider,
together with the statement, "A complete price list will be provided at
the funeral establishment or naturally reduced remains container sale location,"
or the prices of individual naturally reduced remains containers as disclosed
in the manner described in paragraphs (c) and (d);
(12) (13) the
price for the basic services of funeral provider and staff, together with a
list of the principal basic services provided for any quoted price and, if the
charge cannot be declined by the purchaser, the statement "This fee for
our basic services will be added to the total cost of the funeral arrangements
you select. (This fee is already
included in our charges for alkaline hydrolysis, natural organic reduction,
direct cremations, immediate burials, and forwarding or receiving
remains.)" If the charge cannot be declined by the purchaser, the quoted
price shall include all charges for the recovery of unallocated funeral
provider overhead, and funeral providers may include in the required disclosure
the phrase "and overhead" after the word "services." This services fee is the only funeral provider
fee for services, facilities, or unallocated overhead permitted by this
subdivision to be nondeclinable, unless otherwise required by law;
(13) (14) the price range for the markers and headstones offered by the funeral provider, together with the statement "A complete price list will be provided at the funeral establishment or marker or headstone sale location." or the prices of individual markers and headstones, as disclosed in the manner described in paragraphs (c) and (d); and
(14) (15) any
package priced funerals offered must be listed in addition to and following the
information required in paragraph (e) and must clearly state the funeral goods
and services being offered, the price being charged for those goods and
services, and the discounted savings.
(f) Funeral providers must give an itemized written statement, for retention, to each consumer who arranges an at-need funeral or other disposition of human remains at the conclusion of the discussion of the arrangements. The itemized written statement must be signed by the consumer selecting the goods and services as required in section 149A.80. If the statement is provided by a funeral establishment, the statement must be signed by the licensed funeral director or mortician planning the arrangements. If the statement is provided by any other funeral provider, the statement must be signed by an authorized agent of the funeral provider. The statement must list the funeral goods, funeral services, burial site goods, or burial site services selected by that consumer and the prices to be paid for each item, specifically itemized cash advance items (these prices must be given to the extent then known or reasonably ascertainable if the prices are not known or reasonably ascertainable, a good faith estimate shall be given and a written statement of the actual charges shall be provided before the final bill is paid), and the total cost of goods and services selected. At the conclusion of an at-need arrangement, the funeral provider is required to give the consumer a copy of the signed itemized written contract that must contain the information required in this paragraph.
(g) Upon receiving actual notice of the death of an individual with whom a funeral provider has entered a preneed funeral agreement, the funeral provider must provide a copy of all preneed funeral agreement documents to the person who controls final disposition of the human remains or to the designee of the person controlling disposition. The person controlling final disposition shall be provided with these documents at the time of the person's first in-person contact with the funeral provider, if the first contact occurs in person at a funeral establishment, alkaline hydrolysis facility, crematory, natural organic reduction facility, or other place of business of the funeral provider. If the contact occurs by other means or at another location, the documents must be provided within 24 hours of the first contact.
Sec. 44. Minnesota Statutes 2022, section 149A.71, subdivision 4, is amended to read:
Subd. 4. Casket,
alternate container, alkaline hydrolysis container, naturally reduced
remains container, and cremation container sales; records; required
disclosures. Any funeral provider
who sells or offers to sell a casket, alternate container, alkaline hydrolysis
container, hydrolyzed remains container, cremation container, or
cremated remains container, or, effective July 1, 2025, naturally reduced
remains container to the public must maintain a record of each sale that
includes the name of the purchaser, the purchaser's mailing address, the name
of the decedent, the date of the decedent's death, and the place of death. These records shall be open to inspection by
the regulatory agency. Any funeral
provider selling a casket, alternate container, or cremation container to the
public, and not having charge of the final disposition of the dead human body,
shall provide a copy of the statutes and rules controlling the removal,
preparation, transportation, arrangements for disposition, and final
disposition of a dead human body. This
subdivision does not apply to morticians, funeral directors, funeral
establishments, crematories, or wholesale distributors of caskets, alternate
containers, alkaline hydrolysis containers, or cremation containers.
Sec. 45. Minnesota Statutes 2022, section 149A.72, subdivision 3, is amended to read:
Subd. 3. Casket
for alkaline hydrolysis, natural organic reduction, or cremation
provisions; deceptive acts or practices.
In selling or offering to sell funeral goods or funeral services to
the public, it is a deceptive act or practice for a funeral provider to
represent that a casket is required for alkaline hydrolysis or, cremations,
or, effective July 1, 2025, natural organic reduction by state or local law
or otherwise.
Sec. 46. Minnesota Statutes 2022, section 149A.72, subdivision 9, is amended to read:
Subd. 9. Deceptive
acts or practices. In selling or
offering to sell funeral goods, funeral services, burial site goods, or burial
site services to the public, it is a deceptive act or practice for a funeral
provider to represent that federal, state, or local laws, or particular
cemeteries, alkaline hydrolysis facilities, or crematories, or,
effective July 1, 2025, natural organic reduction facilities require
the purchase of any funeral goods, funeral services, burial site goods, or
burial site services when that is not the case.
Sec. 47. Minnesota Statutes 2022, section 149A.73, subdivision 1, is amended to read:
Subdivision 1. Casket
for alkaline hydrolysis, natural organic reduction, or cremation
provisions; deceptive acts or practices.
In selling or offering to sell funeral goods, funeral services,
burial site goods, or burial site services to the public, it is a deceptive act
or practice for a funeral provider to require that a casket be purchased for
alkaline hydrolysis or, cremation, or, effective July 1, 2025,
natural organic reduction.
Sec. 48. Minnesota Statutes 2022, section 149A.74, subdivision 1, is amended to read:
Subdivision 1. Services
provided without prior approval; deceptive acts or practices. In selling or offering to sell funeral
goods or funeral services to the public, it is a deceptive act or practice for
any funeral provider to embalm a dead human body unless state or local law or
regulation requires embalming in the particular circumstances regardless of any
funeral choice which might be made, or prior approval for embalming has been
obtained from an individual legally authorized to make such a decision. In seeking approval to embalm, the funeral
provider must disclose that embalming is not required by law except in certain
circumstances; that a fee will be charged if a funeral is selected which
requires embalming, such as a funeral with viewing; and that no embalming fee
will be charged if the family selects a service which does not require
embalming, such as direct alkaline hydrolysis, direct cremation, or
immediate burial, or, effective July 1, 2025, natural organic reduction.
Sec. 49. Minnesota Statutes 2022, section 149A.93, subdivision 3, is amended to read:
Subd. 3. Disposition
permit. A disposition permit is
required before a body can be buried, entombed, alkaline hydrolyzed, or
cremated, or, effective July 1, 2025, naturally reduced. No disposition permit shall be issued until a
fact of death record has been completed and filed with the state registrar of
vital records.
Sec. 50. Minnesota Statutes 2022, section 149A.94, subdivision 1, is amended to read:
Subdivision 1. Generally. Every dead human body lying within the
state, except unclaimed bodies delivered for dissection by the medical
examiner, those delivered for anatomical study pursuant to section 149A.81,
subdivision 2, or lawfully carried through the state for the purpose of
disposition elsewhere; and the remains of any dead human body after dissection
or anatomical study, shall be decently buried or entombed in a public or
private cemetery, alkaline hydrolyzed, or cremated, or, effective
July 1, 2025, naturally reduced within a reasonable time after death. Where final disposition of a body will not be
accomplished, or, effective July 1, 2025, when natural organic reduction
will not be initiated, within 72 hours following death or release of the
body by a competent authority with jurisdiction over the body, the body must be
properly embalmed, refrigerated, or packed with dry ice. A body may not be kept in refrigeration for a
period exceeding six calendar days, or packed in dry ice for a period that
exceeds four calendar days, from the time of death or release of the body from
the coroner or medical examiner.
Sec. 51. Minnesota Statutes 2022, section 149A.94, subdivision 3, is amended to read:
Subd. 3. Permit
required. No dead human body shall
be buried, entombed, or cremated, alkaline hydrolyzed, or, effective
July 1, 2025, naturally reduced without a disposition permit. The disposition permit must be filed with the
person in charge of the place of final disposition. Where a dead human body will be transported
out of this state for final disposition, the body must be accompanied by a
certificate of removal.
Sec. 52. Minnesota Statutes 2022, section 149A.94, subdivision 4, is amended to read:
Subd. 4. Alkaline
hydrolysis or, cremation, or natural organic reduction. Inurnment of alkaline hydrolyzed or
remains, cremated remains, or, effective July 1, 2025, naturally
reduced remains and release to an appropriate party is considered final
disposition and no further permits or authorizations are required for
transportation, interment, entombment, or
placement of the cremated remains, except as provided in section
149A.95, subdivision 16.
Sec. 53. [149A.955]
NATURAL ORGANIC REDUCTION FACILITIES AND NATURAL ORGANIC REDUCTION.
Subdivision 1. License
required. This section is
effective July 1, 2025. A dead human
body may only undergo natural organic reduction in this state at a natural
organic reduction facility licensed by the commissioner of health.
Subd. 2. General
requirements. Any building to
be used as a natural organic reduction facility must comply with all applicable
local and state building codes, zoning laws and ordinances, and environmental
standards. A natural organic reduction
facility must have, on site, a natural organic reduction system approved by the
commissioner and a motorized mechanical device for processing naturally reduced
remains and must have, in the building, a refrigerated holding facility for the
retention of dead human bodies awaiting natural organic reduction. The holding facility must be secure from
access by anyone except the authorized personnel of the natural organic
reduction facility, preserve the dignity of the remains, and protect the health
and safety of the natural organic reduction facility personnel.
Subd. 3. Aerobic
reduction vessel. A natural
organic reduction facility must use as a natural organic reduction vessel, a
contained reduction vessel that is designed to promote aerobic reduction and
that minimizes odors.
Subd. 4. Unlicensed
personnel. A licensed natural
organic reduction facility may employ unlicensed personnel, provided that all
applicable provisions of this chapter are followed. It is the duty of the licensed natural
organic reduction facility to provide proper training for all unlicensed
personnel, and the licensed natural organic reduction facility shall be
strictly accountable for compliance with this chapter and other applicable
state and federal regulations regarding occupational and workplace health and
safety.
Subd. 5. Authorization
to naturally reduce. No
natural organic reduction facility shall naturally reduce or cause to be
naturally reduced any dead human body or identifiable body part without
receiving written authorization to do so from the person or persons who have
the legal right to control disposition as described in section 149A.80 or the
person's legal designee. The written
authorization must include:
(1) the name of the
deceased and the date of death of the deceased;
(2) a statement
authorizing the natural organic reduction facility to naturally reduce the
body;
(3) the name, address,
phone number, relationship to the deceased, and signature of the person or
persons with the legal right to control final disposition or a legal designee;
(4) directions for the
disposition of any non-naturally reduced materials or items recovered from the
natural organic reduction vessel;
(5) acknowledgment that
some of the naturally reduced remains will be mechanically reduced to a
granulated appearance and included in the appropriate containers with the
naturally reduced remains; and
(6) directions for the
ultimate disposition of the naturally reduced remains.
Subd. 6. Limitation
of liability. The limitations
in section 149A.95, subdivision 5, apply to natural organic reduction
facilities.
Subd. 7. Acceptance
of delivery of body. (a) No
dead human body shall be accepted for final disposition by natural organic
reduction unless:
(1) a licensed mortician
is present;
(2) the body is wrapped
in a container, such as a pouch or shroud, that is impermeable or
leak-resistant;
(3) the body is
accompanied by a disposition permit issued pursuant to section 149A.93,
subdivision 3, including a photocopy of the complete death record or a signed
release authorizing natural organic reduction received from a coroner or
medical examiner; and
(4) the body is
accompanied by a natural organic reduction authorization that complies with
subdivision 5.
(b) A natural organic
reduction facility shall refuse to accept delivery of the dead human body:
(1) where there is a
known dispute concerning natural organic reduction of the body delivered;
(2) where there is a
reasonable basis for questioning any of the representations made on the written
authorization to naturally reduce; or
(3) for any other lawful
reason.
(c) When a container,
pouch, or shroud containing a dead human body shows evidence of leaking bodily
fluid, the container, pouch, or shroud and the body must be returned to the
contracting funeral establishment, or the body must be transferred to a new container,
pouch, or shroud by a licensed mortician.
(d) If a dead human body
is delivered to a natural organic reduction facility in a container, pouch, or
shroud that is not suitable for placement in a natural organic reduction
vessel, the transfer of the body to the vessel must be performed by a licensed
mortician.
Subd. 8. Bodies awaiting natural organic reduction. A dead human body must be placed in the natural organic reduction vessel to initiate the natural reduction process within 24 hours after the natural organic reduction facility accepts legal and physical custody of the body.
Subd. 9. Handling of dead human bodies. All natural organic reduction facility employees handling the containers, pouches, or shrouds for dead human bodies shall use universal precautions and otherwise exercise all reasonable precautions to minimize the risk of transmitting any communicable disease from the body. No dead human body shall be removed from the container, pouch, or shroud in which it is delivered to the natural organic reduction facility without express written authorization of the person or persons with legal right to control the disposition and only by a licensed mortician. The remains shall be considered a dead human body until after the processing and curing of the remains are completed.
Subd. 10. Identification
of the body. All licensed
natural organic reduction facilities shall develop, implement, and maintain an
identification procedure whereby dead human bodies can be identified from the
time the natural organic reduction facility accepts delivery of the body until
the naturally reduced remains are released to an authorized party. After natural organic reduction, an
identifying disk, tab, or other permanent label shall be placed within the
naturally reduced remains container or containers before the remains are
released from the natural organic reduction facility. Each identification disk, tab, or label shall
have a number that shall be recorded on all paperwork regarding the decedent. This procedure shall be designed to
reasonably ensure that the proper body is naturally reduced and that the
remains are returned to the appropriate party.
Loss of all or part of the remains or the inability to individually
identify the remains is a violation of this subdivision.
Subd. 11. Natural
organic reduction vessel for human remains.
A licensed natural organic reduction facility shall knowingly
naturally reduce only dead human bodies or human remains in a natural organic
reduction vessel.
Subd. 12. Natural
organic reduction procedures; privacy.
The final disposition of dead human bodies by natural organic
reduction shall be done in privacy. Unless
there is written authorization from the person with the legal right to control
the final disposition, only authorized natural organic reduction facility
personnel shall be permitted in the natural organic reduction area while any
human body is awaiting placement in a natural organic reduction vessel, being
removed from the vessel, or being processed for placement in a naturally
reduced remains container. This does not
prohibit an in-person laying-in ceremony to honor the deceased and the
transition prior to the placement.
Subd. 13. Natural
organic reduction procedures; commingling of bodies prohibited. Except with the express written
permission of the person with the legal right to control the final disposition,
no natural organic reduction facility shall naturally reduce more than one dead
human body at the same time and in the same natural organic reduction vessel or
introduce a second dead human body into same natural organic reduction vessel
until reasonable efforts have been employed to remove all fragments of remains
from the preceding natural organic reduction.
This subdivision does not apply where commingling of human remains
during natural organic reduction is otherwise provided by law. The fact that there is incidental and
unavoidable residue in the natural organic reduction vessel used in a prior
natural organic reduction is not a violation of this subdivision.
Subd. 14. Natural
organic reduction procedures; removal from natural organic reduction vessel. Upon completion of the natural organic
reduction process, reasonable efforts shall be made to remove from the natural
organic reduction vessel all the recoverable naturally reduced remains. The naturally reduced remains shall be
transported to the processing area, and any non-naturally reducible materials
or items shall be separated from the naturally reduced remains and disposed of,
in any lawful manner, by the natural organic reduction facility.
Subd. 15. Natural
organic reduction procedures; processing naturally reduced remains. The remaining intact naturally reduced
remains shall be reduced by a motorized mechanical processor to a granulated
appearance. The granulated remains and
the rest of the naturally reduced remains shall be returned to a natural
organic reduction vessel for final reduction.
Subd. 16. Natural
organic reduction procedures; commingling of naturally reduced remains
prohibited. Except with the
express written permission of the person with the legal right to control the
final deposition or as otherwise provided by law, no natural organic reduction
facility shall mechanically process the naturally reduced remains of more than
one body at a time in the same mechanical processor, or introduce the naturally
reduced remains of a second body into a mechanical processor until reasonable efforts
have been employed to remove all fragments of naturally reduced remains already
in the processor. The presence of
incidental and unavoidable residue in the mechanical processor does not violate
this subdivision.
Subd. 17. Natural
organic reduction procedures; testing naturally reduced remains. A natural organic reduction facility
must:
(1) ensure that the
material in the natural organic reduction vessel naturally reaches and
maintains a minimum temperature of 131 degrees Fahrenheit for a minimum of 72
consecutive hours during the process of natural organic reduction;
(2) analyze each
instance of the naturally reduced remains for physical contaminants, including
but are not limited to intact bone, dental fillings, and medical implants, and
ensure naturally reduced remains have less than 0.01 mg/kg dry weight of any physical
contaminants;
(3) collect material
samples for analysis that are representative of each instance of natural
organic reduction, using a sampling method such as that described in the U.S. Composting
Council 2002 Test Methods for the Examination of Composting and Compost, method
02.01-A through E;
(4) develop and use a
natural organic reduction process in which the naturally reduced remains from
the process do not exceed the following limits:
|
Metals and other testing parameters |
Limit (mg/kg dry weight), unless
otherwise specified |
|
Fecal coliform |
Less than 1,000
most probable number per gram of total solids (dry weight) |
|
Salmonella |
Less than 3
most probable number per 4 grams of total solids (dry weight) |
|
Arsenic |
Less than or
equal to 11 ppm |
|
Cadmium |
Less than or
equal to 7.1 ppm |
|
Lead |
Less than or
equal to 150 ppm |
|
Mercury |
Less than or
equal to 8 ppm |
|
Selenium |
Less than or
equal to 18 ppm; |
(5) analyze, using a
third-party laboratory, the natural organic reduction facility's material
samples of naturally reduced remains according to the following schedule:
(i) the natural organic
reduction facility must analyze each of the first 20 instances of naturally
reduced remains for the parameters in clause (4);
(ii) if any of the first
20 instances of naturally reduced remains yield results exceeding the limits in
clause (4), the natural organic reduction facility must conduct appropriate
processes to correct the levels of the substances in clause (4) and have the
resultant remains tested to ensure they fall within the identified limits;
(iii) if any of the
first 20 instances of naturally reduced remains yield results exceeding the
limits in clause (4), the natural organic reduction facility must analyze each
additional instance of naturally reduced remains for the parameters in clause (4)
until a total of 20 samples, not including those from remains that were
reprocessed as required in item (ii), have yielded results within the limits in
clause (4) on initial testing;
(iv) after 20 material
samples of naturally reduced remains have met the limits in clause (4), the
natural organic reduction facility must analyze at least 25 percent of the
natural organic reduction facility's monthly instances of naturally reduced
remains for the parameters in clause (4) until 80 total material samples of
naturally reduced remains are found to meet the limits in clause (4), not
including any samples that required reprocessing to meet those limits; and
(v) after 80 material samples
of naturally reduced remains are found to meet the limits in clause (4), the
natural organic reduction facility must analyze at least one instance of
naturally reduced remains each month for the parameters in clause (4);
(6) comply with any
testing requirements established by the commissioner for content parameters in
addition to those specified in clause (4);
(7) not release any
naturally reduced remains that exceed the limits in clause (4); and
(8) prepare, maintain,
and provide to the commissioner upon request, a report for each calendar year
detailing the natural organic reduction facility's activities during the
previous calendar year. The report must
include the following information:
(i) the name and address
of the natural organic reduction facility;
(ii) the calendar year
covered by the report;
(iii) the annual
quantity of naturally reduced remains;
(iv) the results of any
laboratory analyses of naturally reduced remains; and
(v) any additional
information required by the commissioner.
Subd. 18. Natural
organic reduction procedures; use of more than one naturally reduced remains
container. If the naturally
reduced remains are to be separated into two or more naturally reduced remains
containers according to the directives provided in the written authorization
for natural organic reduction, all of the containers shall contain duplicate
identification disks, tabs, or permanent labels and all paperwork regarding the
given body shall include a notation of the number of and disposition of each
container, as provided in the written authorization.
Subd. 19. Natural
organic reduction procedures; disposition of accumulated residue. Every natural organic reduction
facility shall provide for the removal and disposition of any accumulated
residue from any natural organic reduction vessel, mechanical processor, or
other equipment used in natural organic reduction. Disposition of accumulated residue shall be
by any lawful manner deemed appropriate.
Subd. 20. Natural
organic reduction procedures; release of naturally reduced remains. Following completion of the natural
organic reduction process, the inurned naturally reduced remains shall be
released according to the instructions given on the written authorization for
natural organic reduction. If the
remains are to be shipped, they must be securely packaged and transported by a
method which has an internal tracing system available and which provides a
receipt signed by the person accepting delivery. Where there is a dispute over release or
disposition of the naturally reduced remains, a natural organic reduction
facility may deposit the naturally reduced remains in accordance with the
directives of a court of competent jurisdiction pending resolution of the
dispute or retain the naturally reduced remains until the person with the legal
right to control disposition presents satisfactory indication that the dispute
is resolved. A natural organic reduction
facility must not sell naturally reduced remains and must make every effort to
not release naturally reduced remains for sale or for use for commercial
purposes.
Subd. 21. Unclaimed
naturally reduced remains. If,
after 30 calendar days following the inurnment, the naturally reduced remains
are not claimed or disposed of according to the written authorization for
natural organic reduction, the natural organic reduction facility shall give
written notice, by certified mail, to the person with the legal right to
control the final disposition or a legal designee, that the naturally reduced
remains are unclaimed and
requesting further release
directions. Should the naturally reduced
remains be unclaimed 120 calendar days following the mailing of the written
notification, the natural organic reduction facility may return the remains to
the earth respectfully in any lawful manner deemed appropriate.
Subd. 22. Required
records. Every natural organic
reduction facility shall create and maintain on its premises or other business
location in Minnesota an accurate record of every natural organic reduction
provided. The record shall include all
of the following information for each natural organic reduction:
(1) the name of the
person or funeral establishment delivering the body for natural organic
reduction;
(2) the name of the
deceased and the identification number assigned to the body;
(3) the date of
acceptance of delivery;
(4) the names of the
operator of the natural organic reduction process and mechanical processor
operator;
(5) the times and dates
that the body was placed in and removed from the natural organic reduction
vessel;
(6) the time and date
that processing and inurnment of the naturally reduced remains was completed;
(7) the time, date, and
manner of release of the naturally reduced remains;
(8) the name and address
of the person who signed the authorization for natural organic reduction;
(9) all supporting
documentation, including any transit or disposition permits, a photocopy of the
death record, and the authorization for natural organic reduction; and
(10) the type of natural
organic reduction vessel.
Subd. 23. Retention
of records. Records required
under subdivision 22 shall be maintained for a period of three calendar years
after the release of the naturally reduced remains. Following this period and subject to any
other laws requiring retention of records, the natural organic reduction
facility may then place the records in storage or reduce them to microfilm, a
digital format, or any other method that can produce an accurate reproduction
of the original record, for retention for a period of ten calendar years from
the date of release of the naturally reduced remains. At the end of this period and subject to any
other laws requiring retention of records, the natural organic reduction
facility may destroy the records by shredding, incineration, or any other
manner that protects the privacy of the individuals identified.
Sec. 54. REQUEST
FOR INFORMATION; EVALUATION OF STATEWIDE HEALTH CARE NEEDS AND CAPACITY AND
PROJECTIONS OF FUTURE HEALTH CARE NEEDS.
(a) By November 1, 2024,
the commissioner of health must publish a request for information to assist the
commissioner in a future comprehensive evaluation of current health care needs
and capacity in the state and projections of future health care needs in the
state based on population and provider characteristics. The request for information:
(1) must provide
guidance on defining the scope of the study and assist in answering
methodological questions that will inform the development of a request for
proposals to contract for performance of the study; and
(2) may address topics that
include but are not limited to how to define health care capacity, expectations
for capacity by geography or service type, how to consider health centers that
have areas of particular expertise or services that generally have a higher
margin, how hospital-based services should be considered as compared with
evolving nonhospital-based services, the role of technology in service
delivery, health care workforce supply issues, and other issues related to data
or methods.
(b) By February 1, 2025,
the commissioner must submit a report to the chairs and ranking minority
members of the legislative committees with jurisdiction over health care, with
the results of the request for information and recommendations regarding conducting
a comprehensive evaluation of current health care needs and capacity in the
state and projections of future health care needs in the state.
Sec. 55. REPEALER.
Minnesota Statutes 2023
Supplement, section 144.0528, subdivision 5, is repealed.
ARTICLE 6
DEPARTMENT OF HEALTH POLICY
Section 1. [62J.461]
340B COVERED ENTITY REPORT.
Subdivision 1. Definitions. (a) For purposes of this section, the
following definitions apply.
(b) "340B covered
entity" or "covered entity" means a covered entity as defined in
United States Code, title 42, section 256b(a)(4), with a service address in
Minnesota as of January 1 of the reporting year. 340B covered entity includes all entity types
and grantees. All facilities that are
identified as child sites or grantee associated sites under the federal 340B
Drug Pricing Program are considered part of the 340B covered entity.
(c) "340B Drug
Pricing Program" or "340B program" means the drug discount
program established under United States Code, title 42, section 256b.
(d) "340B entity
type" is the designation of the 340B covered entity according to the
entity types specified in United States Code, title 42, section 256b(a)(4).
(e) "340B ID"
is the unique identification number provided by the Health Resources and
Services Administration to identify a 340B-eligible entity in the 340B Office
of Pharmacy Affairs Information System.
(f) "Contract
pharmacy" means a pharmacy with which a 340B covered entity has an
arrangement to dispense drugs purchased under the 340B Drug Pricing Program.
(g) "Pricing
unit" means the smallest dispensable amount of a prescription drug product
that can be dispensed or administered.
Subd. 2. Current
registration. Beginning April
1, 2024, each 340B covered entity must maintain a current registration with the
commissioner in a form and manner prescribed by the commissioner. The registration must include the following
information:
(1) the name of the 340B
covered entity;
(2) the 340B ID of the
340B covered entity;
(3) the servicing address
of the 340B covered entity; and
(4) the 340B entity type
of the 340B covered entity.
Subd. 3. Reporting
by covered entities to the commissioner.
(a) Each 340B covered entity shall report to the commissioner by
April 1, 2024, and by April 1 of each year thereafter, the following
information for transactions conducted by the 340B covered entity or on its
behalf, and related to its participation in the federal 340B program for the
previous calendar year:
(1) the aggregated
acquisition cost for prescription drugs obtained under the 340B program;
(2) the aggregated
payment amount received for drugs obtained under the 340B program and dispensed
or administered to patients;
(3) the number of
pricing units dispensed or administered for prescription drugs described in
clause (2); and
(4) the aggregated
payments made:
(i) to contract
pharmacies to dispense drugs obtained under the 340B program;
(ii) to any other entity
that is not the covered entity and is not a contract pharmacy for managing any
aspect of the covered entity's 340B program; and
(iii) for all other
expenses related to administering the 340B program.
The information under clauses (2) and (3)
must be reported by payer type, including but not limited to commercial
insurance, medical assistance, MinnesotaCare, and Medicare, in the form and manner
prescribed by the commissioner.
(b) For covered entities
that are hospitals, the information required under paragraph (a), clauses (1)
to (3), must also be reported at the national drug code level for the 50 most
frequently dispensed or administered drugs by the facility under the 340B
program.
(c) Data submitted to
the commissioner under paragraphs (a) and (b) are classified as nonpublic data,
as defined in section 13.02, subdivision 9.
Subd. 4. Enforcement
and exceptions. (a) Any
health care entity subject to reporting under this section that fails to
provide data in the form and manner prescribed by the commissioner is subject
to a fine paid to the commissioner of up to $500 for each day the data are past
due. Any fine levied against the entity
under this subdivision is subject to the contested case and judicial review
provisions of sections 14.57 and 14.69.
(b) The commissioner may
grant an entity an extension of or exemption from the reporting obligations
under this subdivision, upon a showing of good cause by the entity.
Subd. 5. Reports
to the legislature. By
November 15, 2024, and by November 15 of each year thereafter, the commissioner
shall submit to the chairs and ranking minority members of the legislative
committees with jurisdiction over health care finance and policy, a report that
aggregates the data submitted under subdivision 3, paragraphs (a) and (b). The following information must be included in
the report for all 340B entities whose net 340B revenue constitutes a
significant share, as determined by the commissioner, of all net 340B revenue
across all 340B covered entities in Minnesota:
(1) the information
submitted under subdivision 2; and
(2) for each 340B entity
identified in subdivision 2, that entity's 340B net revenue as calculated using
the data submitted under subdivision 3, paragraph (a), with net revenue being
subdivision 3, paragraph (a), clause (2), less the sum of subdivision 3,
paragraph (a), clauses (1) and (4).
For all other entities, the data in the
report must be aggregated to the entity type or groupings of entity types in a
manner that prevents the identification of an individual entity and any
entity's specific data value reported for an individual data element.
Sec. 2. Minnesota Statutes 2022, section 62J.61, subdivision 5, is amended to read:
Subd. 5. Biennial
review of rulemaking procedures and rules Opportunity for comment. The commissioner shall biennially seek
comments from affected parties maintain an email address for submission
of comments from interested parties to provide input about the
effectiveness of and continued need for the rulemaking procedures set out in
subdivision 2 and about the quality and effectiveness of rules adopted using
these procedures. The commissioner shall
seek comments by holding a meeting and by publishing a notice in the State
Register that contains the date, time, and location of the meeting and a
statement that invites oral or written comments. The notice must be published at least 30 days
before the meeting date. The
commissioner shall write a report summarizing the comments and shall submit the
report to the Minnesota Health Data Institute and to the Minnesota
Administrative Uniformity Committee by January 15 of every even-numbered year
may seek additional input and provide additional opportunities for input as
needed.
Sec. 3. Minnesota Statutes 2022, section 144.05, subdivision 7, is amended to read:
Subd. 7. Expiration of report mandates. (a) If the submission of a report by the commissioner of health to the legislature is mandated by statute and the enabling legislation does not include a date for the submission of a final report, the mandate to submit the report shall expire in accordance with this section.
(b) If the mandate requires the submission of an annual report and the mandate was enacted before January 1, 2021, the mandate shall expire on January 1, 2023. If the mandate requires the submission of a biennial or less frequent report and the mandate was enacted before January 1, 2021, the mandate shall expire on January 1, 2024.
(c) Any reporting mandate enacted on or after January 1, 2021, shall expire three years after the date of enactment if the mandate requires the submission of an annual report and shall expire five years after the date of enactment if the mandate requires the submission of a biennial or less frequent report, unless the enacting legislation provides for a different expiration date.
(d) The commissioner shall
submit a list to the chairs and ranking minority members of the legislative
committees with jurisdiction over health by February 15 of each year, beginning
February 15, 2022, of all reports set to expire during the following calendar
year in accordance with this section. The
mandate to submit a report to the legislature under this paragraph does not
expire.
EFFECTIVE DATE. This
section is effective retroactively from January 1, 2024.
Sec. 4. Minnesota Statutes 2023 Supplement, section 144.0526, subdivision 1, is amended to read:
Subdivision 1. Establishment. The commissioner of health shall
establish the Minnesota One Health Antimicrobial Stewardship Collaborative. The commissioner shall appoint hire
a director to execute operations, conduct health education, and provide
technical assistance.
Sec. 5. Minnesota Statutes 2022, section 144.058, is amended to read:
144.058 INTERPRETER SERVICES QUALITY INITIATIVE.
(a) The commissioner of
health shall establish a voluntary statewide roster, and develop a plan
for a registry and certification process for interpreters who provide high
quality, spoken language health care interpreter services. The roster, registry, and certification
process shall be based on the findings and recommendations set forth by the
Interpreter Services Work Group required under Laws 2007, chapter 147, article
12, section 13.
(b) By January 1, 2009, the commissioner shall establish a roster of all available interpreters to address access concerns, particularly in rural areas.
(c) By January 15, 2010, the commissioner shall:
(1) develop a plan for a registry of spoken language health care interpreters, including:
(i) development of standards for registration that set forth educational requirements, training requirements, demonstration of language proficiency and interpreting skills, agreement to abide by a code of ethics, and a criminal background check;
(ii) recommendations for appropriate alternate requirements in languages for which testing and training programs do not exist;
(iii) recommendations for appropriate fees; and
(iv) recommendations for establishing and maintaining the standards for inclusion in the registry; and
(2) develop a plan for implementing a certification process based on national testing and certification processes for spoken language interpreters 12 months after the establishment of a national certification process.
(d) The commissioner shall consult with the Interpreter Stakeholder Group of the Upper Midwest Translators and Interpreters Association for advice on the standards required to plan for the development of a registry and certification process.
(e) The commissioner shall
charge an annual fee of $50 to include an interpreter in the roster. Fee revenue shall be deposited in the state
government special revenue fund. All
fees are nonrefundable.
Sec. 6. Minnesota Statutes 2022, section 144.0724, subdivision 2, is amended to read:
Subd. 2. Definitions. For purposes of this section, the following terms have the meanings given.
(a) "Assessment reference date" or "ARD" means the specific end point for look-back periods in the MDS assessment process. This look-back period is also called the observation or assessment period.
(b) "Case mix
index" means the weighting factors assigned to the RUG-IV case
mix reimbursement classifications determined by an assessment.
(c) "Index maximization" means classifying a resident who could be assigned to more than one category, to the category with the highest case mix index.
(d) "Minimum Data Set" or "MDS" means a core set of screening, clinical assessment, and functional status elements, that include common definitions and coding categories specified by the Centers for Medicare and Medicaid Services and designated by the Department of Health.
(e) "Representative" means a person who is the resident's guardian or conservator, the person authorized to pay the nursing home expenses of the resident, a representative of the Office of Ombudsman for Long-Term Care whose assistance has been requested, or any other individual designated by the resident.
(f) "Resource
utilization groups" or "RUG" means the system for grouping a
nursing facility's residents according to their clinical and functional status
identified in data supplied by the facility's Minimum Data Set.
(g) (f) "Activities
of daily living" includes personal hygiene, dressing, bathing,
transferring, bed mobility, locomotion, eating, and toileting.
(h) (g) "Nursing
facility level of care determination" means the assessment process that
results in a determination of a resident's or prospective resident's need for
nursing facility level of care as established in subdivision 11 for purposes of
medical assistance payment of long-term care services for:
(1) nursing facility
services under section 256B.434 or chapter 256R;
(2) elderly waiver services under chapter 256S;
(3) CADI and BI waiver services under section 256B.49; and
(4) state payment of alternative care services under section 256B.0913.
Sec. 7. Minnesota Statutes 2022, section 144.0724, subdivision 3a, is amended to read:
Subd. 3a. Resident
reimbursement case mix reimbursement classifications beginning
January 1, 2012. (a) Beginning
January 1, 2012, Resident reimbursement case mix reimbursement
classifications shall be based on the Minimum Data Set, version 3.0 assessment
instrument, or its successor version mandated by the Centers for Medicare and
Medicaid Services that nursing facilities are required to complete for all
residents. The commissioner of health
shall establish resident classifications according to the RUG-IV, 48 group,
resource utilization groups. Resident
classification must be established based on the individual items on the Minimum
Data Set, which must be completed according to the Long Term Care Facility
Resident Assessment Instrument User's Manual Version 3.0 or its successor
issued by the Centers for Medicare and Medicaid Services. Case mix reimbursement classifications
shall also be based on assessments required under subdivision 4. Assessments must be completed according to
the Long Term Care Facility Resident Assessment Instrument User's Manual
Version 3.0 or a successor manual issued by the Centers for Medicare and
Medicaid Services. The optional state
assessment must be completed according to the OSA Manual Version 1.0 v.2.
(b) Each resident must be classified based on the information from the Minimum Data Set according to the general categories issued by the Minnesota Department of Health, utilized for reimbursement purposes.
Sec. 8. Minnesota Statutes 2022, section 144.0724, subdivision 4, is amended to read:
Subd. 4. Resident assessment schedule. (a) A facility must conduct and electronically submit to the federal database MDS assessments that conform with the assessment schedule defined by the Long Term Care Facility Resident Assessment Instrument User's Manual, version 3.0, or its successor issued by the Centers for Medicare and Medicaid Services. The commissioner of health may substitute successor manuals or question and answer documents published by the United States Department of Health and Human Services, Centers for Medicare and Medicaid Services, to replace or supplement the current version of the manual or document.
(b) The assessments required
under the Omnibus Budget Reconciliation Act of 1987 (OBRA) used to determine a
case mix reimbursement classification for reimbursement include:
(1) a new admission comprehensive assessment, which must have an assessment reference date (ARD) within 14 calendar days after admission, excluding readmissions;
(2) an annual comprehensive assessment, which must have an ARD within 92 days of a previous quarterly review assessment or a previous comprehensive assessment, which must occur at least once every 366 days;
(3) a significant change in status comprehensive assessment, which must have an ARD within 14 days after the facility determines, or should have determined, that there has been a significant change in the resident's physical or mental condition, whether an improvement or a decline, and regardless of the amount of time since the last comprehensive assessment or quarterly review assessment;
(4) a quarterly review assessment must have an ARD within 92 days of the ARD of the previous quarterly review assessment or a previous comprehensive assessment;
(5) any significant
correction to a prior comprehensive assessment, if the assessment being
corrected is the current one being used for RUG reimbursement
classification;
(6) any significant
correction to a prior quarterly review assessment, if the assessment being
corrected is the current one being used for RUG reimbursement
classification; and
(7) a required
significant change in status assessment when:
(i) all speech,
occupational, and physical therapies have ended. If the most recent OBRA comprehensive or
quarterly assessment completed does not result in a rehabilitation case mix
classification, then the significant change in status assessment is not
required. The ARD of this assessment
must be set on day eight after all therapy services have ended; and
(ii) isolation for an
infectious disease has ended. If
isolation was not coded on the most recent OBRA comprehensive or quarterly
assessment completed, then the significant change in status assessment is not
required. The ARD of this assessment
must be set on day 15 after isolation has ended; and
(8) (7) any
modifications to the most recent assessments under clauses (1) to (7) (6).
(c) The optional state
assessment must accompany all OBRA assessments.
The optional state assessment is also required to determine
reimbursement when:
(i) all speech,
occupational, and physical therapies have ended. If the most recent optional state assessment
completed does not result in a rehabilitation case mix reimbursement
classification, then the optional state assessment is not required. The ARD of this assessment must be set on day
eight after all therapy services have ended; and
(ii) isolation for an infectious disease h